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CALCITONIN 
HISTORICAL DEVELOPMEN~ 
CHAPTER I 
INTRODUCTION 
Calcium is among the best regulated ionic constituents of ex-
tracellular fluid in mammals. Many vital processes, including mus-
cular contraction, neuromuscular excitability, membrane permeability, 
blood clot formation, and the activity of a number of enzyme systems 
are critically dependent on the level of ionic calcium. At blood 
calcium levels below 4 to 5 mg/100 ml, some mammalian forms enter 
into tetanic convulsions, often resulting in death, while blood cal-
cium levels of 12 to 13 mg/100 ml in most mammals often results in 
cardiac disturbances and renal calcification which may also prove 
fatal. Therefore, the precise regulation of blood calcium concen-
tration within a narrow range is of vital importance in maintaining 
mineral haemostasis and hence normal physiological and metabolic 
function of all mammalian forms. 
The regulation of blood calcium level requires a~ internal. 
balance between calcium mobilization from the skeleton and calcium 
deposition in new and maturing bone. The latter process depends on 
the rate of ne\; bone deposition and on the concentrations of ionic 
Calcium and phosphate in blood. Diminished levels of either calcium 
or phosphate will interfere with this process resulting in rickets 
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or osteomalacia and defective mineral depositidn on bone matrix. 
The precise regulation of plasma calcium, especially in young mam-
mals, is dependent on the metabolic interaction of two hormones, 
parathyroid hormone (PTH) and calcitonin (CT), both of which influ-
ence calcium mobilization from bone, by as yet, undetermined mechan-
isms. 
The first calcium-regulating hormone to be discovered was the 
parathyroid hormone which is secreted by the parathyroid glands. 
In 1880, Sandstrom, a Swedish anatomist, presented a detailed des-
cription of these minute endocrine glands which have an intimate 
association with the thyroid glands of many mammalian species. How-
ever, he was unaware of their physiological role in maintaining 
mineral homeostasis of mammals. Gley (1891) was the first investi-
gator to recognize the physiological importance of the parathyroid 
glands, since their unintentional removal during tota.l thyroidectomy 
in dogs often resulted in tetanic convulsions and ultimate death of 
.the animals. However, their important role in calcium metabolism 
was determined by Maccallum and Voegtlin (1909), who demonstrated 
that parathyroidectomy resulted in a precipitous fall in plasma cal-
cium, associated with tetany and convulsions. These symptoms could 
be alleviated by calcium administration. Collip (1925) successfully 
prepared an acid extract of parathyroid tissue which proved to be 
biologically potent since it elevated plasma calcium levels in nor-
mal dogs and alleviated the hypocalcemia and tetany in parathyroid-
ectomized dogs. 
Rasmussen and Craig (1959) and Aurbach (1959), working indepen-
dently, announced almost simultaneously, the isolation of essentially 
-3-
PTH by phenol extraction of bovine parathyroid glands and coun-pure . 
tercurrent dis~ribution of the extracteJ material. Rasmussen and 
Craig, utilizing ultracentrifugation and dialysis, estimated that 
the molecular weight of their purified extract was on the order of 
7,000 ± 1,500. 
Niall~ al. (1970) determined the complete amino acid sequence 
of the bovine PTH molecule, consisting of 84·amino acids and having 
a molecular weight of 9,500. Studies by Potts ~ al. (1968) have 
established that the amino-terminal JO residues of the 84 amino 
acid molecule are an absolute requisite for full biological activi-
ty. This has recently been verified by Potts et al.(1971) who 
have synthesized biologically active fragments of bovine P'I'H com-
prising the J4 amino acid sequence from the amino terminus of the 
molecule. The synthetic J4 amino acid peptide exhibited all of the 
- specific properties of the native molecule which included stimula-
tion of adenyl cyclase in both bone and kidney cells, elevation of 
blood calcium in rats and dogs, and increased excretion of cyclic 
AMP and phosphate in rats. 
In contrast to the slow progression of parathyroid hormone re-
search, encompassing a 63 year period since Maccallum and Voegtlin 
(1909) elucidated the role of the parathyroid glands in calcium 
metabolism, the progression of calcitonin research has been extreme-
ly rapid since the proposal of Copp et al. (1961) of a hormone in-
volved in regulating the "tone" of calcium in body fluids. The 
series of experiments which led to the identification, isolation, 
structural analysis, synthesis and characterization of the physio-
logical role of calcitonin have all been successfully accomplished 
Within the last 11 years. 
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Prior to the discovery of calcitonin, the precision of calcium 
~omeostasis, the maintainence of blood calcium concentration in a 
narrow range, was thought to depend entirely on the parathyroid 
glands and the interaction of PTH with the calcium reservoir in the 
skeleton. McLean and Urist (1955) and McLean (1957) had proposed a 
simple negative feedback system in which a fall in plasma calcium 
prompted the parathyroid glands to secrete additional amounts of 
pTH, which consequently increased bone resorption and the release 
of calcium from the skeleton. McLean (1957) proposed that there was 
no positive means by which the organism could respond to hypercal-
·cemia, the only control being that of parathyroid hormone secretion. 
The first definitive study which clearly demonstrated the inadequacy 
of this concept was performed by Sanderson~ al. (1960). These 
investigators demonstrated that in thyroparathyroidectomized dogs 
there was an inability to adequately respond to either an acute 
calcium load or calcium deprivation. The hypocalcemia which resul-
ted could readily be attributed to removal of the parathyroid glands; 
however, the impaired recovery of these animals from the effects of 
calcium infusions could not be readily explained by the prevailing 
concept of calcium regulation. Sanderson et ~~· (1960) did not 
realize the import of these findings. It remained for Copp and co-
workers to evaluate the effects on systemic blood calQium of acute 
stimulation or suppression of parathyroid glandular activity. In a 
series of classic experiments, Copp and Davidson (1961) and Copp 
~ ~l. (1961, ~962) evaluated parathyro~d gland activity by noting 
the effects of acute calcium load or c~lcium deprivation on blood 
Calcium levels. Regional perfusion of the dog thyroid-parathyroid 
-5-
gland complex was performed by successive 2 hour perfusion periods 
with blood containing higher (+2 mg/100 ml) or lower (-2 mg/100 ml) 
calcium concentrations than normal levels. Hypocalcemic perfusion 
of the gland complex resulted in hypercalcemia through the action 
of increased PTH secretion, an anticipated result; however, the 
hypocalcemia which developed more rapidly after hypercalcemic per-
fusion of the isolated thyroid-parathyroid gland complex as com-
pared to the hypocalcemia which resulted after total thyroparathy-
roidectomy could not be accounted for by simple suppression of PTH 
secretion. Therefore, Copp and coworkers proposed the existence 
of a humoral factor which exerted a positive control on hypercal-
cemia. Copp and Henze (1964) proposed that the source of this 
hypocalcemic factor was the parathyroid glands, and that it be 
called calcitonin because it was exerting a positive role in regula-
ting the level or "tone" of calcium in plasma and extracellular 
fluids. 
Copp and coworkers' proposal of the existence of a hypocal-
cemic hormone which played a significant role in calcium homeosta-
sis proved to be correct; however, their proposal that calcitonin 
originated from the parathyroid gland proved to be incorrect. 
Hirsch, Gauthier, and Munson (1963) made a second and highly 
significant observation. These investigators noted that parathy-
roidectomy by the Erdheim cautery technique, which involves hot 
wire cauterization of adjacent thyroid tissue in the rat, resulted 
in a much more rapid and profound hypocalcemia than simple surgical 
Parathyroidectomy. Thus, the postulation by Hirsch et al. (1963), 
that the cautery procedure released into the circulation a potent 
hypocalcemic substance stored in the thyroid glands, proved to be 
-6-
correct. Hirsch~ al. (1964) were able to demonstrate that injec-
tion of as little as 0,1 mg of an acidic extract of rat thyroid 
gland into recipient intact rats prompted a marked hypocalcemia. 
Hirsch and coworkers assigned the name, thyrocalcitonin, to their 
thyroid extract in order to distinguish the gland of origin, al-
though their extract was possibly identical to the factor studied by 
Copp and his associates. Since their isolatfon of a hypocalcemic 
hormone from the thyroid glands, this hormone has been referred to 
by both names, calcitonin and thyrocalcitonin. However, the name, 
calcitonin, is gaining more acceptance since potent hypocalcemic 
extracts have recently been isolated from non-thyroid sources such 
as the ultimobranchial glands of both mammalian and non-mammalian 
forms thereby ruling out the thyroid gland as the exclusive source 
for this hormone. 
The first definitive experiments confirming the ability of the 
thyroid gland to protect against hypercalcemia and ruling out the 
parathyroid gland as an important factor were supplied by Talmage 
et al. (1964, 1965). These investigators used rats with functional 
parathyroid gland transplants, thereby allowing them to determine 
the effects of acute calcium load in thyroidectomized as well as 
parathyroidectomized animals. Talmage et al. (1965) determined 
that rats with intact thyroids could respond adequately to calcium 
load while thyroidectomized animals could not. Moreover, parathy-
roidectomy did not significantly alter this response. 
Foster et al. (1964) demonstrated that hypercalcemic perfu8ion 
of isolated external parathyroid glands of the goat which had all 
thyroid tissue removed did not result in any hypocalcemic effect. 
-7-
hypercalcemic perfusion of the thyroid lobe with its con-However, 
tained internal parathyroid resulted in a 15% decrease in systemic 
calcium indicating that· the thyroid was essential for a hypo-plasma 
caicemic effect. Confirmatory evidence for the release of a hypo-
calcemic factor from the thyroid glands in response to hypercalcemic 
perfusion was presented by Care (1965). Care examined serial sec-
tions of perfused pig thyroid tissue and demonstrated that it con-
tained no parathyroid tissue which could affect the response to 
hypercalcemic perfusion. 
CELL OF ORIGIN 
With the unequivocal demonstration by Care (1965) that the 
thyroid gland was the gland of origin of calcitonin, it was then 
possible to investigate the cell of origin of this hypoca.lce:r.'d.c 
hormone. Munson et al. (1966) presented evidence which ruled out 
-- . 
the possibility that calcitonin was synthesized and released from 
the thyroid follicular cells. These investigators demonstrated that 
thyroid-stimulating hormone (TSH), essential for thyroxine and tri-
iodothyronine production of the follicular cells, did not alter the 
calcitonin content of the thyroid glands. 
Attention was therefore focused on the "light0 , cell or para-
follicular cell, a cell type of the thyroid which previously had no 
function assigned to it. This cell type had been referred to as the 
"light" cell by Stux et al. (1961) because it stained poorly witu 
Periodic acid-Schiff reagent. These cells were examined by Nonidez 
in l9Jl. He described the cells in the thyroid glands of dogs as 
-8-
arising in the follicular epithelium, later migrating into the 
.interfollicular spaces, and remaining around the periphery of the 
follicle; hence, the term "parafollicular" cells. Nonidez noted 
the presence of argyrophile granules within these cells and pro-
posed that "the granules represented the antecedent of an endocrine 
secretion poured directly into the vessels." 
Wissig (1962) presented the first report of the electron mi-
croscopy of the parafollicular cells of the rat thyroid. He indi-
cated that. these cells had a high content of spherical vesicles 
which were contained within their cytoplasm. These subcellular 
structures measured between 1500 and 2000 ~ in diameter and some 
contained electron-dense material which appeared as discrete gran-
ules. Pearse (1966) demonstrated that these cells were primarily 
epifollicular (oriented towards blood vessels rather than the fol-
licular lumen) in pigs while in man these cells appear to be both 
epifollicular and parafollicular. He therefore referred to these 
·cells as "C" cells to indicate their possible role in calcitonin 
secretion. The name, "C" cell, avoided reference to the staining 
qualities of the cells and to their precise localization. For this 
reason, the new name, "C" cell, could be applied to all species and 
to organs and tissues other than the thyroid. 
There are three lines of experimental evidence' that, combined, 
conclusively identify the "C" cells as the source of calcitonin. 
First, these cells were sensitive to small changes in serum calcium 
levels. Foster et al. (1964) had demonstrated that the "C" cells 
responded to high calcium concentrations by discharging their elec-
tron dense vesicular content. Similarly, Matsuzawa and Kurosu~i 
-9-
(l96?) demonstrated that during hypercalcemic stimulation of the 
rat with calcium chloride, there was a decrease in secretory gran-
ule number reaching a minimum at 4 hours after injection. Secondly, 
an immunofluorescent-antibody technique developed by Bussolati and 
Pearse (1967) based on antiserum obtained from guinea pigs injected 
with highly purified porcine CT, indicated that CT in the pig thy-
roid was present in cells which were morphologically indistinguish-
able from the "C" cells. Thirdly, a preferential uptake of 5-hy-
droxytryptophan (5-HTP) by mouse thyroid "C" cells was described by 
Ritzen et al. (1965) while Larsen et al. (1966) noted that the bio-
genic amine precursor, L-dihydroxyphenylalanine (1-DOPA) was stored 
selectively by these cells. By utilizing specific staining tech-
niques, these compounds would exhibit their characteristic fluores-
cence in the "C" cells. Pearse and Carvalheiro (1967) took advan-
tage of this unexplained amine concentrating mechanism of the "C" 
cells to determine the embryological origin of these cells. Since 
both 1-DOPA and 5-HTP cross the placenta freely, these compounds 
were injected into pregnant mice and rats and the initial appearance 
of fluorescent "C" cells in the embryos was monitored. Pearse and 
Carvalheiro (1967) first noticed fluorescence on the 12th day in 
the fourth pharyngeal pouch and the ultimobranchial body of 14-day 
old rat embryos. The fluorescent "C" cells, compri~in~ the ultimo-
branchial body, finally fused with the thyroid gland and assumed 
their characteristic distribution within the thyroid. 
Final proc f of the ultimobranchiaJ. origin of CT was obtained 
by Copp, Cockcroft, and Kueh, in studies on the hypocalcemic effect 
of extracts of these glands in chickens and turkeys (Copp, Cockcroft, 
-10-
and Kueh. 1967a), and in dogfish shark (Copp, Cockroft, and Kueh, 
196?b), in amphibia {bullfrog) and reptiles (Copp and Parkes, 1968), 
and in fish (salmon) (O'Dor et al., 1969). In addition, Copp and 
coworkers demonstrated that CT was absent from the thyroids of birds 
which had potent ultimobranchial CT. In all of these species, the 
ultimobranchial gland was separate and distinct from the thyroid. 
Subsequent work with the isolation and characterization of the bio-
logically active material from the ultimobranchial glands of salmon 
(O'Dor et al., 1969b), has established that the ultimobranchial 
glands contain CT that has many similarities to mammalian CT. More-
over, the salmon hormone exhibited 25 times the biological activity 
of the most potent mammalian extracts. 
BIOLOGICAI, ASSAY AND RADIOIMMUNOASSAY 
Biological Ass~y 
Determination of the amino acid sequence and chemical synthe-
sis of CT necessitated the development of purification procedures 
leading to the isolation of the hormone in pure form. Hence, it 
was essential that a reliable biological assay for CT be developed 
in order to assess extent of purification at each stage of the iso-
lation procedure. The rat and the mouse proved to be ideal test 
animals for assaying the hypocalcemic activity of CT preparations 
(Hirsch et al., i964; Kumar et al., 1965). Most researchers 
today utilize the rat assay of Hirsch et al. (1964), or a modi-
fication of this method. The assay of Hirsch et al. (1964) was 
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based on the decline in plasma calcium 1 or 1~5 hours after intra-
venous or subcutaneous injection of rat thyroid extracts into lOJ to 
150 gram rats. 
In 1966, the Division of Biological Standards of the National 
Institute of Medical Research, Mill Hill, London, England, estab-
lished an international reference standard which was termed "Thyroid 
Calcitonin Research Standard A." This was a crude but stable acid 
extract of porcine thyroid glands prepared in accordance with the 
salt fractionation procedure of Baghdiantz et al. (1964). 
The Medical Research Council unit (MRC Unit) was defined as 
the calcium lowering activity contained in four ampoules (40 mg or 
10 mg/ampoule) which was equivalent to 250 µg protein/mg and 0.25 
MRC units per ampoule. Approximately 0.01 MRC unit of this material 
given intravenously in the biological assay procedure of Kumar et al. 
(1965), in which blood calcium is determined 50 minutes after injec-
tion of test solution in rats, produced a 10 percent fall in plasma 
calcium. In 1967, Research Standard A was superseded by Research 
Standard B, a more highly purified, but less stable preparation of 
porcine CT furnished by Dr. Robert Schleuter of Armour Pharmaceuti-
cal Company, Kankakee, Illinois to the Medical Research Council. 
This preparation was standardized against Research Standard A by 
international collaborative assays (Parsons and Reynolds, 1968) 
' -
that established the ratio of specific biological activity of A to 
B to be equal to 1 to 900. Standard B had a potency of 22 MRC 
units/mg. 
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~ioimrnunoassa.y 
Deftos et al. (1968) and Lee et al. (1969) developed a highly 
sensitive and specific radioimmunoassay for porcine CT whereby as 
little as 15 to 20 µµg of porcine hormone could be detected repro-
ducibly. Their studies with rabbits indicated that CT circulated 
in the blood of the normal animal, that secretion of the hormone 
increased 15-fold in response to induced hypercalcemia (CaC12 load), 
and that the disappearance of CT in the blood was rapid. The half-
life of secreted CT was estimated to be 5 to 15 minutes. Deftos 
and coworkers were also able to demonstrate CT in normal and malig-
nant human thyroid tissue. This meant that normal human CT, which 
could not be detected by biological assay except in patients with 
thyroid carcinoma, could now be detected routinely by the highly 
sensitive radioimmunoassay procedure. 
CHEMIST'RY 
Hirsch et ~1.· (1963) prepared the first potent extracts of cal-
citonin from rat thyroid glands~ The injection of extract from as 
little as one-third of a rat thyroid gland resulted in a marked 
hypocalcemia in recipient normal and thyroidectomized rats one hour 
after injection. However, Hirsch and coworkers se~ec~ed hog rather 
than rat thyroid extract for purification procedures due to the 
availability and abundance of material, even though the biological 
activity of ho~ CT preparations was less than rat CT extracts. ~lso, 
contamination with parathyroid tissue was not of concern since the 
Parathyroid glands of the ltog a.re embedded at sites remote from the 
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thyroid gland and in the thymus gland. Hirsch~~· (1964) accom-
d a ten-fold purification of the starting acid extracts of 
_plishe 
hog thyroids by centrifuging this material at 100,000 x g for 24 
hours. The supernatant was hypocalcemic in intact rats. A subse-
quent two-step purification procedure consisting of fractionation 
on Sephadex G-50, and Sephadex G-25 resulted in a total ·500-fold 
ification of calcitonin from the starting extract. 
An effective alternative method for partial purification of 
porcine CT, utilizing dried, defatted thyroid tissue which subse-
--f!ue.ntly underwent salt fractionation ( 2-J M NaCl) and gel fil tra-
tion on Sephadex G-100 columns was reported by Baghdiantz et al. 
(1964). 
Baghdiantz et al. (1964), Hirsch et al. (1964), and Tashjian 
and Warnock (1967) also demonstrated the peptide nature and the 
pur-
concomitant loss of biological activity of their relatively impure 
- CT preparations. These hypocalcemic preparations were readily in-
.activated by incubating them with a variety of proteolytic enzymes 
such as trypsin and pepsin. 
Further purification of porcine material was accomplished by 
Tenenhouse et ..§1.. (1965) who successfully applied a method for tre 
partial purification of bovine PTH. Hog thyroid glands were de-
hydrated and defatted by successive extractions with acetone and 
Chloroform. The resulting powder was treated with 8 M urea - 0.2 N 
HCl - O.l M cysteine at 4° C for one hour, followed by solvent and 
Salt fractionation, precipitation of tlbactive material with tri-
Chloroacetic acid (TCA), and recovery of this precipitate as a 
lyophilized powder. This TCA powder was passed through a column of 
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hadeX G-75 and yielded a preparation which Tenenhouse et al. sep 
(l965) considered to be homogeneous after fractionation by starch 
ge l electrophoresis. This hypocalcemic preparation was given the 
name, TA.~ peptide, since Tenenhouse, Arnaud, and Rassmussen (1965) 
devised the isolation procedure for its preparation. These inves-
tigators determined the molecular weight of the TAR peptide, which 
they presumed to be pure CT, to be 8700 on the basis of amino acid 
composition. Munson et al. (1966 and 1968) repeated the work of 
Tenenhouse et al. (1965) and demonstrated that more retarded eluates 
fro~ Sephadex columns yielded CT preparations having up to 10 times 
the biological activity of the TAR peptide. Munson and coworkers 
clearly demonstrated that the TAR peptide could be further frac-
tionated into 5 bands on highly sensitive analytical polyacrylamide 
gels thereby furnishing conclusive evidence that the TAR peptide was 
still a heterogeneous preparation. Potts et al. (1967) and Munson 
-- -
et al. (1968) utilized preparative polyacrylamide gel electrophore-
sis to obtain a porcine CT preparation which represented a 50,000-
fold purification of the starting acetone-chloroform dried extract. 
Potts et al. (1967) determined the molecular weight of their most 
purified porcine CT extract to be 4,ooo as calculated from their 
estimate of the amino acid composition. This value was in rather 
close agreement with the value of 5,000 to 6,000 as determined by 
' . 
the sucrose density centrifugation procedure of O'Riordan et al. 
(1966) and the Sephadex G-100 gel filtration experiments of Mcintyre 
tl fil_. (1965) in which a molecular weigtt of less than J,000 was 
assigned to their CT preparations. The first correct report of the 
amino acid composition of porcine CT was presented by Putter et al. 
(1967). 
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Based on the findings of Mcintyre~ al. (1965), O'Riordan 
t al. (1966) and Potts et al. (1967), all of whom had extracted 
~-
and isolated CT by different techniques, the molecular weight of 
the hormone was variously estimated at 3,000 to 6,ooo. Final proof 
of isolation of essentially pure CT necessitated the determination 
of the entire amino acid sequence, chemical synthesis of a peptide 
with the proposed structure, and demonst~ation that the synthetic 
peptide had the hypoc~lcemic activity of the isolated, naturally 
occurring CT. All of these extremely important projects were suc-
cessfully accomplished by a number of research groups in 1968. 
The complete amino acid sequence of pure porcine calcitonin 
was reported by Potts et al. (1968). It was determined through the 
use of sequential degradation by the phenylisothiocyanate procedure, 
digestion with exopeptidases, and isolation and analysis of peptide 
subfragments resulting from cleavage of the polypeptide by trypsin, 
pepsin, chymotrypsin, papain, cyanogen bromide, and limited hydroly-
sis in dilute acid and concentrated acid. Neher et al. (1968) 
simultaneously arrived at the identical amino acid sequence for por-
cine CT and Bell et al. (1968) arrived at the same sequence finding 
the weight-average molecular weight of porcine CT to be 3700, which 
was in excellent agreement with the value of 3604 as required by the 
amino acid sequence of the molecule. Distinctive structural fea-
tures of the 32 amino acid molecule are that the proportion of 
charged amino acids is low, the carboxyl-terminal amino acid is pro-
linamide, and ~here is a 1-7 intrachain disulfide bridge, providing 
a 2J-membered ring at the amino terminus. Brewer £1 al. (1968) 
demons~rated that pure porcine CT did not contain more than 0.02% 
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indicating the distinct difference between this molecule iodine, 
and the iodinated thyroid hormones. Ri·~tel et §.1_. ( 1968) and 
Guttmann .§! al. (1968) confirmed the sequence determination of por-
cine CT by chemical synthesis of a polypeptide which possessed the 
same specific biological activity as the isolated, naturally occur-
ring hormone. 
Utilizing gel filtration and ion-exchange chromatographic 
methods, Brewer et al. (1970) isolated bovine CT and determined its 
amino acid sequence while Potts et al. (1970), utilizing similar 
techniques, determined the amino acid composition of ovine CT. 
_Sauer et al. (1970) succeeded in determining the amino acid sequence 
of ovine CT which is depicted in Figure 1. The specific biological 
activity of the bovine and ovine calcitonin when compared to the 
porcine molecule was found to be closely similar, ranging from 50-
120 Medical Research Council Units/mg. The amino acid composition 
-of these three calci tonin differed by only a few residues. 
Neher et al. (1968) isolated and determined the complete amino 
acid sequence of human CT from extracts of a single medullary car-
cinoma of the thyroid. This tumor exhibited an overabundance of 
"C" cells when compared to normal human thyroid tissue. The human 
CT molecule also consisted of 32 amino acids; however, 18 of the J2 
amino acid residues differed from the corresponding_po~itions 
occupied in the porcine CT molecule. Riniker et al. (1968) pre-
sented evidence that human tumor CT existed in two forms. The 
first, termed CT "M", consisted of 32 amino acids, while the seccnd, 
CT "D", proved to be an antiparallel dimer of CT "M". The dimer 
could be converted into the monomer by treatment with base. Riniker 
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1 7 8 9 10 11 12 
CVS CVS VAL L EU SER ALA TVR 13 
TRP 14 2 SER LVS lS 
3ASN 
THR6 
SER 5 ASP 
LEU 
4 
LEU16 
ASN17 
ASN18 
TVR19 
HIS20 
ARO 21 
TVlt 22 
SER23 
GLV24 
MET25 
Gl V26 
PHE27 ~o GLV PRO GLU THR PRO C 
28 29 30 31 32 -.NH2 
OVINE CALCI TONIN 
Figure 1. The amino acid sequence of ovine calcitonin 
(Sauer et al. 1970). 
.. 
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Coworkers proposed that the dimer exhibited full biological and 
activity. However, no dimer of porcine1 bovine, or ovine CT has 
n identified. bee The concept of a biologically active dimer of 
an CT was revised when Mcintyre hum (1970) presented evidence which 
suggested the dimer was without activity until its gradual conver-
sion into an active monomer by incubation for one hour with bovine 
plasma albumin. 
Copp §..1 al. (1967) had demonstrated the ultimobranchial origin 
of CT in several submammalian vertebrate species and he and his 
ass~ciates (O'Dor et al., 1969) successfully isolated CT.in homo-
geneous form from salmon. These extracts were extremely potent in 
mammalian bioassay systems. Niall ~%1• (1969) achieved final pur-
ification of salmon ultimobranchial CT in quantities sufficient to 
permit sequential determination of the molecule by use of the Edman 
degradation method. The salmon molecule possesses, in common with 
other calcitonins, a 32-amino acid peptide chain terminating in 
-prolinamide and a 1-7 intrachain disulfide bridge. Keutmann et al. 
(1970) detected two chemically different forms of salmon CT termed 
CT I and II. The major isohormonal form, CT I, had the )2 amino 
acid sequence determined by Niall et al. (1969), while the minor 
component, CT II, exhibited similar biological potency to the major 
peptide having a specific activity in rabbit of 2409 lf~C units per 
mg as compared to 2700 MRC units for the major component, or 10 
times the potency of the most active mammalian preparations. 
The amino acid sequence of CT molecules from 5 different spe-
cies, (porcine, bovine, ovine, human, and salmon), is now known and 
is depicted in Figure 2. Each of the five calci tonin molecules con-
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PORCINE CALCITONIN 
s-----------------------s I I 
H N-CYS-SER-ASN-LEU-SF..R-THR-CYS-VAL-LEU-SER-ALA-TYR-TRY-ARG 14 
2 -r- 2 3 -r;- 5 --e;- 7 8 9 10 11 12 lJ ASN 15 
LEU 16 
~SN 17 
A~N 18 
O"-PRO-THR-GLU-PRO-GLY-PHE-GLY-MET-GLY-SER-PHE-ARG-HIS-PBE 19 
NH(°--s2 Jl JO 29 ~ 27 26 25 24 23 22 21 20 
BOVINE CALCITONIN 
s-----------------------s I I 
tt2N-CYS-SER-ASN-!&1l.-SER-THR-CYS-VAL-!&Q-SER-ALA-TYR-TRY-L;s 14 
ASP 15 
I LEU 16 
ASN 17 
I 
o ASN 18 
"PRO-THR-GLU-PRO-GLY-PHE-GLY-MET-GLY-SER-PHE-ARG-HIS-TYR 19 NH~""'J2 31 JO 29 ~ 27 26 25 24 23 22 21 20 
OVINE CALCITONIN 
s-----------------------s I I 
H N-CYS-SER-ASN-LEU-SER-THR-CYS-VAL-LEU-SER-ALA-TYR-TRY-LYS 14 
2 -r- 2 ~ ~ ~ --e;- -:r- 8 ~ 10 11 12 lJ ASP 15 
I 
LEU 16 
I 
ASN 17 
I 
O ASN 18 
"PRO-THR-GLU-PRO-GLY-PHE-GLY-MET-GLY-SER-TYR-ARG-HIS-TYR 19 NH~ 32 Jl JO 29 -ZS 27 26 25 24 23 22 21 20 
Figure 2. The complete amino acid sequence of porcine 
(Potts .£1 al. 1968), bovine (Brewer et al. 1970), ovine 
(Sauer et al. 1970), human (Neher et al. 1968), and salmon 
(Niall et al. 1969) calcitonin. 
2, continued Figure 
-
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HUMAN CALCITONIN 
s-----------------------s 
I I 
H N-CYS-GLY-,ASN-LEU-SER-THR-.Ql.§.-MET-LEU-GLY-THR-TYR-THR-GLN 14 
2 --r- 2 3 -i;- 5 ~ 7 8 9 10 11 12 13 ASP 15 
I 
PHE 16 
ASN 17 
• LYS 18 
___ O ......_PR 0-ALA-GLY-V AL-GLY-ILE-ALA-THR-GLN-PR 0-PHE-THR-HI S-PBE 19 NH~~ Jl JO 29 28 27 26 25 24 23 22 21 20 
SALMON CALCITONIN 
s-----------------------s 
I I 
H N-CYS-SER-ASN-LEU-SER-THR-CYS-VAL-LEU-GLY-LYS-LEU-SER-GLN 14 
2 -r- 2 ~ -i;- ~5~ ~ --rr- 8 ~ 10 11 12 13 GLU 15 
I 
LEU 16 
I 
HIS 17 
I 
o LYS 18 
.......... I /'"PRO-THR-GLY-SER-GLY-THR-ASN-THR-ARG-PRO-TYR-THR-GLN-LEU 19 
NH2 32 Jl JO 29 28 27 26 25 24 2J 22 21 20 
I 
I. 
I 
i 
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·sts of a J2 amino acid chain exhibiting a 1-7 amino terminal di-
s1 
sulfide bridge and a carboxyl terminal prolinamide. Only nine 
acids occupy identical sequence positions in the five calci--
arnino 
tonin molecules depicted in Figure 2. Seven of these nine occur in 
the amino terminal disulfide loop region occupying positions one, 
three, four, five, six, seven and nine. The carboxyl-terminal pro-
linamide at position J2 and the glycine, at position 28, are the 
two remaining constant positions. 
In the porcine, bovine, and ovine calcitonins, a marked simi-
larity in sequence occurs in the positions between 10 and 27; how-
_ever, a noticeable difference exists between these three calcitonins 
when compared to human and salmon calcitonin which also differ from 
each other considerably. Habener et al. (1971) have suggested the 
increased potency of the salmon CT as compared to porcine CT may be 
due to an increased resistance to metabolic destruction. These in-
---v-estigators were able to demonstrate that a progressive decrease in 
lmmunoassayable activity of porcine CT occurred after in vitro incu-
bation of the preparation in dog plasma while salmon CT remained 
completely stable. Salmon CT differs from porcine CT in 19 of J2 
residues, and in 11 positions it contains amino acids not found in 
any other CT. These structural differences might well be involved 
in a lesser inactivation of the molecule in the extravascular com-
partrnent, vascular bed, or one or more organs, and thereby result 
in greater stability of the salmon CT molecule. 
Sieber et al. (1969) evaluated the biological activity of a 
variety of synthetic peptide fragments of porcine CT. Their studies 
indica.ted that fragments of the molecule, the peptide sequence 1-9 
from the amino terwinal of the molecule, which includes the disulfide 
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or the peptide sequence l0-32, and a number of other peptide bridge, 
-yariants such as the residues 1-10 joirn'd to residues 20-32, ex-
hibited no or little biological activity. Deleting even one or two 
amino residues from the carboxyl-terminal end of the porcine mole-
cule while retaining the carboxyl terminal prolinamide, resulted in 
almost complete loss of biological activity. 
Fragments of many other peptide hormones exhibit full or par-
tial biological activity. For example, the peptide sequence, l 
through 29, of PTH exhibits full biological activity. However, the 
entire J2 amino acid chain together with the carboxyl terminal 
amide must remain intact or a dramatic decrease of hypocalcemic 
activity of the CT molecule occurs. 
Although small variations in the length of the CT molecule dras-
tically decrease biological activity, considerable amino acid sub-
stitution or modification within the 32 amino acid chain have little 
···influence on biological activity, as shown by Potts et .§1.. (1971). 
SITES AND MODE OF ACTION 
The principal, physiologically important action of calcitonin 
is the inhibition of bone resorption thereby producing its charac-
teristic hypocalcemic and hypophosphatemic effects. Considerable 
' . 
evidence has been presented which indicates that calcitonin inhibits 
PTH-induced bone resorption both in vi..YQ and in vi.:tf:Q.. 
The hypocalcemic effect of calci tonin is the primary attrib:1.te 
Which resulted in its discovery in rat thyroid glands by Hirsch et al. 
(1963); however, Kenny (1964) and Hirsch et al. (1964) soon discov-
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d that injections of porcin~ CT preparations into rats also re-ere 
suited in a significant hypophosphatemir. response. The decreases 
. plasraa calcium and phosphate usually occurred over the same time 
in 
interval and exhibited similar dose-response relationships. The 
hypophosphatemic effect of CT is now attributed to the primary ac-
tion of CT in inhibiting bone resorption since hypocalcemia induced 
by CT probably results in a compensatory increase in PTH secretion. 
The increased PTH levels would then lead to decre.ased reabsorption 
of phosphate by the kidney and hence a hypophosphatemic response. 
In vivo investigations relying on administration of radioactive 
·--
bone-seeking iostopes have been utilized to evaluate the mechanism 
of action of CT on bone. In order to interpret data from these 
types of experiments, one would have to accept the concept that there 
are both stable pools of calcium in bone, which are PTH-sensitive, 
and labile, or readily exchangeable, pools of bone calcium. Twenty-
-four hours after the administration of 45ca, the isotope is inter-
changed to a great extent with the labile pools of bone calcium. 
Consequently, the specific activity of the radioisotope in the blood 
declines rapidly in the first 24 hours since there is little reab-
sorption of 45ca during this time interval. However, two weeks after 
injection of 45ca, when all bone pools are labeled, alterations in 
PTH levels change the 45ca concentration in blood proportionately 
to changes in tot2l serum calcium, thereby resulting in no change in 
specific activity of serum calcium. Milhaud and Moukhtar (1966) 
injected a single tracer dose of 45ca (50 pCi) intravenously into 
rats two hours after the first of a series of injections of calci-
tonin which produced a low plasma calcium level for three days. The 
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in their study, were fasted and any calcium absorption from 
rats 
the gut was negligible. Their studies suggest.ed that the dilution 
of the radioactive calcium pool by unlabeled calcium could only be 
to bone catabolism since they found that following injection of due 
the hormone, there was the expected hypocalcemic response; however, 
the specific radioactivity in the blood remained constant. There-
fore, Milhaud and Moukhtar (1966) proposed that the action of CT 
was on the stable or slowly exchangeable pool of bone rather than 
the labile pool which would have exhibited a drastic decline in spe-
cific activity as well as the hypocalcemic response. 
Johnston and Deiss (1966) noted the effect of CT injections on 
the levels of radioactive calcium in rats whose bones were labeled 
with 45ca either three hours or two weeks before CT injection. CT 
produced a significant decrease in labeled as well as unlabeled cal-
cium (no change in specific activity) in serum of rats which had 
received 40 µCi of 45ca prior to hormone injection. However, in 
three-hour labeled rats (receiving 10 µCi) in which stable bone was 
not labeled, serum calcium also decreased but there was an increase 
in serum calcium specific activity. Their experiments indicated 
that CT causes inhibition of the metabolically active bone resorp-
tion. 
Klein et al. (1967) studied the effect of porc·ine. CT in rats 
by utilizing a peritoneal lavage technique which employs a calcium-
ana phosphate-free rinse. 45ca and 32p were administered to rats 
either three weeks or 18 hours before peritoneal lavage. The remov-
al of 45ca andJ2p administered 18 hours prior to peritoneal lavage 
of normal and parathyroidectomized rats was decreased by CT as was 
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t 
of total calcium and phosphate; however, CT decreased the re-
tha 
of the isotopes from bone to a greater degree in rats labeled 
1110val 
weeks prior to lavage. In concurrence with other investiga-
th!'ee 
their results indicated that the labile calcium in bone as tors, 
well as the stable calcium was affected by CT, but to a lesser de-
gree. o'Riordan and Aurbach (1968) presented evidence that CT 
caused no detectable change in the disappearance of radioactive cal-
cium from rats injected with 45ca 2.5 hours earlier although serum 
calcium levels fell precipitously and there was an interruption in 
the normal decline in specific activity. Their data implied that 
CT had inhibited further dilution of radioactive calcium in the cir-
culation with unlabeled calcium by blocking the mobilization of cal-
cium from bone. 
The most direct evidence indicating an effect of CT on bone 
in vivo was that presented by Macintyre ,fil al. ( 1967). These inves-
-- -tigators demonstrated that CT infusion caused a net retention (+5%) 
of calcium in the isolated perfused tibia of the cat. This reten-
tion was associated with a small increase in acidity of the out-
flowing venous blood, possibly indicative of the formation of a 
calcium phosphate salt with release of hydrogen ion. In other 
lnYiY.Q. experiments, the rate of urinary excretion of hydroxyproline, 
a major component of collagen and hence, of the bone matrix, has 
. . 
been utilized as an indicator of the rate of matrix breakdown~ and 
indirectly, of bona resorption. In line with this concept, Harris 
and Sjoerdsma ( 1966) demonstrated that prnH injection into rats wh2.ch 
had received isotopically labeled L-proline four to twelve weeks 
earlier, increased the urinary hydroxyproline output, indicating 
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t ruction of mature collagen. Martin et al. (1966) demonstrated des 
t infusion of 20 µg per hour of CT dramatically decreased the ex-tha 
tl·on of hydroxyproline in intact rats after a three hour period. ere 
Similarly, Rasr.1ussen et al. (1967) have demonstrated that CT, admin-
istered in conjunction with PTH, could inhibit the rise in urinary 
hydroxyproline in thyroparathyroidectomized rats. The effects of 
CT administration on extracellular levels (serum and lavage fluid) 
of hydroxyproline in rats were examined by Klein and Talmage (1968) 
following peritoneal lavage, parathyroidectomy, nephrectomy, and 
calcium-restricted diet. These investigators noted that CT markedly 
reduced hydroxyproline levels in all instances, being especially 
efficacious in reducing the total amounts of hydroxyproline and cal-
cium removal during an 8-hour lavage period with a calcium and phos-
phate free rinse. The foregoing in vivo experiments provided sub-
stantial evidence that CT administration resulted in inhibition of 
all phases of bone resorption. 
In vitro experiments have been of two kindsa those in which the 
effect of CT has been studied on cultured bone and those in 
which changes in an isolated, perfused limb have been investigated. 
Alipoulious et al. (1966) produced resorption in cultured calvariae 
from five day old mice by the daily addition of 0.5 units of PTH to 
the in vitro culture system over a seven day period. The PTH-in-
duced resorption of cultured bones had previously been well estab-
lished by Gaillard (1965). However, these inves~igators noted that 
CT added to tissue cultures of calvariae could counteract, in a dose-
related manner, the resorption of bone stimulated by daily PTH 
additions. Similarly, Friedman and Raisz (1965) and Friedman et al. 
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(l968) noted the effectiveness of CT in inhibiting PTH-induced bone 
resorption of radii and ulnae obtained from 19-day fetal rats whose 
mothers had been injected with 45ca on the 17th day of gestation. 
The inhibition of bone resorption was independent of the action of 
PTH since CT could also be shown to inhibit spontaneous resorption 
which occurred in control bone cultures in the absence of PTH. The 
inhibitory effect of CT on bone resorption could not be overcome by 
increased. PTH doses. However, the inhibition in tissue culture 
appeared to be of limited duration. Friedman et al. (1968) and 
Wener et al. (1972) demonstrated that after a period of J6 to 48 
hours of treatment with both PTH and CT, the cellular transformation 
and the elevated 45ca release, characteristic of PTH-induced bone 
resorption in tissue culture, reappeared despite the addition of 
fresh CT in maximal or supra-maximal doses. However, fresh addi-
tions of CT to culture media after several days without CT resulted 
once again in active inhibition of resorption. Wener and coworkers 
demonstrated that the initiation and magnitude of this "escape" 
phenomenon was proportional to the intensity of stimulation of bone 
resorption. Concentrations of PTH which produced submaximal stim-
ulation of bone resorption either delayed the onset of "escape" or 
resulted in uincomplete" escape. Further, these investigators 
showed that a 24 hour pre-incubation of bones with PTH could result 
in a prolonged resorptive response which they termed "induction." 
This inductive response occurred even though the_bones were washed 
and transferred to fresh media without PTH and with or without CT. 
Low concentrations of calcium or phosphate in the culture medium 
impaired "induction" and also impaired or delayed "escape." The 
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· of the "escape" and ''induction" phenomena are unknown, mechanisms 
t it is likely that both depend upon changes in nuclear trans-bu . 
cription which leads to an increase in the activity and number of 
r esorbing cells. Brand and Raisz (1972) carried out bone cul-bone 
ture studies which indicated that PTH stimulates the release of both 
previously incorporated 45ca from the mineral and JH-hydroxyproline 
from the matrix of fetal rat bone. Moreover, their studies suggest 
that mineral breakdown must precede matrix breakdown, since the 45ca 
label was lost earlier and at a more rapid rate than 3H-hydroxypro-
liDe. The addition of 2 or 3 mM phosphate to the incubation medium 
provided sustained inhibition of PTH-induced resorption of matrix as 
well as mineral. However, CT addition promp~ed inhibition of min-
eral resorption which was short-lived and which was not effective 
in preventing the release of 3H-hydroxyproline. These investigators 
proposed that the ineffectiveness of CT in blocking matrix resorp-
tion was attributable to the inability of the hormone to block re-
lease of collagenases into the culture medium after PTH exposure. 
Thus, Brand and Raisz proposed that CT has no direct effect on the 
activity or synthesis of PTH-induced collagenolytic enzymes, but 
was effective in blocking resorption of calcium from bone mineral. 
The preceding in vitro experiments indicate that bones under-
going PTH-induced resorption are more responsive t9 aqditions of CT. 
However, Munson et al. ( 1966) and Gudmundsson et .?J_. ( 1966) clearly 
indicated that CT does not act by direct inhibition of PTH, since 
its unique hypocalcemic response could be demonstrated in parathy-
roidectomized rats which remained normocalcemic by feeding of a 
high calcium diet. 
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in vitro bone culture experiments of Raisz and Niemann 
---
(l96?) and Reynolds and Dingle (1968) indicate that the effective-
ness of CT in inhibiting PTH-induoed bone resorption may be suf-
ficiently rapid to account for the hypocalcemic effect in vivo. 
Raisz and Nieman's in vitro culture system consisted of paired radii 
and ulnae from 19-day old rat fetuses which had been prelabeled with 
45ca on the seventeenth day of gestation. Their studies indicated 
that CT addition to the culture medium could effectively inhibit 
release of 45ca from PTH-stimulated bones within three hours. 
Reynolds and Dingle labeled calvariae of two day old mice with 45ca 
and removed the labeled calvariae for tissue culture six days after 
birth. The PTH-induced resorption of these calvariae could be sig-
nificantly suppressed by CT within JO minutes after the addition of 
the hormone. 
Nisbet and Nordin (1967), utilizing an in vitro bone culture 
system consisting of calvariae from 5-day old mice, demonstrated 
that these PTH-treated calvariae released more citrate while CT and 
PTH addition reduced the levels of citrate and of calcium in the 
medium. These investigators noted that the PTH induced inhibition 
of metabolism of 1, 5-14c-citrate was not affected by CT. It was 
possible that CT was exerting its inhibitory effect on citrate accu-
mulation in the medium by blocking a step in glucose metabolism 
before citrate. Even though this possibility existed, a popular 
concept of the primary action of PTH was thought to be that of in-
creasing the citrate concentration at the bone/blood interface and 
that a rise in citrate concentration was the initial event in PTH-
inctuced mobilization of calcium from bone. However, this concept 
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of th.e ·contrasting metabolic actions of PTH and CT when closely 
1·ned, was not tenable since Firsche~ et al. (1959) had demon-exam - -
~trated that a rise in citrate concentration in intact dogs after 
PTH-induced resorption was accompanied by a ·concomitant rise in 
lactate concentration. It is riow clear that changes in citrate and 
lactate do not precede mobilization of calcium from bone, but may 
well be secondary to changes in calcium concentration. 
Reynolds (1968) induced resorption of near term (19-day) mouse 
calvariae, grown in vitro, by using vitamin A (22 international units 
of retinol/ml of medium) and PTH. Vitamin A and PTH treatment for 
two days induced resorption of calvariae with the appearance of 
numerous multinucleated osteoclasts. Moreover, most recognizable 
osteocytes disappeared, and a transformation of osteoblasts into a 
fibroblastic form occurred when CT was added to the culture media 
with vitamin A or PTH; bone resorption was suppressed since, his-
tological sections showed a decline in the number of multinucle-
ated osteoclasts. However, CT did not prevent the PTH and vitamin 
A-induced loss of osteocytes, or the transformation of osteoblasts. 
These investigators therefore proposed that CT primarily inhibited 
in vitro resorption of calvariae by altering the number of multi-
nucleated osteoclasts. 
In contrast to the work of Reynolds (1968), th~ in vivo work 
of Belanger and Rasmussen (1968) demonstrated that CT inhibited 
bone resorption (PTH-induced bone resorption was thought to occur 
through a process termed ttosteocytic osteolysis" by Belanger in 
1965) in thyroparathyroidectomized rats infused with PTH and CT for 
l4 to 16 hours. These investigators noted changes in the cellular 
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cture of osteocytes and chemical changes in the matrix imme-
stru 
diatelY adjacent to the lacunae containing osteocytes within four 
r s of increased PTH activity or after long term treatment with hOU 
iow calcium diets, hypervitaminosis D, pregnancy, or parathyroid 
tumor. Histochemical studies revealed that osteocytes released 
alkaline phosphatase and lysosomal proteases. Similarly, there was 
a reduction in mineral and matrix content around the osteocyte as 
well as an increase in stainable mucopolysaccharide. The lacunae 
became enlarged with irregular borders, indicating increased resorp-
tive activity. However, CT-treated rats showed a reversal of some 
of these processes since there were fewer enlarged lacunae and the 
matrix was more dense. 
In further in vitro experiments with rat calvaria, Reynolds 
~al. (1968) demonstrat~d that vitamin A, in a manner similar to 
that of PTH, increased release of lysosomal enzymes. This release 
was not blocked by CT even though vitamin A-induced resorption (in-
creased multinucleated osteoclastic activity) was halted. These 
investigators proposed that CT acted by inhibiting the release of 
bone mineral from resorbing bone and preventing the breakdown of 
mature collag~n. However, the hormone was not thought to affect the 
turnover of other matrix components (hexosamine and hydroxyproline) 
from immature collagen of embryonic bones which are degraded by the 
release of PTH and vitamin A-induced lysosomal enzymes. 
On the other hand, there was abundant evidence based on tissue 
Culture studies of Gaillard and Goldhaber and peritoneal lavage ex-
Periments of Talmage and coworkers that implicated the osteoclast 
in mediation of PTH-induced bone resorption. Gaillard (1965) had 
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that administration of PTH to cultured mouse radii resulted 
.shown 
in decreased osteoblastic activity in bcne shafts and increased 
· bers of multinuclear osteoclasts in areas of active bone resorp-
num 
, -·· -··tion. Goldhaber (1965), utilizing the calvaria of 5-day old mice, 
demonstrated the appearance of numerous giant vacuolated osteoclasts 
(40_50 µ in diameter) which developed and accumulated in areas of 
rapid resorption 24 hours after PTH or vitamin D-treatment. 
The peritoneal lavage studies of Talmage (1967) and Park and 
Talmage (1968) confirmed the stimulation of osteoclast production 
following PTH-treatment. However, their experiments indicate that 
.-these effects on osteoclasts do not correlate in time or location 
with the rapid mobilization of calcium from bone due to PTH-treat-
ment since stimulation of osteoclast productio~ did not occur until 
six to eight hours after PTH administration. These investigators 
proposed that both mechanisms of bone resorption, osteocytic and 
osteoclastic, are physiologically important. Park and Talmage pro-
posed that osteocytic osteolysis may be the principal mechanism for 
rapid mobilization of calcium from bone in response to PTH-treat-
ment and the osteocytes are the bone cells which are responsive to 
CT-treatment. The act~on of PTH on osteocytes did not appear to 
require increased RNA synthesis as a prerequisite for hormone ac-
tion. These investigators propose that the osteoclqst _plays a prom-
inent role in the normal remodeling of bone and the chronic, or 
longer term effects of continued PTH-induced bone resorption. The 
Production of i~creased numbers of osteoclasts may proceed throush 
Changes in RNA synthesis in mesenchyme cells, the progenitors of 
0steoclasts. 
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Although the gastrointestinal tract has an important influence 
on the extent of absorption of dietary calcium, and to some extent, 
the levels of calcium excretion, it is not critical in mediating 
the hypocalcernic effect of CT. Aliapoulious et~· (1965) and 
Munson tl al. (1966) have clearly demonstrated that CT was effec-
tive in lowering blood calcium levels of rats even after removal 
of the entire gastrointestinal tract. Additional evidence point-
ing to the lack of CT involvement in modulating calcium absorption 
was presented by Robinson et al. (1968) who demonstrated that CT 
had no influence on calcium absorption from isolated gut loops of 
rats. The other organ system which is important in calcium metab-
olism, the kidney, was also shown by Munson~ al. (1966) and 
Gudmundsson et al. (1966) not to be essential in mediating the 
action of CT. These investigators showed that CT was effective in 
lowering blood calcium levels of rats when given immediately after 
nephrectomy, indicating the fall in plasma calcium was not due to 
increased renal excretion of calcium. 
MECHANISM OF ACTION 
Currently, there exists no convincing data suggesting an ex-
planation of the biochemical mode of action of CT in inhibiting 
PTH-induced bone resorption as mediated either by the osteocyte 
or the osteoclast bone cells in YiY.Q or in vitro. However, it has 
been clarified that the hormone's hypocalcemic effect is not depen-
dent upon direct inhibition of PTH. This view was well documented 
by the studies of Tashjian (1965) and Robinson et al. (1967) who 
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deID t ted that CT was fully active Ons ra in surgically parathyroidec-
tomized rats. It is unlikely that CT administration affects procein 
synthesis, or the formation of new RNA since the action of the hor~ 
mone is unaffected by prior administration of actinomycin D to rats 
as demonstrated by Tashjian (1965) and Gudmundsson et al. (1966). 
Tashjian's work indicated an unaltered hypocalcemic response in 
rats which had been injected with actinomycin D, J, 8, or 11 hours 
prior to CT administration. The hypocalcemic effect could be ob-
served at 8 to 12 hours after actinomycin D injection when endoge-
nous or exogenous PTH proved completely ineffective. Moreover, the 
action of CT is not dependent on vitamin D, since the hormone exerts 
its hypocalcemic and hypophosphatemic effect in vitamin D-deficient 
rats as shown by Morii and DeLuca (1967). 
Chase and Aurbach (1967 and 1968) and Chase et al. (1969) 
presented experimental evidence that suggested that cyclic J', 5'-
adenosine monophosphate (cyclic AMP) was a mediator in the mechanism 
of action of PTH on the kidney and bone in vitro, PTH stimulated 
adenyl cyclase, the enzyme which converts ATP to cyclic AMP, in rat 
renal cortex preparations within 15 seconds after in vi..1£2. hormone 
addition. In line with Chase and Aurbach's work, Wells and Lloyd 
(1967 and 1968) have advanced the hypothesis that CT exerts its 
characteristic hypocalcemic and hypophosphatemic effec~ by altering 
the activity of the enzyme, phosphodiesterase, which degrades cyclic 
AMP. Their hypothesis was based on indirect evidence derived from 
Utilizing the fharmacologic agents, imi~azole, isoproterenol, and 
theophylline. According to their hypothesis, agents which activate 
Phosphodiesterase should have a hypocalcemic action similar to that 
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of CT· Wells and Lloyd (1968) found that injection of imidazole, 
which stimulates phosphodiesterase activity, led to hypocalcemia in 
intact, parathyroidectomized or thyroparathyroidectomized rats, 
thereby mimicking the action of CT. On the other hand, administra-
tion of large doses of theophylline, (Wells and Lloyd, 1967) which 
was thought to act by diminishing the degradation of cyclic AMP, 
and isoproterenol (Wells and Lloyd, 1968) which enhances adenyl 
cyclase and consequently, cyclic AMP synthesis, should affect serum 
calcium levels in a similar fashion to PTH. These investigators 
found that the two agents were effective in blocking the hypocalce-
mic effect of exogenous or endogenous CT in intact and parathyroid-
ectomized rats. Based on these observations, Wells and Lloyd hy-
pothesized that the rate of mobilization of calcium from bone and, 
secondarily, the level of blood calcium, are related to variations 
·in the level of cyclic AMP within bone cells. The hypercalcemic 
effect of parathyroid hormone was thought to depend on its ability 
to elevate bone cell cyclic AMP by enhancing bone adenyl cyclase 
activity while the hypocalcemic effect of CT might be due to the 
ability of this agent to lower cyclic AMP levels by activating phos-
phodiesterase activity. 
Wells and Lloyd's hypothesis is no longer tenable, since Care 
~al. (1971) have demonstrated that a diacylated derivative of 
cyclic AMP, dibutyryl cyclic AMP, stimulated CT secretion in vivo 
in pigs, and that this stimulatory effect was shared by theophylline, 
a recognized inhibitor of endogenous degradation of cyclic AMP. In 
addition, Chase and Aurbach (1970) and Murad et al. (1970) found 
that porcine CT caused small increases (about two-fold) in concen-
-J6-
tration of cyclic AMP in bone and in kidney homogenates in vitro 
(Murad et al., 1970). These investigators demonstrated that there 
was little or no effect of dose, whereas PTH showed a log-dose re-
sponse in this system over a ten to twenty-fold range of cyclic AMP 
concentration. Moreover, Chase and Aurbach demonstrated that CT 
did not activate adenyl cyclase or affect phosphodiesterase levels 
in this tissue. Therefore, it would be difficult to conceive that 
the action of both PTH and CT, recognized as physiological antago-
nists, could be mediated through increased cyclic AMP concentrations 
in the same cell. The foregoing experimental observations tend to 
indicate that whatever the mechanism of action of CT on bone, it 
most likely does not occur at the level of cyclic AMP effects, but 
rather antagonizes the action of PTH by another, as yet, undetected 
subcellular mechanism. The observations of Wells and Lloyd could 
thus be explained simply as another example of the overall physio-
logical antagonism of PTH and CT in maintaining mineral homeostasis. 
Another set of biochemical observations in which CT has been 
implicated are the effects of PTH and CT in, respectively, inl\ibit-
ing and stimulating the activity of bone pyrophosphatase (P-Pase). 
Fleisch et al. {1966) have proposed that inorganic pyrophosphate 
(PPi), an anhydrodimer of orthophosphate, might be one of the physi-
ological regulators of calcification. These investigators proposed 
that calcium phosphate deposition can occur only after the destruc-
tion of pyrophosphate by pyrophosphatase {alkaline phosphatase), an 
enzyme present in large concentration in calcifying tissues. Fleisch 
ana coworkers demonstrated that addition of PPi inhibited the calci-
fication of chick femurs in tissue culture, an observation which 
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might be explained as a blockage of crystal growth centers by adsorp-
tion of PPi onco apatite crystals at the site of calcification. 
Their studies indicated that pyrophosphate-coated crystals dissolved 
more slowly. The physiological importance of this observation was 
uncertain; however, it is possible that CT might diminish PTH-in-
duced bone resorption through a mechanism of increasing ·the protec-
tive PPi layer. 
Orimo et al. (1971) demonstrated that CT caused a significant 
and rapid ~ncrease in alkaline phosphatase activity of rat tibia 
within 15 minutes after injection. The increased alkaline phospha-
tase level preceded the development of a significant hypocalcemia. 
PTH injection into thyroparathyroidectomized rats significantly de-
creased the alkaline phosphatase activity of tibia within six hours. 
These investigators have suggested that CT activates alkaline phos-
phatase which consequently degrades PPi and subsequently may facili-
tate bone mineralization or accretion. Bone resorption may occur 
.through PTH-induced activation of acid phosphatase. Their experi-
ments utilizing physiological concentrations of PTH and CT suggested 
that the various pyrophosphatases were directly involved in the mech-
anism of action of CT and PTH. 
Rasmussen and Tenenhouse (1967) and Tenenhouse and Rasmussen 
(1968) have utilized an in vitro system consisting -0f Ehrlich asci-
tes tumor cells. This would allow them to study a homogeneous cell 
population incubated in a chemically defined medium, which would be 
responsive to CT and PTH in an easily detectable fashion, and the 
hormonal response might be likened in some way to the in vi V....Q. action 
Of these two hormones. These investigators harvested the tumor cells 
-J8-
them with CT and PTH. The response was either re-
. and incubated 
45 
JD011a1 of Ca from dead, prelabeled mouse bone, or P-Pase activity. 
. -4 ++ . parathyroid hormone, in the presence of 10 M Ca , increased the 
45 elease of Ca from the bone, increased cyclic AMP concentration 
r -
in the tumor cells, and inhibited the activity of P-Pase which was 
released into the medium (Rasmussen and Tenenhouse, 1967). CT 
s~imulated pyrophosphatase activity in the absence of PTH and re-
-- -
moved the blocking effect of PTH on P-Pase. However, Tenenhouse 
and Rasmussen (1968) demonstrated that CT did not inhibit the PTH-
indµced increase in cyclic AMP within these cells. 
Although a number of interesting hypotheses explaining the bio-
chemical basis of action of both CT and PTH in regulating mineral 
homeostasis have been advanced in recent years, none have been suf-
ficiently well-documented to date, and this still remains an area 
of intensive research. 
CONTROL OF SECRETION 
As implied by the previously cited results of Copp et aJ.. 
(1962), Kumar et al. (1963), Foster et al. (1964), Talmage ~t al. 
(1965), and Care (1965), the rate of secretion of calcitonin is 
regulated by the calcium concentration of the blood.flowing through 
the thyroid gland, rising as the calcium level increases and falling 
as it decreases. 
Care et al. (1968) examined the relationship between CT secre-
tion rate and plasma calcium concentration in pigs in an endeavor 
to clarify the control mechanism of CT secretion as related to blood 
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calcium. Pig thyroid glands, which have no embedded parathyroid 
tissue, were surgically isolated and perfused with blood, the cal-
cium concentration of which varied between 5 to 11 mEq/l. The thy-
roid venous effluent from these perfused pig thyroids was assayed 
for.hypocalcemic activity and CT content by intravenous injection 
into 5 to 6 week old rats. These investigators demonstrated that 
there was a high correlation between plasma calcium concentration 
in the thyroid venous plasma and the rate of CT secretion since a 
linear rel~tionship existed between these two parameters over the 
range of 6-10 mEq Ca/l. It was determined that no significant change 
in CT secretion occurred over a 3-fold range of blood flow rates 
through the perfused thyroid, from which Care and coworkers con-
cluded that the CT released by the 'C' cell of the thyroid was dir-
ectly controlled by the ambient plasma calcium concentration and not 
by the rate, degree, or direction of calcium flux in the plasma. 
However, these investigators were unable to detect CT secretion at 
·normocalcemic levels, below 6 mEq/l, whic~ they attributed to the 
limitations of their bioassay technique rather than to the absence 
of CT in normocalcemic blood. The evidence of Care and coworkers 
supported a direct proportional control of plasma calcium. 
Klein and Talmage (1968) and Minkin and Talmage (1968) carried 
out a number of experiments in rats utilizing the peritoneal lavage 
technique which supported the concept that CT was continuously se-
creted throughout the normal range of plasma calcium levels (9 to 11 
mg/100 ml). In their studies, all the l'ats were parathyroidecto-
mized and half of these were thyroidectomized, and received 85sr 
and/or 45ca one or two weeks before experimental use. The lavage 
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edure utilizing a lavage fluid of 12 mg% calcium, allowed cal-proc 
. m transfer into the hypocalcemic rats and gradually raised the 
ClU . 
starting plasma calcium values of 7.0 mg% to the normocalcemic range 
of 10 mg%. Although only slight differences in both plasma calcium 
and total transfer of calcium out of lavage fluid were observed be-
tween the parathyroidectomized and thyroparathyroidectomized rats, 
a marked difference developed in the amount of radioisotope trans-
ferred to lavage fluid. Rats with functional thyroids transferred 
25% less radioactivity into lavage fluid than thyroparathyroidec-
· tomized rats. These investigators interpreted this to mean that CT 
secretion was prompted by calcium challenge (12 mgi; lavage fluid) 
and that CT was secreted and was effective in preventing removal of 
the stable pool c45ca and 85sr) of bone mineral, even at normal plas-
ma calcium levels. 
Although Care et al. (1968) had suggested that CT was secreted 
at normocalcemic ranges and the experimental evidence of Klein and 
Talmage (1968) and Minkin and Talmage (1968) allowed such an inter-
pretation, no direct experimental evidence was available which would 
indicate that CT was continuously secreted in the regulation of nor-
mal blood calcium concentrations. The subsequent development of the 
radioimmunoassay technique by Deftos et al. (1968) and Lee et .§1._. 
-(1969) made possible the confirmation that the hormone is secreted 
continuously under normal physiological concentrations of blood cal-
cium. Calcitonin concentration in rabbits was measured both in the 
Peripheral circulation and thyroid effluent blood by Deftos et al. 
(1968). The concentration of· CT found in thyroid effluent blood in 
unstimulated rabbits was 10 mµg/ml while that in the peripheral cir-
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cuiation was 0.14 mµg/ml. These investigators detected rapid 
changes in CT concentration following hypercalcemic challenge. 
peripheral blood concentratipns of the hormone were elevated three 
to fifteen-fold shortly after infusion~ of calcium chloride. How-
ever, no CT was detected in the blood of thyroidectomized rabbits, 
before, during, or after the calcium challenge. Recent studies by 
cooper et al. (1971) utilizing a radioimmunoassay for porcine CT 
clearly demonstrated that there was a rapid response in CT secre-
tion rate, when hypercalcemia was induced by calcium chloride in-
fusion. Hormone concentrations rose dramatically from basal lev-
els of 10-20 mµg/ml in thyroid venous effluent plasma to as much 
as 2000-3000 mpg/ml when blood calcium was elevated to 15 mg/100 
ml. When hypercalcemia was eliminated by administration of EDTA, 
a rapid decline of CT occurred in thyroid venous blood and hormone 
was essentially undetectable as calcium fell ·to 8 mg/lOOml. 
Radde et al. (1970) carried out experiments to determine if 
varying concentrations of divalent cations (Ca++ and Mg++) would 
stimulate the release of CT from fresh pig thyroid slices in a Krebs-
Ringer bicarbonate buffer incubation medium. These investigators 
demonstrated that the levels of CT in the incubation media rose with 
increasing calcium levels in the media. A 20 to 25% increase in 
calcium concentration was necessary to produce enhanced CT release 
into the incubation media indicating that the effect of calcium ion 
was direct. Increasing magnesium concentrations also stimulated in-
creased CT release, but this did not occur until magnesium levels 
had been raised to double the normal value (to 3.0 meq/l), a situa-
tion which probably never occurs under normal circumstances; more-
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0yer, by measuring the residual biological activity in incubated 
thyroid slices, these investigators confirmed that increasing cal-
cium concentrations increased both synthesis and release of CT. 
Gittes et al. (1968) assayed thyroid glands of rats, subjected 
to either prolonged hypocalcemia or hypercalcemia for CT content 
and demonstrated that levels of CT within the glands were consis-
tent with the experimentally achieved levels of blood calcium. 
systemic hypercalcemia induced in intact rats by intraperitoneal in-
jections of calcium chloride reduced the CT content of the thyroid 
glands to 35% of the content in normocalcemic controls as early as 
two hours after the onset of hypercalcemia. However, recovery to 
normal CT levels in the gland occurred within sixteen hours after 
cessation of a two hour hypercalcemia. In parathyroidectomized rats 
fed a normal diet, a chronic hypocalcemia occurred with concomitant 
12-fold accumulation of CT over normal levels within 14 weeks. Rats 
which received parathyroid homografts returned to normocalcemic 
ranges, although the CT content of the glands was not markedly re-
duced. Gittes and coworkers concluded that systemic hypercalcemia 
was the stimulus for rapid release of CT; however, the rate of CT 
biosynthesis was not sufficiently increased to maintain an elevated 
rate of secretion. During chronic hypocalcemia, minimal amounts of 
stored CT are secreted, although hormone biosynthesis re~ains un-
altered and consequently more CT was stored in the glands. 
The studies of Deftos et al. ( 1968), -Lee et al. ( 1969), and 
Cooper et al. (1971) confirmed the observations of Care et al. (1968) 
-- --
that the rate of CT secretion was directly related to the degree of 
hypercalcemia. Moreover, these studies demonstrated that CT was 
-4 J-
t inuously secreted and that the rate of hormone secretion was con 
under ~irectly proportional control of blood calcium even in the 
normocalcemic range. 
It is currently well-established that blood calcium concentra-
tion is under reciprocal control of PTH and CT. Hypercalcemia stim-
ulates CT secretion and inhibits PTH secretion; this change leads 
to a reduction in the rate of bone resorption and a consequent de-
cline in blood calcium concentration. Conversely, hypocalcemia in-
hibits CT secretion and stimulates PTH secretion; the resultant in-
crease in bone resorption provides sufficient calcium from skeletal 
mineral deposits to restore blood calcium concentration toward nor-
mal levels. 
METABOLISM AND DURATION OF ACTION 
Scant information exists concerning the metabolic fate of cal-
ci tonin. Deftos et al. (1968) injected a rabbit with a potent ex-
tract of porcine CT (90 MRC units) and monitored the disappearance 
of the hormone from the peripheral circulation utilizing their ra-
dioimmunoassay technique. Although CT concentrations were as high 
as 500 mU/ml ten minutes after hormone injection, the levels dropped 
precipitously to o.6 mU/ml after one hour. On the basis of this 
observation and from the decline of endogenous CT which occurred in 
rabbits after the cessation of calcium chloride infusion, these in-
Vestigators proposed that the circulating half-life of the hormone 
Was approximately 10 to JO minutes. Foster et al. (1972) demon-
strated that the rate of clearance of CT from blood was extremely 
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rapid. These investigators have established by use of radio-
immunoassay that human CT injected into dogs disappeared rapidly 
having an initial half-life of three minutes which was followed by 
a second, more prolonged half-life of 40 minutes. Injectior:2 into 
dogs of calcitonin labeled with lJlI demonstrated that the hormone 
was mainly concentrated by the liver and kidney. Although both of 
these organs concentrated radioiodinated human CT, Foster and co-
workers demonstrated that nephrectomized dogs exhibited higher 
levels of circulating hormone and that the initial disappeara.nce of 
the hormone was prolonged. Similarly, arterio-venous differences 
across the dog kidney following infusion of human CT indicat?d that 
nearly one-third of the infused hormone was removed whereas only 
minor amounts were removed following liver infusion. Although these 
studies indicated that the circulating half-life of CT was of short 
duration (J to JO minutes) and that the kidney played a role in hor-
mone degradations, no studies have been carried out or hypotheses 
advanced which endeavor to explain the rather long duration of the 
hormone's hypocalcemic effect. 
ROLE IN CLINICAL DISORDERS OF CALCIUM METABOLISM 
Since it has been thoroughly established that calcitonin in-
hibits bone resorption both in vitro and in vivo and thereby lowers 
blood calcium concentrations, the hormone might be efficacious in 
the treatment of both hypercalcemic conditions and diseases involv-
ing increased bone resorption. 
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A number of experimenters have successfully lowered blood cal-
cium levels with CT in hypercalcemic patients. Foster et al. (1966) 
were the first investigators to utilize porcine CT as a therapeutic 
agent in the treatment of three patients with hypercalcemia as a 
result of metastic carcinoma of bone. Calcitonin injection at a 
dose level of 1 to 22 MRC units, resulted in a marked reduction in 
serum calcium levels for periods up to 18 hours, although serum 
calcium values never quite reached normal levels. Haas and 
nambacher (1968) observed remissions of hypercalcemia in 12 patients 
with hyperparathyroidism which were injected with porcine calcitonin. 
Milhaud (1968) demonstrated that children with hypercalcemia result-
ing from hypersensitivity to vitamin D or vitamin D intoxification 
responded well to injections of O.l MRC units calcitonin by an en-
hanced and prolonged hypocalcemia which was manifested one hour 
after hormone injection. 
The syndromes, hypervitaminosis D, hyperparathyroidism, and 
metastic carcinoma of bone, all involve extensive resorption of bone 
and.should therefore prove amenable to the therapeutic use of cal-
citonin. 
A number of investigators have also attempted to investigate 
the effects of CT injection in preventing bone resorption in several 
types of experimentally-induced osteoporosis. Foster et al. (1968) 
Produced experimental osteoporosis in rats by subcutaneous injec-
tions of 2500 international units of vitamin A three times a week. 
It was found that 100 mU of CT administered over a four-week period 
not only prevented vitamin A-induced resorption, but also retarded 
some of the general systemic effects produced by vitamin A. Experi-
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t al conditions similar to osteoporosis were produced in rats by 111en 
pujita £.! .01.• (1968) ty feeding the animals low calcium diets and 
b treatment with corticosteroids. Tibia of rats treated with the y .. 
corticosteroid, prednisolone, were decreased in thickness and were 
less resistant to bending stress than control rats or animals which 
bad r~ceived CT injections concurrent with corticosteroid treatment 
and low calcium diet. However, the possibility that CT might prove 
to be effective in treating human osteoporosis, especially the post-
menopausal variety, remains uncertain. 
Considerable therapeutic success has been achieved in patients 
with generalized Paget's disease. This is a syndrome which is char-
acterized by a rapid rate of bone turnover without hypercalcemia, 
increased urinary hydroxyproline excretion, and elevated serum alka-
line phosphatase. Bijvoet et ~l. (1968) noted a marked decline in 
plasma calcium, phosphate, and hydroxyproline of patients with gen-
eralized Paget's disease subsequent to injections of small doses of 
porcine CT. It was likely that CT administration was efficacious 
in retarding the rate of bone turnover. 
' PHYSIOLOGICAL ROLE 
Despite all that has been learned about calcitonin. since its 
postulated existence by Copp et al. (1962), and discovery in the 
thyroid by Hirsch et ~l. (1963), its physiological role in the main-
tenance of vertebrate mineral homeostasis remains uncertain. In 
response to an adequate stimulus, PTH-induced hypercalcemia, CT is 
secreted by the thyroid gland into the general circulation where 
the hormone markedly retards bone resorption as evidenced by the 
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rapid decline in blood calcium levels. However, calcitonin may also 
plaY a key role in combatting hypercalcemia of dietary origin, al-
though it is well known that starvation or calcium deficiency are 
Jl'lore Commonplace, natural occurrences than calcium excess. 
Cooper ~1 al. (1970) showed that endogenous CT could adequately 
protect rats against a hypercalcemic challenge which did not evoke 
a detectable rise in blood calcium in animals with intact thyroid 
glands. This was demonstrated by injecting sufficient PTH to ele-
vate the serum calcium levels of thyroparathyroidectomized rats 
about J mg/100 ml whereas sham-operated rats which had been given 
identical doses of PTH exhibited normal blood calcium ranges. How-
~ver, thyroidectomizing half of the sham-operated rats within three 
hours after PTH administration prompted a persistent hypercalcemia 
which was no longer opposed by the action of endogenous CT. Munson 
and Grey (1970) demonstrated that thyroidectomized and thyroparathy-
roidectomized rats became transiently hypercalcemic (60 to 90 min-
utes) after a gavage of 10 mg of calcium chloride whereas sham-oper-
ated rats exhibited unaltered blood calcium concentrations. More-
over, these investigators noted that feeding as little as three mg 
of calcium chloride by stomach tube markedly increased serum calcium 
levels after thyroidectomy. In an attempt to simulate natural con-
ditions, fasted thyroidectomized rats were permitted to eat food 
containing a normal concentration of calcium (1%) over a 90-minute 
Period, and it was demonstrated that very similar results occurred. 
These observations of Munson and Grey provided the first direct phys-
iological data which indicated that CT was functioning at normo-
calcemic ranges to protect rats against hypercalcemia. Thyroidec-
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tomized (calcitonin deficient) rats were unable to cope with hyper-
caicemia of naturally occurring dietary origin, this deficiency state 
being directly attributable to the loss of this hypocalcemic hormone. 
However, it was possible that the importance of CT in combatting 
hypercalcemia may be confined to the actual time of food consumption 
or immediately thereafter. 
In order to fully substantiate the concept that CT is a hormone 
which exerts a tonic effect at normal blood calcium concentrations, 
it would be necessary to demonstrate spontaneous hypercalcemia in 
thyroidectomized animals since parathyroidectomy has been shown to 
result in spontaneous hypocalcemia. However, such an effect has not 
yet been demonstrated, and no initial hypercalcemic signal which 
would stimulate calcitonin release has been detected. However, 
Cooper and coworkers (1970) carried out an experiment which provided 
direct evidence that such a signal actually occurred. These inves-
tigators demonstrated that elevation in serum calcium of sham-oper-
ated rats could not be detected three hours after injection of 85 
units of PTH; although, at this time interval, thyroidectomized rats 
which had received an identical dose of PTH were markedly hyper-
calcemic. Moreover, thyroidectomy of sham-operated (PTH-treated) 
rats three hours after PTH injection, while they were still normo-
calcemic resulted in elevation of serum calcium similar to rats 
Which had been thyroidectomized at time zero. These results were 
further indirect proof that the presence of the thyroid gland 
(endogenous CT secretion) had prevented a rise over the first three 
hours in serum calcium due to PTH injection. 
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some experimental evidence exists that indicates CT may also 
influence the rate of mineral accretion. Foster ~ ..§1.. (1966) 
demonstrated that CT increased the metaphyseal area of trabecular 
bone in vertebra of growing rats and diminished the number of osteo-
clasts. Since the metaphyseal area of all bones exhibit rapid turn-
over rat~s, these investigators proposed that this is the area of 
bone which may serve as a ready source of calcium. Therefore, CT 
may prevent cortical mineral loss during periods of calcium defic-
iency by augmenting metaphyseal bone reserve. 
Although the action of CT does not depend on the presence of 
the kidney, Bijvoet et al. (1971) have presented evidence that in-
fusions of synthetic human CT into humans resulted in a transient 
increase in the urinary excretion of sodium. This was attributed 
to a decrease of fractional reabsorptiqn from the proximal kidney 
tubules. These investigators suggest that CT.in physiological con-
centrations exerts a natriuretic effect sufficient to influence 
volume homeostasis (decreases expanded extracellular volumes) in 
man, an effect that endogenous CT may also bring about. 
Investigations attempting to determine the exact physiological 
role of CT are still being actively pursued. However, evidence is 
accumulating that suggests calcitonin is continuously being secreted 
and exerting a tonic or fine control in maintaining normal blood 
calcium levels in healthy animals and keeping PTH-induced bone re-
sorption at minimal levels. ·It is likely that CT has a more signi-
ficant role in vertebrate mineral homeostasis in young, rapidly 
growing animals, during pregnancy, lactation, bone-healing processes, 
and periods of starvation or limited calcium intake. 
STATEMENT OF THE PROBLEM 
----
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A number of in vitro biosynthetic studies, some of which ~ave 
employed subcellular fractionation procedures, have provided "/8.l-
uable infor~ation about the physiological role of a number of hor-
mones. 
Brown and Ulvedal (1960) prepared subcellular fractions from 
the anterior pituitary lobe of pigs by differential ultracentrifuga-
tion. The hormones of the anterior pituitary were shown by these 
investigators to be present in separate subcellular fractions; LH 
and STH, in the secretory granules; TSH, in the mitochondria; and 
ACTH, in the microsomes and supernatant; and FSH, in several frac-
tions. Similarly, Hamilton and Cohn (1969) were able to demor~strate 
hypercalc.emic activity in the 100, 000 x g particulate fractio:r; from 
bovine parathyroid tissue. Fractions obtained by differential cen-
trifugation of pig thyroid homogenates (Bauer and Teitelbaum, 1966) 
and rat thyroid homogenates (Cooper and Tashjian, 1966) were assayed 
for the hypocalcemic activity of calcitonin. Most of the recovered 
activity appeared in 100,000 x g particulate fraction which also 
contained numerous secretory granules when examined by electron mi-
croscopy. 
An insight into the mechanism of in vivo synthesis and release 
of a number of hormones has been achieved by utilizing in vitL.Q. bio-
synthetic media containing either slices or homogenates of e~~ocrine 
glands and monitoring biosynthesis and release of the hormones by 
biological assay. Takabatake and Sachs (1964) accomplished i;1 vitro 
biosynthesis of vasopressin in hypothalamic tissue, and Adiga et al. 
(1965), using various labeled amino acids, demonstrated the i~ vitro 
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biosynthesis of ACTH in anterior pituitary tissue. Studies of 
aamilton and Cohn (1969) and Hamilton~ ..§:1• (1971) demonstrated 
1the in vitro incorporation o~ several labeled amino acids into para-
thyroid hormone isolated from bovine parathyroid glands. Incorpor-
ation of the tracer amino acids was found to vary inversely with the 
concentration of calcium in the medium suggesting that the tissue 
retained the physiological regulatory mechanism which is character-
istic of the function of the gland in .YJ.vo. When the concentration 
of calcium was lowered, there was an increase in radioactive PTH 
isolated from the tissue and the incubation medium. The identity of 
the newly synthesized radioactive species with PTH was established 
by chromatography, polyacrylamide gel electrophoresis, and rat bio-
assay. Sorgente (1969) utilized an in vitro biosynthetic medium 
containing sheep thyroid slices to establish the role of varying 
calcium and magnesium ion concentrations on the synthesis and re-
lease of calcitonin. The incorporation of glycine-C-14 into ovine 
calcitonin was directly related to the calcium concentration of the 
incubation medium. High calcium concentration stimulated both syn-
thesis and release of calcitonin while varying the magnesium con-
centration was without effect in the calcitonin regulatory mechanism. 
The experimental work to be reported in this investigation 
concerns a study of the hypocalcemic activity of cytoplasmic par-
ticulate fractions obtained from ovine thyroid glands in an effort 
to determine more precisely its localization and to define the role 
of calcium ion on its biosynthesis. Such a study will be useful in 
the further analysis of factors affecting the biosynthesis and secre-
tion of this hypocalcemic hormone. A differential centrifugation 
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procedure will be utilized to obtain mitochondrial, nuclear, and 
microsomal subcellular fractions from the thyroid slices. These 
slices have been incubated i~ vitro in a biosynthetic medium con-
taininr, glycine-C-14. The subcellular fractions will be assayed 
for hypocalcemic activity in rats and the influence of low, phys-
iological, and high calcium concentrations on the biosynthesis of 
the hormone in theseihree fractions will be determined. Standard 
and subcellular calcitonin preparations will be fractionated into 
their protein components by polyacrylamide gel electrophoresis. 
This will be done to establish the identity of the hypocalcemic 
subcellular fraction with calcitonin preparations of known potency 
and to determine the homogeneity of these preparations at each 
stage of hormone purification. An isoelectric focusing procedure 
will be utilized to determine the isoelectric point of subcellular 
and standard calcitonin preparations, thereby providing a physical 
constant which may serve to further characterize this hormone. 
Moreover, the highly sensitive resolving power of this technique 
will be employed to obtain milligram quantities of purified sub-
cellular preparations exhibiting hypocalcemic activity. 
CHAPTER II 
MATERIALS AND METHODS 
GENERAL EXPERIMENTAL PROCEDURE 
-
The first part of this investigation consisted of determining 
the hypocalcemic activity of particulate fractions of ovine thyroid 
glands and the influence of low, physiological and high calcium con-
centrations on the biosynthesis of the hormone in mitochondrial, 
nuclear, and microsomal subcellular fractions obtained from sheep 
thyroid slices utilizing the in yij;ro biosynthetic medium, described 
by Sorgente (1969). Sheep thyroid glands were obtained fresh from 
the slaughter-house 10 to 20 minutes after the animals were killed. 
The glands with all adhering tissue were placed in ice-cold Krebs-
Ringer bicarbonate buffer (pH 7.4) containing glucose (320 mg/100 ml) 
and all the amino acids of calcitonin (20 mg/liter) with the excep-
tion of the tracer amino acid, glycine-C-14 (UL), which was added 
during the incubation period. The glands were brought to the labor-
atory and dissected free from fat, connective tissue, and possible 
contaminating parathyroid tissue. Thyroid slices ranging in thick-
ness from 0.5 to 1.0 mm were prepared with a Stadie-Riggs tissue 
slicer. Two grams of slices were transferred to each of a series of 
50 ml Erlenmeyer flasks containing 10 ml of the Krebs-Ringer bicar-
bonate buffer. To each flask, 2.5 µCi of the tracer amino acid, gly-
cine-C-14 (UL) (International Chemical and Nuclear Corp., Irvine, Calif., I 
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s.A• 80 me/mm), was added, gland slices were incubated for 4 hrs at 
7o c in biosynthetic media containing low calcium (4.8 mg/100 ml), J . 
physiological calcium (11.5 mg/100 ml), and high calcium (26.o mg 
/lOO ml) concentrations. The incubation period was terminated by 
placing the Erlenmeyer flasks containing the gland slices into an 
ice bath after which the gland slices were minced and thoroughly 
homogenized. 
A standard procedure of differential centrifugation was then 
utilized to obtain mitochondrial, nuclear, and microsomal subcellu-
1ar fractions from thyroid slices obtained from the incubation media 
containing low, physiological, and high concentrations of calcium. 
The subcellular preparations were inspected for homogeneity by phase 
contrast and electron microscopy. In some instances, the three 
lyophilized fractions were assayed for hypocalcemic activity in rats 
without further purification. However, in the majority of experi-
ments, the lyophilized mitochondrial, nuclear, and microsomal pre-
parations were further purified by passage through a column of 
Sephadex G-100 before assaying for biological activity. The sub-
cellular fractions were then assayed for hypocalcemic activity in 
lJO to 160 gm male Holtzman rats which had been fasted for 18 hours. 
Radioactivity and protein content of mitochondrial, nuclear, 
and microsomal preparations were determined at each stage of the 
purification. The hypocalcemic activity of a particular fraction 
was estimated by determining spectrophotometrically the change in 
serum calcium level before, and 50 minutes after, the injection of 
aliquots of each of the subcellular fractions into rats. Radioacti-
vity was measured by the use of a Beckman LS 250 Liquid Scintilla-
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tion Spectrometer and total protein was determined by a modification 
f the Lowry method. The difference between the hypocalcemic ac-
o . 
tiYitY of subcellular fractions obtained from media containing high 
and 1ow calcium concentrations and fractions obtained from the me-
dium containing a physiological calcium concentration was used as 
an index of calcitonin biosynthesis. 
In the second part of this investigation, the microsomal frac-
tion which had consistently demonstrated hypocalcemic activity was 
-~ssayed for homogeneity by polyacrylamide gel electrophoresis. 
Microsomal calcitonin preparations were inspected for homogeneity 
in polyacrylamide gels after passage through Sephadex G-100 and G-50 
.~olumns. A standard calcitonin preparation of known potency was 
electrophoretically fractionated along with the microsomal prepara-
tions to establish the identity of the microsomal preparation. The 
standard calcitonin preparation had a potency of 88 Medical Research 
.C2uncil Units and was fractionated along with the microsomal frac-
tion into their component protein bands in anionic polyacrylamide 
gels under identical conditions of milliamperage per gel column 
(2.5 ma), electrophoretic separation time (1 hour and 20 minutes), 
and gel concentration (7.5%). 
Finally, an isoelectric focusing procedure utilizing an LKB 
·8100 Electrofocusing Column (LKB Instruments, Inc., Rockville, 
Maryland) was employed to characterize microsomal calcitonin prepa-
rations, by determining their isoelectric points. The highly sensi-
tive resolving power of· this technique which is based on the ampho-
~eric nature of protein molecules was employed to obtain milligram 
quantities of the component protein bands of microsomal subcellular 
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preparations. The resolved protein bands were then assayed for 
radioactivity and hypocalcemic activity utilizing a rat bioassay. 
All chemicals utilized in this investigation were of analyti-
cal reagent grade. 
PREPARATION OF INCUBATION MEDIA 
Krebs-Ringer bicarbonate buffer with modifications of the 
calcium ion concentration served as the incubation medium for 
ovine thyroid slices. The composition of Krebs-Ringer bicarbonate 
buffer at a physiological calcium ion concentration (11.5 mg ca++) 
/100 ml) is represented below: 
100 part(s) 0.90% (0.154 M) NaCl solution (0.1180 M)* 
4 " 1.15 " KCl " (0.0047 M)* 
3 " 1.22 (0.110 M) CaC12 If (0.0025 M)* 
1 " 2.11 (0.154 M) KH2P04 II (0.0012 M)* 
1 " 3.82 " MgSO ·7H 0 II (0.0012 M)* 4 2 
21 If 1.30 If NaHC03 
If (0.0248 M)* 
*Final concentration Ionic strength = 0.16 
(ca++= 11. 5 mg/100 ml) 
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TWenty milligrams of each of the amino acids of calcitonin 
eicept the glycine-C-14 (UL) and J.2 grams of glucose were added 
to each liter of freshly prepared buffer. A 95% oxygen-5% carbon 
dioxide mixture was bubbled into the medium for 15 minutes and the 
pH was adjusted to 7.4 before it was used for the incubation. 
The calcium ion concentration of the above mentioned Krebs-
Binger bicarbonate buffer was altered to prepare- incubation media 
Y"'Containing low calcium (4.8 mg Ca++/100 ml) and high calcium 
-(26.0 mg Ca++;100 ml) concentrations. The composition of media is 
Tepresented as followss 
Low-calcium medium 
100 part(s) 0.090% (0.154 M) NaCl solution (0.1180 M)* 
4 .. 1.15 .. KCl " Co. 0047 M)* 
· 1.4 
" 
1.22 ( 0.110 M} CaC12 .. (0.0012 MJ* 
1 .. 2.11 (0.154 M} KH2Po4 " (0.0012 !!1)* 
1 .. 3.82 .. MgS04 •7H20 " (0.0012 .M)* 
21 .. l.JO .. NaHCOJ " (0.0248 M)* 
*Final concentration Ionic strength = 0.16 
(Ca++ = 4.8 mg/100 ml} 
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~i.um medium 
100 part( s) 0.90% (0.154 M) NaCl solution (0.1180 M)* 
4 .. 1.15 .. KCl ff ( o. 0047 fil)* 
8 .. 1.22 ( 0.110 _M) CaC12 .. ( o. 0062 .fil)* 
1 " 2.11 (0.154 .r:J.) KH2Po4 ff (0.0012 fil)* 
1 " 3.82 " MgS04 •7H20 " Co. 0012 M)_* 
21 " l.JO ... NaHCOJ (0.0248 fil)* 
*Final concentration Ionic strength = 0.17 
(Ca++ = 26.o mg/100 ml) 
TISSUE PREPARATION AND INCUBATION 
Ovine thyroid glands were obtained fresh from the slaughter-
house, usually 10 to 20 minutes after the sheep were killed. The 
glands with all adhering tissues were placed in cold Krebs-Ringer 
bicarbonate buffer (pH 7.4) containing J20 mg glucose/100 ml, and 
20 mg/L of all the amino acids of calcitonin. The glands were 
brought to the laboratory where they were dissected free from fat, 
connective tissue, and possible contaminating parathyroid tissue. 
In sheep, one of the two pairs of parathyroid glands is located 
near the posterior extremity on the deep surface of the lobes of 
the thyroid. The whole· thyroid glands were then sliced in the cold 
into slices approximately 0.5-1.0 mm in thickness with a Stadie-
Riggs tissue slicer. The time interval between killing of the 
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sheep and incubation of about 100 grams of thyroid slices was 
usually three hours. Approximately two grams of slices were placed 
in each of a series of 50 ml Erlenmeyer flasks. Each flask con-
tained 10 ml of Krebs-Ringer bicarbonate buffer and 2.5 µCi of the 
labeled glycine. Air served as the gas phase and all incubations 
were carried out in a hood for 4 hours at 37° C in a shaker water 
bath. The incubation period was terminated by placing the Erlen-
meyer flasks containing the thyroid slices into an ice bath. 
To determine the effect of low, physiological, and high calcium 
-~on concentration on altering the hypocalcemic response (a reflec-
tion of the synthesis of calcitonin) of the mitochondrial, nuclear, 
and microsomal preparations, the incubations were carried out in 
buffer containing low calcium (4.8 mg Ca++/100 ml), physiological 
calcium (11.5 mg ca++/100 ml), and high calcium (26.0 mg Ca++; 
100 ml) concentrations. After the 4 hour incubation period, the 
thyroid slices were thoroughly homogenized and mitochondrial, nu-
clear, and microsomal subcellular fractions were obtained by dif-
ferential centrifugation. 
ISOLATION SUBCELLULAR FRACTIONS 
After the 4 hr incubation period, the ovine thyroid slices 
were minced with scissors. Mitochondrial, nuclear, and microsomal 
subcellular fractions were obtained by utilizing a fractionation 
scheme described by Mahler and Cordes (1966) in their text, 
Biological Chemistry. A 25% thyroid homogenate was prepared by 
I 
Placing 5 gm of minced thyroid tissue in 15 ml of "homogenizing 
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medium" (0.32 M sucrose, containing 0.02 M Tris, pH 7.6, and 3 x 
1o-3 M MgC12 ) in a glass Duall homogenizer. Five slow, up and 
down pestle movements were us_ed to break up the fibrous tissue 
which is dispersed throughout the thyroid gland. This crude homog-
enate was then filtered through 2 layers of cheesecloth to remove 
the remnants of the fibrous tissue. The filtrate was then trans-
ferred to a Kontes Teflon homogenizer for a more thorough homogen-
ization (15 slow, up and down pestle movements) to completely dis-
rupt cell walls. Each 12.5 ml of homogenized thyroid preparation 
was diluted to a final volume of 20 ml by adding 7.5 ml of "dilut-
ing medium" (0.25 M sucrose containing 0.02 M Tris, pH 7.6, and 3 
x 10-3 M MgC12 ). Twenty milliliters of homogenizing medium was 
then layered underneath this preparation. The entire volume was 
centrifuged for 10 minutes at 700 x g at 4° C in an International 
Model PR-2 Centrifuge (International Equipment, Company, Needham Hts., 
Massachusetts). Two fractions were obtaineds (1) a supernatant 
fraction, containing mitochondrial and microsomal material, and (2) 
a residue, termed the crude nuclear preparation. The residue was 
resuspended in 13 ml of a solution of 2.4 M sucrose containing 1.0 
mM MgC12 • The crude nuclear preparation was centrifuged for 1 hr 
at 50,000 x g at 4° C in a Spinco Model L Ultracentrifuge (Beckman 
Instruments Incorporated, Palo Alto, California). Two fractions 
were obtaineds - (1) the supernatant which was discarded, and (2) 
a residue, termed the purified nuclei. The purified nuclear prepa-
ration was then taken up in 1 ml of diluting medium. This prepara-
tion was checked for homogeneity by phase contrast and electron mi-
croscopy. The electron microscopy was performed by Dr. John U. Balis 
Associate Professor of Pathology, Loyola University, Medical Center. 
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Twenty milliliters of 0.1 M formic acid was added to the suspension 
and the entire preparation was lyophilized. 
The supernatant fraction containing mitochondrial and micro-
somal material was thoroughly mixed and centrifuged for 10 minutes 
at 7,000 x g at 4° C in the International Centrifuge resulting in 
a residue, termed the crude mitochondrial preparation, and a super-
natant, containing crude microsomal material. The crude mitochon-
drial preparation was taken up in 10 ml of diluting medium and cen-
trifuged for 10 minutes at 24,000 x g at 4° C in the International 
Centrifuge. The residue from this centrifugation was termed the 
purified mitochondrial preparation and the identity of this prepa-
ration was established by examining an aliquot by phase contrast 
and electron microscopy. This fraction was prepared for lyophiliza-
tion in a manner identical to the nuclear preparation. The super-
natant, containing crude microsomes, was added to the 7,000 x g 
supernatant. This combined material was then centrifuged for 100 
minutes at 105,000 x g at 4° C in the Spinco Ultracentrifuge. The 
supernatant was discarded. The residue, termed the crude micro-
somal preparation, comprised of free ribosomes and smooth and rough 
endoplasmic reticulum, and dense granules, was suspended in one ml 
of diluting medium. The identity of this subcellular fraction was 
checked by electron microscopy. The remainder of the crude micro-
somal preparation was added to 20 ml of 0.1 M formic acid and lyo-
Philized. A diagram of the.scheme for the subcellular fractionation 
is shown in Figure J. Electron micrographs of the microsomal and 
mitochondrial fractions are shown in Figure 4 and in Figure 5, while 
a phase contrast photograph of the nuclear fraction is presented 
in Figure 6. 
_Subcellular Fractionation Scheme 
25 °/o Thyroid homogenate C1 part tissue, 3 parts 
homogenizing medium). Prepared in a Duall homogen-
izer. 5 up and down pestle movements. 
I 
Teflon homogenizer -15 pestle movements & filtered. I . 
Diluted each 12.5 ml of homogenized tissue to a final 
volume of 20 ml using the diluting medium. 
I 
Layered 20ml of homogenizing medium underneath 
this preparation. 
I 
Centrifuged for 10 minutes at 700 - g at 4 ° C. 
Residue Supernatant 
Figure 3. Fractionation scheme utilized to obtain 
mitochondrial, nuclear, & microsomal fractions from 
incubated ovlne thyroid gland slices. 
I 
°' f\) 
I 
,Figure 3, continued r-______________ .._ ______________ -a 
Residue (crude nuclei) resuspended 
to a volume ol 13 ml in 2.4 M sucrose. 
-
Supernatant - centri tuged tor 
10 minutes at 7,~oo- g 
Centrifuged .60 minutes al 50,000·g 
I 
I I 
Residue Supernatant 
(purified nuclei) {Discard) 
Supernatant 
Centrifuged 100 
minutes at 105,000-g 
Residue (crude mitochondria) I 
Taken· up in 10 ml ol diluting / 
medium. centrifuged tor 10 / 
minutes at 24,000-g l>I I -tit' 
I I I I 
Res'idue Supernatant 
(purified mitochondria) 
Residue 
(crude m icrosomes) 
Supernatant 
(Discard) 
I 
°' \...0 
I 
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Figure 4. Electron micrograph of the thyroid microsomal frac-
tion (105 ,000xg) containing smooth and rough endoplasmic retic-
ulum, free ribosomes, and dense granules. Very little contamin-
ation from the mitochondrial fraction was observed (x39,SOO). 
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Figure 5. Electron micrograph of a crude mito-
chondrial fraction (7,000xg) exhibiting some micro-
somal contamination. Purified thyroid mitochond-
rial fractions (24,000xg) were assayed for hypo-
calcemic activity. 
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Figure 6. Phase contrast photograph of a puri-
fied thyroid nuclear fraction (50,000xg). Very 
little contamination was observed (xSSO). 
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In some instances, the mitochondrial, nuclear, and microsomal 
prepar~tions were assayed for hypocalcemic activity in rats without 
further purification. Two milligrams of the respective subcellular 
ftactions were dissolved in 250 µl of deionized water and injected 
intravenously into rats. Subcellular fractions were purified by 
dissolving the lyophilized preparations in 0.1 M formic acid 
(18 mg/ml) and applying the dissolved material to a 2.5 x 60 cm 
column of Sephadex G-100 (Pharmacia Fine Chemicals, Inc., Picataway, 
New Jersey) and eluting with the same solvent. The transmission of 
the effluent was monitored with a Uvicord Absorptiometer and Re-
corder (LKB Instruments, Inc., Rockville, Maryland) and 50 drop 
fractions (approximately 4 ml per fraction) were collected on a 
unifrac Fraction Collector (Savant Instruments Inc., Hicksville, 
New York). The fractions representing the elution peak, usually 
-numbering 6 to 7 were pooled and lyophilized in 0.1 M formic acid 
as were the 10 to 12 fractions beyond the elution peak. In every 
instance, lyophilized material could be recovered only from the 
}>ooled fractions representing the elution peak. These purified 
subcellular fractions were assayed for radioactivity, protein con-
tent, and hypocalcemic activity. In some instances, microsomal 
preparations which had already been passed through a Sephadex G-100 
column were purified further by passage through a 2.5 x 45 cm col-
umn (at a concentration of 2.5 mg/ml) of Sephadex G-50 Superfine 
and eluted with O.l M formic acid. The microsomal fractions ob-
tained from the elution· peak (usually numbering 4 to 5) were then 
lyophilized. Lyophilized microsomal material from the elution 
Peaks of both Sephadex G-100 and G-50 columns were assayed for homo-
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geneity by polyacrylamide gel electrophoresis. The identity of 
ch of these microsomal preparations was established ty fraction-
ea 
ating a standard ca.lcitonin preparation under identical conditions 
in polyacrylamide gels. 
SOLUTIONS 
-
HPmogenizing Mediums 109.6 gm of sucrose (C12H22o11 ), o.61 gm of 
MgC12 •6 H2o, and 1.7 gm of Trizma-HCl (Tris (hydroxymethyl) amino-
methane hydrochloride) and 1.4 gm of Trisma-Base (Tris (hydroxy-
methyl) aminomethane) were dissolved in one liter of deionized 
~ater. A pH of 7.6 was attained by slight adjustments of either 
the Trisma-Base or Trisma-HCl concentrations. 
_,Diluting Mediums 85.6 gm of sucrose, o.61 gm of MgC12 •6 H2o, 1.7 gm 
of Trizma-HCl, and 1.4 gm of Trizma-Base were dissolved in one 
liter of deionized water. 
2.4 M Sucrose Solution: 822 gm of sucrose and 0.2 gm of MgC12 •6 H2o 
were dissolved in one liter of deionized water. 
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~MINATION OF SERUM CAI,CIUM 
Serum calcium was determined with the use of the HPE Calcium 
oetermination KIT, commercially available from the American Monitor 
Corporation, Indianapolis, Indiana. The technique is a modifica-
tion of Burr's (1969) automated method of serum calcium detection. 
/·fhe Monitor HPE Calcium Determination utilizes a dye, di(o-hydroxy-
phenylimine)-ethane in methyl alcohol. This dye forms a colored 
complex with calcium at pH 12. Specificity for calcium is maintained 
by a combination of dye-specificity and pH. The dye binds-prefer-
entially to calcium, forming a red-colored complex which is spec-
trophotometrically determined at 545 nm. Polyvinylpyrrollidone is 
~- utilized in this method to catalyze the complexing of phosphate by 
molybdate, thus eliminating occasional low results caused by the 
formation of a phosphate-calcium complex. Individual serum blanks 
are obtained by complexing all calcium. Calcium and phosphate com-
plexes are quickly dissociated at an acid pH. The dissociated phos-
phate is removed by a catalyzed reaction with molybdate. A strongly 
·alkaline pH is then established. The phosphate remains complexed 
with rnolybdate and calcium reacts with the dye causing a change 
from a pale yellow to an intense red-colored complex. 
Blood samples (400 µl) were collected in microcentrifuge tubes 
by tail bleeding.(cutting off t inch of the tip of the tail) of 
anesthetized rats. Blood was obtained from each rat before and 50 
minutes after the injection of aliquots of the three subcellular 
fractions. The blood was allowed to clot for JO minutes before the 
sample was centrifuged for 4 minutes in a Beckman Spinco Microfuge 
resulting in approximately 200 ul of serum. Fifty rnicroliters of 
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serum collected from each rat before and SO minutes after the in-
jection of aliquots of the test material was utilized for the 
determination of serum calcium levels. 
The calcium determination is carried out by the addition of 
1 ml of molybdic acid reagent to a plastic tube (glass tubes often 
1each out calcium and interfere with this sensitive assay) con-
taining molybdate and polyvinylpyrrolidone. This tube is termed 
the ''Reagent Blank" and the same amount of acid reagent is added 
to a second tube termed the "Test." One then adds SO pl of rat 
serum to the "Test" tube followed by a thorough mixing. This is 
followed by the addition of 2 ml of 0.2 N NaOH to both the "Rea-
gent Blank" and the "Test" tubes followed by mixing of the con-
tents. Two milliliters of 0.0002 M di(o-hydroxyphenylimine)ethane 
are then added to both the "Reagent Blank" and the "Test" tubes 
and both are mixed once again. After waiting two minutes, one 
determines the absorbance of the "Test tube and the "Reagent 
Blank" at S4S nm with a Beckman DU Spectrophotometer. Readings 
are performed within S minutes of completion of the procedure since 
color stability decreases significantly after 10 minutes. 
Calculations 
Absorbance of Unknown 
Serum Calcium (mgi'o) - X Absorbance of 10.0 mg% 
Calcium Standard 
Concentration 
of the 
Standard (10.0 mg%) 
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~ALYS IS 
Protein was determined by utilizing the method of Lowry (1951) 
as modified by Oyama and Eagle (1956). There are two distinct 
steps which lead to the final color with proteins (1) a reaction 
with copper in alkali, and (2) a reduction of the phosphomolybdic-
phosphotungstic acid reagent by the copper-treated protein. One 
milliliter of reagent "C" was placed in each of a series of 10 x 
75 mm test tubes. Two hundred microliters of sample was added to 
the sample tubes and 200 pl of deionized water was added to each 
blank tube. The contents of each tube were immediately mixed on a 
vortex mixer and allowed to stand for 10 minutes. Then O.l ml of 
Folin-Ciocalteu (Hartman-Leddon Company, Philadelphia, Pa.) reagent 
was added to each tube and the samples were thoroughly mixed again. 
The reaction mixtures were allowed to stand undisturbed for a mini-
mum of JO minutes while color development of the reaction was com-
pleted. The transmittance of blank and sample solutions was deter-
mined with a Beckman DU spectrophotometer at a wavelength setting 
of 750 nm. A standard curve was prepared following this procedure 
using bovine serum albumin as the standard. The calibration curve 
data are indicated in Table! and the standard curve is shown in 
Figure 7. 
Q.alcula ti ons 
The percent transmittance values are converted to absorbance 
and the density of the reagent blank is subtracted from that of 
Unknown and standard preparations to obtain the absorbance of each 
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TABLE I 
STANDARD CURVE DATA FOR PROTEIN DETERMINATION 
Albumin (µg) 
5 
10 
20 
JO 
40 
50 
Number of 
Determinations 
'6 
6 
5 
6 
5 
6 
Absorbance 
750 nm 
0.0932 
0.1435 
0.2434 
0.3229 
0.3975 
o.4690 
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o! these preparations. The concentration of the unknown (pg protein/ 
ml of unknown sample) is calculated using the formulas 
pg of protein/ 
ml of unknown = 
sample 
Solutions 
Absorbance of Unknown (concentration of 
Absorbance of Standard x Standard in µg) x 5 
!eagent A: 20 gm of Na2co3, 4 gm of NaOH and 200 mg of KNaC4
H
4
o
6 
•4 H20 were dissolved in one liter of deionized water. 
Reagent Ba 5 gm of Cuso4•5 H2o were dissolved in one liter of 
deionized water. 
Folin-Ciocalteu Reagents Folin-Ciocalteu Reagent was obtained from 
Hartman-Leddon Company and diluted with deionized water in the 
ratio of 5 parts of the phenol reagent to 7 parts of deionized water 
as recommended by Oyama and Eagle (1956). 
~agent Ca Fifty parts of reagent A and one part of reagent B 
were mixed fresh just prior to use. 
MEASUREMENT OF RADIOACTIVITY 
~ 
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A Beckman LS-250 Liquid Scintillation Spectro8eter was utilized 
for all measurements of radioactivity. Samples were counted in 22 
ml low potassium-40 content glass vials with tin-foil lined plastic 
screw caps. Ten milliliters of scintillation fluid was added to 
each vial. The scintillation fluid mixture was prepared fresh on 
the day of use by dissolving 4.o gm of PPO in 1 liter of toluene 
of scintillation grade. Twenty milliliters of Bio-Solv solubilizer 
BBS-J (Beckman Instruments, Fullerton, California) was then added 
to each 100 ml of this fluid. An appropriate amount of sample was 
then added to the 10 ml of scintillation fluid in each vial and the 
sample was counted three times, each time for 10 minutes. 
The Automatic Quench Compensation function (AQC) of the Beck-
man instrument was utilized, the gain was set at 500 and the exter-
nal standard Isoset was set at 0.766. The 2 sigma statistical 
counting error ranged from J to 7%• Radioactivity was expressed 
as disintegrations per minute {dpm) per mg of protein. Quenching 
was not a problem in the measurement of the radioactivity of the 
samples. This conclusion was based upon an evaluation of a quench 
correction curve of a plot relating % efficiency versus external 
standard ratio, for a series of counting vials prepared by adding 
various amounts of protein (2 to 10 mgs) isolated from the mito-
chondrial fraction of thyroid homogenates, in 1 ml of O.l B formic 
acid, to 10 mls of the toluene-based fluor containing 0.025 micro-
curies of 14c-glycine. · No quenching effect was found. 
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~TION OF BIOLOGICAL ACTIVITY 
Male Holtzman rats (Holtzman Company, Madison, Wisconsin) in 
the weight range of 110 to 120 grams were kept in the animal rooms 
and fed a standard rat diet until they reached a weight of lJO to 
i60 grams. The animals were fasted 18 hours prior to their use for 
determination of hypocalcemic activity of standard calcitonin prep-
arations and of mitochondrial, nuclear, and microsomal subcellular 
preparations. The rats were anesthetized with sodium pentobarbital 
which was injected intraperitoneally at a dose of 5 mg per 100 gm 
of body weight. At this dose level, the rats remained anesthetized 
for approximately one hour and a half. At zero time, a tail-blood 
sample was collected after cutting off i inch of the tip of the 
rat's tail. The femoral vein of the rat was exposed and 2000 pg of 
the desired subcellular preparation dissolved in 250 pl of deionized 
water was injected into the vein over a JO second period using a 
250 pl Hamilton syringe. The incision was then closed with wound 
clips. A second blood sample was collected into a microcentrifuge 
tube by snipping off an additional portion of the tail fifty min-
utes after the injection of the test material. Kumar et al. (1965) 
noted that the maximal hypocalcemic response after intravenous in-
jection of calcitonin preparations occurred JO to 60 minutes after 
injection. They therefore selected 50 minutes as the standard 
Collection time for the second blood sample. 
The blood was allowed to clot for ! hour. It was then centri-
fuged in a Beckman Spinco Microfuge for 5 minutes to separate the 
serum. Serum calcium level (mg/100 ml) was determined for both the 
time zero and fifty minute samples. Hypocalcemic activity was 
I 
.:1 
1. 
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d as the change in serum calcium between time 0 and 50 
.,ipresse 
·nutes per 10 pg of protein of the test materials. 
1111 . 
pQLYACRYI.AMIDE GEL ELECTROPHORESIS OF MICROSOMAL AND STANDARD 
----CALCI'I'ONIN PREPARATIONS 
---- Standard calcitonin preparations having a potency of 88 MR.C 
units and microsomal preparations which had been passed through a 
sephadex G-100 or through both a G-100 and G-50 columns were sub-
jected to polyacrylamide gel electrophoresis utilizing a Canalco 
.-·Model 66 Disc Electrophoresis Unit (Canal Industrial Corp., Rock-
ville, Maryland). This was done to establish the identity of the 
hypocalcemic microsomal fraction with a calcitonin preparation of 
known potency. Microsomal and standard calcitonin preparations 
were fractionated into their component protein bands in anionic 
polyacrylamide gelso In some instances, calcitonin standard pre-
parations were fractionated in cationic gels and under identical 
conditions of milliamperage per gel column (2.5 ma), electrophoretic 
separation time (1 hour and 20 minutes), and gel concentration (7.5%). 
Electrophoresis was performed in small gel columns consisting 
of three sections (Figure 8 ) ; ( 1) a large-pore anticonvection gel, 
termed the sample gel, into which the ionic mixture (microsomal and 
standard calcitonin preparations) was introduced; (2) a large-pore 
gel, termed the spacer ~r stacking gel, which has an identical chem-
ical composition to that of the sample gel and in which the sample 
Was electrophoretically concentrated; (3) a small-pore gel, termed 
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Figure 8. Disc electrophoresis is performed in glass columns filled 
with polyacrylamide gel consisting of a sample, stacking, and separation 
gel. A power supply, electrolyte compartments, and electrodes complete 
the arrangement. 
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running or separation gel, in which the sample was separated the 
eiectrophoretically and by molecular sieving. The gel column was 
-positioned between two buffer chambers and an electrical field was 
applied across the gels. Each component migrated as a band with 
characteristic electrophoretic migration rate depending on its size 
and net charge t> 
Williams and Reisfeld (1964-65) have designated the necessary 
ionic constituents of a zonal polyacrylamide gei setup as the trail-
ing ion (usually glycine or a weak acid or base), ~he leading ion 
(usu~lly chloride ion), and the buffer counterion (Trizma-Base). 
The trailing ion (the correct term is trailing ion constituent, which 
-!'efers to a weak ion forming species regardless of whether or not 
it is actually ionized) is in two electrode compartments; the lead-
ing ion is in the sample, spacer, and running gels; and the sample 
is in the sample gel. The buffer is in both the upper and lower 
electrode compartments as well as throughout the entire gel. A 
marked pH variation occurs at the boundary of the spacer gel and 
separation gel. 
As the electrophoretic run commences (Figure 9 ) , the sample 
"migrates electrophoretically from the sample gel into the stacking 
gel. In the stacking gel, two things happen to the migrating ionic 
species. First, the constituent ions of the sample are segregated 
from one another and stacked into contiguous zones. Their stacking 
alignment is dependent on the order of their relative electrophor-
etic mobilities. The entire sample is sandwiched between the trail-
anq leading ions. Second, a concentration step for all these segre-
~ted stacks occurs. The thickness of these concentrated zones of 
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Figure 9. In polyacrylamide gel electrophoresis, the sample is first 
electrophoretically stacked. Once the components of this stacked zone 
have passed the pH discontinuity, they are separated electrophoreti-
cally and by molecular sieving. 
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the various ionic species present in the stacks is independent of 
the initial concentrations in the mixture, but is entirely depen-
dent upon the leading ion concentration. Therefore, sample mixtures 
which were initially very dilute in the sample gel can be readily 
stacked and concentrated in the stacking gel by varying the concen-
tration of the leading ion whose movement in the gel sets up an 
electrical gradient. No molecular sieving effect is thought to 
occur in the sample and stacking gels. These are the two gel areas 
where electrophoretic effects predominate. 
The concentrated sample ions in the stacking gel then migrate 
into the separation gel. At the stacking gel/separation gel inter-
iace a new set of conditions prevail. There is a discontinuity in 
pH between the gels and a change in pore size. As the leading ion/ 
trailing ion boundary passes the pH discontinuity of the stacking 
gel/separation gel interface, the previously observable schlieren 
··boundary (boundary of leading ion/trailing ion) breaks up. It is 
at this stacking gel/separation gel interface that the mobility of 
the trailing ion now surpasses even that of the fastest sample 
ionic species. The trailing ion species which formerly had trailed 
the sample species in the stacking gel now continuously overtakes 
and passes through the sample species. This leading ion/trailing 
ion boundary migrates down the separation gel leaving behind a ra-
ther uniform voltage gradient in which the sample ionic species now 
resolve into a number of characteristic boundaries. This is due to 
the combined effects of the electrophoretic voltage gradient and 
the molecular sieving effect of the separation gel. The molecular 
sieving effect has been shown to depend upon the concentration of 
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monomer used in the polymerization of the separation gel. Chrambach 
a.nd Ro.dbard ( 1971) have shown that the synthetic polymer, polyacryl-
amide, can be made to provide an effective median pore radius of 
o.5 to 3 nm by simply adjusting the total acrylamide concentration 
(3 to JO% w/v), and the concentration of the cross-linking agent 
(1 to 25% w/v) of the total monomer concentration in the polymer-
ization reaction. The structural formula of acrylamide, the cross-
linking reagent, initiators of the polymerization reaction, and the 
cross-linked polymer (polyacrylamide) are shown in Figure 10. 
STANDARD PROCEDURE--ANIONIC GEL SYSTEMS 
Stock Solutions 
Stock solutions (Table II) were prepared using deionized water 
and were filtered and stored in brown glass bottles or bottles 
wrapped in foil in the refrigerator. Most of these stock solutions 
had a shelf-life of up to three months. 
Working Solutions 
Working solutions (TableI7I) were prepared fresh from the stock 
solutions on the day they were to be used. However, the persulfate 
solution, when kept stored in the refrigerator, was usable for a 
Period of a week. 
I 
I 
~ I 
I' 
'1' 
'I 
+ LIGHT 
Figure 10. After Chrambach and Rodbard, Science (1971) 172 No. 3982. 
The polymerization reaction of acrylamide. The structures of acryla-
mide, N,N'-methylenebisacrylamide and of a representative segment of 
cross-linked polyacrylamide are shown. Initiators shown are per-
sulfate, riboflavin, and N,N,N' ,N'-tetramethylethylenediamine. 
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TABLE II 
ANIONIC GEL STOCK SOLUTIONS 
Separation Gel 
(Small-pore gel) 
(A)* 
l 1! HCl approx. 48 
TRIZMA-BASE 36.3 
TEMED o.46 
water to 100 
(pH 8.9) 
(C) 
Acrylamide** 30.0 
BIS o.8 
Potassium Ferri-
ml 
gm 
ml 
ml 
gm 
gm 
cyamide o.015gm 
water to 100 ml 
( E) 
Sample and Stacking Gels 
(Large-pore gels) 
( B) 
1 N HCl approx. ·48 
TRIZMA-BASE 5.98 
TEMED o.46 
water to 100 
(pH 6. 7) 
(D) 
Acrylamide 10.0 
BIS 2.5 
water to 100 
( F) 
ml 
gm 
ml 
ml 
gm 
gm 
ml 
Ammonium Persulfate 0.14 gm Riboflavin - o.oo4gm 
water to . 100 ml water to 100 ml 
* pH adjusted by titrating with 1 N HCl. 
** Acrylamide is a neurotoxin in powder form--avoid inhaling. 
The following abbreviations were usedz 
TEMED (N, N, N', N'-Tetramethylethylenediamine); 
BIS (N, N'-Methylene-bisacrylamide). 
Separating Gel 
(Small-pore gel) 
1 Part A 
2 Parts C 
4 Parts E 
1 Part Water 
pH 8. 9 ( 8. 8-9. 0) 
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TABLE III 
WORKING SOLUTIONS 
Sample and Stacking Gel 
(Large-pore gel) 
1 Part 
2 Parts 
1 Part 
4 Parts 
B 
D 
F 
Water 
pH 6.7 (6.6-6.8) 
Buffer Solution 
TRIZMA-BASE 6.0 gm 
Glycine 28.8 gm 
Water to 1 liter 
pH 8.J 
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~ixative, Fixative-Stain, and Destaining Solutions 
 
Fixative solutions (Table IV ) and solutions for washing and de-
staining the polyacrylamide gels were prepared in advance and stored 
indefinitely at room temperature. The naphthol blue-black was added 
to acetic acid or trichloroacetic acid and the mixture was stirred 
and filtered through Whatman No 1 filter paper. These solutions 
could be reused a number of times. The Coomassie Brilliant Blue 
R-250 was prepared as an aqueous stock solution which was stirred 
and filtered prior to use. This stock solution was diluted 1:20 
with trichloroacetic acid (TCA) just prior to staining the gels. 
The fixative-stain solution was made up fresh from the stock solu-
ti on each time. 
The following procedure was utilized to resolve microsomal and 
standard calcitonin preparations into their component protein frac-
tions. 
1) Pyrex glass columns (6.5 cm long and having an inner diameter 
of 0.5 cm) were acid cleaned and coated with a wetting agent 
(1 part Kodak Photo-Flo or Canalco Column-Coat to 200 parts 
water). Base caps (vacutainer tops) were placed at one end 
of the gel columns which were then placed into a loading rack 
in which front-to-back vertical alignment of the gels could 
be assured. 
2) Stock solutions A, C, and E were removed from the refrigera-
TABLE l.V 
FIXATIVE, STAINING AND DESTAINING SOLUTIONS 
Fixative Solutions Fixative-Stain Solutions 
Acetic Acid 12% 1) Naphthol Blue Black* 0.5 gm 
TCA 10% 7% Acetic Acid 100 ml 
2) Naphthol Blue Black*** 0.5 gm 
10% TCA 100 ml 
J) Coomassie Brilliant Blue 
(Stock Solution) 
Coomassie Brilliant Blue 1 gm 
Water to 100 ml 
(Working Solutions) 
12.5-20.0% TCA***** 20 ml 
Stock Solution 1 ml 
* Fixative-stain solution commonly used for serum proteins. 
** Destaining solution commonly used for serum proteins. 
*** Fixative-stain solution used for staining calcitonin. 
**** Destaining solution used for calcitonin preparations. 
Destaining Solutions 
1) Acetic Acid** 70 ml 
Water to 1 liter 
2) Acetic Acid****l20 ml 
Water to 1 liter 
***** Fixative-stain solution used for staining calcitonin preparations. A further in-
crease in sensitivity can be achieved by the use of a 20% TCA dye solvent. 
I 
(X) 
---J 
I 
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tor and 2 ml of solution A, 8 ml of solution E, 4 ml of solu-
tion C, and 2 ml of deionized water were placed in separate 
flasks and allowed to warm up to room temperature. Sixteen 
mls of separation gel solution is the volume required to run 
twelve 6.5 cm long gels. When at room temperature, the four 
components were then added to a single flask and swirled gent-
ly to prevent air bubble formation and to provide thorough 
mixing. This was the separation gel solution. Using a 1 ml 
tuberculin syringe, to which 5 cm of tygon tubing was attached, 
exactly o.8 ml of the separating gel solution was dispensed 
(without bubble formation) into each of the 12 vertical gel 
columns. 
3) An Eppendorf or Oxford pipette was then used to carefully 
layer 100 pl (2-3 mm) of water on top of the gel solution. 
If the gel columns are not coated with a wetting agent prior 
to their use, a bolus of water will form which will drop into 
the gel solution and dilute it. However, if the gel columns 
are coated, water will layer evenly on top of the unpolymer-
ized gel solutions. The purpose of the water layering of gel 
solutions is that it prevents a gel-air meniscus and produces 
a flat gel surface which is essential for obtaining good pro-
tein band formation. It also prevents oxygen, which retards 
gel formation, from diffusing into the gels. 
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The separation gels remained undisturbed for one-half hour, 
during which time complete chemical polymerization occurred. 
one could determine if polymerization was complete by viewing 
the gel columns from the side. A distinct interface between 
the gel and water layers was visible when polymerization had 
occurred. 
The gel columns were then removed from the loading rack and 
the water layer was removed by giving the column a quick 
flick of the wrist. The lip of the gel column was then 
touched to a piece of absorbant paper to remove the last 
traces of water. 
Two milliliters of solution B, 4 ml of solution D, 2 ml of 
solution F, and 8 ml of water were put into another set of 
small flasks. These solutions were warmed to room tempera-
ture and gently mixed in a flask that was completely wrapped 
in foil to protect this gel solution from premature photopo-
lymerization. This solution was to serve as the photopolymer-
izing stacking and sample gel. A 1 ml syringe with tygon 
tubing adapter was then used to add 0.2 ml of this solution 
to each gel column. This was to serve as the stacking gel. 
Once again, 100 µl of water was layered over this gel solu-
tion as previously described. The entire loading rack was 
positioned approximately JO cm from a fluorescent light 
source. This resulted in stacking gels with a more uniform 
pore size. Fifteen minutes were allowed for photopolymeriza-
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tion to begin as evidenced by the appearance of opalescence 
in the stacking gel. When photopolymerization had begun, 
the light source was moved to within 5 cm of the columns and 
another 15 minutes were allotted to insure total photopolym-
eriza tion. The water layer was then removed as previously 
described. 
Sample Application 
Generally 200 to 500 µg of solid sample can be resolved in a 
single polyacrylamide gel. However, samples that are rela-
tively homogeneous can be assayed in quantities as small as 
50 to 100 µg range. Samples whjch are heterogeneous can be 
assayed at concentr.ation ranges of 500 to 2,000 µg. Normally, 
calcitonin standard and microsomal preparations were dissolved 
in sufficient sample gel solution that JJJ µg of calcitonin 
standard and 1,500 pg of microsomal calcitonin preparation 
were present in 0.2 ml of sample gel solution. The sample 
gel solution (0.2 ml) was added on top of the stacking gel 
and layered with 100 µl of water. The sample gel solution 
was allowed to photopolymerize for JO minutes while positioned 
5 cm from a fluorescent light source. 
Bromphenol blue {O.l to 0.2 ml), serving as a tracking dye, 
was incorporated into the sample gel solution prior to its 
addition to the gel column. This dye migrates faster than 
the fastest sample ion species. 
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The t,el columns were then removed from the loading rack and 
inserted into the holes of the upper bath stoppers (sample 
gel uppermost). After all the gel columns were inserted in 
this manner, buffer solution was added on top of the sample 
gels making certain that no air bubbles were entrapped in the 
remaining space of the upper gel column. The entire upper 
bath assembly containing the gel columns was then lifted out 
and sufficient buffer solution was added to the separation 
gels such that a hanging drop of buffer solution remained at 
the bottom of all the gel columns. 
The lower bath (containing the anode) of the Canalco Electro-
phoresis unit was then filled with 500 ml of buffer solution. 
The upper bath assembly was then carefully placed into posi-
tion making certain that no air bubbles had formed at either 
end of the gel column. Air bubbles result in uneven band for-
mation because a uniform current flow through the gels is pre-
vented. The upper buffer reservoir of the Canalco apparatus 
was then filled with 250 ml of buffer solution. 
The upper bath lid was then placed on the upper bath. The 
power supply was connected. A current of 2.5 milliamps per 
gel column provided for good resolution of protein bands. 
Currents over 5 milliamps were avoided because they cause ex-
cessive ohmic heating within the gel, resulting in band dis-
tortion. Electrophoresis was carried out until the now dis-
crete front of tracking dye band had migrated to within t 
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inch of the separation gel end. This required approximately 
1 hour and 20 minutes at 2.5 ma per gel column. 
At the completion of electrophoresis, the power supply was 
turned off and the electrode jacks were disconnected. Buffer 
from the upper and lower baths was decanted into separate con-
tainers and was reused a number of times in the respective 
buffer compartments as long as the upper buffer did not drop 
below pH 8.2 or become contaminated with sample. 
The gel columns were removed from the upper reservoir and were 
placed in a wash tray containing ice-cold water. The gels 
remained immersed in the ice-cold water for 5 minutes which 
was sufficient time for maximal gel contraction. A ten milli-
liter syringe fitted with an 18 gauge needle was filled with 
the ice-cold water. The gel columns were kept submerged while 
the tip of this needle (beveled edge towards the gel to avoid 
scratching the gel) was inserted between the glass column and 
the gel. The needle was inserted slightly beyond the sample 
gel of the gel column. Keeping the gel columns submerged 
and the needle flat against the glass surface, the entire gel 
column was rotated with one hand while the position of the 
needle was maintained. This freed the entire circumference 
of the sample gel from the glass column. Ice-cold water was 
continuously injected around the gel surface as the gel column 
was rotated. The water pressure freed the stacking and sep-
arating gels and in a few moments the intact gel was expelled 
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from the separating gel end of the glass column. 
l4) Microsomal and calcitonin standard preparations were fixed and 
stained in fixative-stain No 2 (Table N ). Ten per cent TCA 
solution was found to be a good fixative for calcitonin pre-
parations. The gels were fixed and stained in this solution 
for at least one hour. Another method that was used in-
volved fixing the gels in 10% TCA or 12% acetic acid for one 
hour. The gels were then placed in fixative-stain solution 
No 3 (Table IV) for a minimum of one hour or as long as 24 
hours. Chrambach et .§1_. (1967) demonstrated that Coomassie 
Brilliant Blue, the stain in fixative-stain No J, was approx-
imately five times as sensitive a stain for proteins and pep-
tides when compared to the naphthol blue black stain. Minute 
protein bands were well detailed in 20% TCA-Coomassie Brilliant 
Blue stain solutions. Gels that were fixed and stained with 
the No J fixative-stain solution destained themselves over a 
period of several weeks. Electrophoretic destaining of TCA-
fixed gels was more prolonged then those prepared in fixative-
stain solution No 1. 
15) Electrophoretic destaining of microsomal and standard calci-
tonin gels stained by fixative-stain No 2 (Table IV) was per-
formed in the same apparatus. The gels, sample gel uppermost, 
were placed.in destaining tubes, which had been attached by 
their wide ends to the upper buffer reservoir. The gels were 
wedged firmly against the constricted ends of the tubes. 
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The destaining tube was then carefully filled (using a 
syringe to avoid bubble formation) with destaining solution 
No 2. Five-hundred milliliters of destaining solution No 2 
were poured into the lower bath of the Canalco apparatus. 
The upper reservoir was filled with 250 ml of destaining 
solution No 2. The electrodes were connected, the cathode to 
the upper reservo~r. A constant current of 4 ma per tube 
was set on the power supply. On applying the current, the 
unbound dye migrated down the gels into the lower reservoir. 
At this milliamperage setting, it took 2 to J hours to de-
stain the gels. 
16) When the section of gel containing no separated fractions 
was completely clear of stain, the power supply was turned 
off. The destaining solution was decanted, and the gels were 
transferred to small test tubes containing destaining solu-
tion No 2 for storage. Alternatively, the gels were stored 
in 10% TCA or in a solution comprised of equal parts of gly-
cerol and deionized water. This solution allows for storing 
the gels up to two years without shrinkage. 
iTANDARD PROCEDURE--CATIONIC GEL SYSTEM 
In some instances, cationic gels were utilized to fractionate 
calcitonin standard preparations. 
stock Solutions 
----
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Stock solutions (Table V} were prepared and stored in the 
same manner as anionic gel solutions. 
Working Solutions 
Working solutions (Table VI) were prepared fresh from the 
stock solutions on the day they were to be used. 
Fixative and Fixative-Stain Solutions 
Cationic gels were fixed in 10% TCA. Either fixative-stain 
solution No 2 or No 3 (see Table IV) were utilized for staining 
cationic gels. However, Coomassie Brilliant Blue in 12.S to 20% 
TCA was the most sensitive and therefore the most commonly em-
ployed fixative-stain solution for cationic gels. 
Procedure 
The experimental procedure for running cationic gels was 
nearly identical to that described previously for anionic gels. 
Any differences in procedure are listed below: 
1) Separation gels were allowed to stand undisturbed for one 
hour while chemical polymerization was completed (see step 
4, anionic gel system). 
2) Since electrical polarity had to be switched (see step 11, 
anionic gel system), no tracking dye (see step 8, anionic gel 
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TABLE V 
CATIONIC GEL STOCK SOLUTIONS 
Separation Gel Sample and Stacking Gels 
(A)* 
1 J:! KOH 
Acetic Acid 
TEMED 
Water to 
(pH 2.9) 
(C) 
Acrylamide 
BIS 
Water to 
(E) 
Ammonium Persulfate 
Riboflavin 
Water to 
12 ml 
53.2 ml 
0.24 ml 
100 ml 
JO gm 
o.a gm 
100 ml 
0.12 gm 
0.002 gm 
100 ml 
(B)* 
1 N KOH 
Acetic Acid 
TEMED 
Water to 
(pH 6.7) 
(D) 
Acrylamide 
BIS 
Water to 
(F) 
Ammonium Persulfate 
Riboflavin 
Water to 
* pH adjusted by tit+ation with acetic acid. 
24 ml 
1.47 ml 
0.1 ml 
100 ml 
10 gm 
o.a gm 
100 ml 
0.06 gm 
0.001 gm 
100 ml 
' 
I 
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TABLE VI 
WORKING SOLUTIONS 
separating Gel Sample and Stacking Gel Buff er Solutions 
_ 2 parts A 1 Part B UPPER BUFFER 
l-1 ! Parts* c , 1-2 Parts** D Glycine 28.1 gm 
l Part*** E 2 Parts F Acetic Acid 3.05 ml 
(pH 2.9) (pH 6.7) Water to 1 liter 
(pH 4.0) 
LOWER BUFFER 
Acetic Acid 43 ml 
1 N KOH 120 ml 
Water to 1 liter 
--···-··-(pH 4.J) 
* Separating gel concentration may be increased in some instances 
to resolve protein samples into narrower bands (requires longer 
running time). 
** Sample gel contration may be increased for samples which retard 
photopolymerization or those which are partially insoluble in 
sample gel solution. 
*** To insure stock solution stability, the catalyst, ammonium per-
sulfate, may be deleted from stock solutions (E) and (F) until 
the working solutions are being prepared. At that time, ammon-
ium persulfate (6 mg/5 ml) of stock solution (E) and 3 mg/5 ml 
of stock solution -(F) may be added to the proper ratios of stock 
solutions for- the separation, stacking, and sample gels. pH of 
the buffer solutions if titrated with acetic acid. 
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system) could be -utilized to gauge the distance of electro-
phoretic migration of the standard calcitonin preparations. 
Therefore, one must experiment with different fractionation 
times (at constant milliamperage) to determine the length of 
electrophoresis that will result in optimal resolution of 
protein bands. 
3) The lower bath {containing the cathode) was then filled with 
500 ml of the 1 N KOH/acetic acid buffer (see Table VI) at 
pH 4.3 and the upper bath was filled with 250 ml of glycine/ 
acetic acid buffer {see TableVI ) at pH 4,0, 
DENSITO:vJETRY OF POJ.,YACRYLAMIDE GELS 
Densitometry of gels was performed with a Densicord Model 542 
densitometer {Photovolt Corporation, New York, N. Y.). This densi-
tometer in conjunction with an automatic integrator attachment can 
be utilized to give accurate quantitation of all electrophoretically 
destained polyacrylamide gels. The proper response setting was 
chosen and the stained separation gels were scanned over their entire 
length by the Densicord. The automatic integrator attachment allows 
one to determine the percentages of the various fractions from the 
densitometer trace. The number of integrator marks was in exact 
proportion to the area under the curve at all points. 
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.PJiOTOGRAPHY OF POLYACRYLAMIDE GEL~ 
--- A Polaroid camera with a close-up lens was the most convenient 
method of photographing stained polyacrylamide gels. 
CHEMICALS REQUTR~D FOR POLYACRYLAMIDE GEL ELECTROPHORESIS 
-
Acrylamide, Eastman Organic Chemicals, No. 5521. 
Bromphenol Blue (Water Soluble), Hartman-Leddon Company, No. 859. 
coomassie Brilliant Blue R250, Colab Laboratories, Inc., No. ll-152B. 
Glycine (Ammonia-free), Eastman Organic Chemicals, No. 445. 
N, N'-Methylene-bis acrylamide (BIS), Eastman Organic Chemicals, 
No. P8J8J. 
Naphthol Blue Black, Eastman Organic Chemicals, No. 9763. 
Potassium Ferricyanide, Sargent-Welch Scientific Company, AR. 14180. 
Riboflavin, Eastman Organic Chemicals, No. 5181. 
N, N, N', N'-Tetramethyethylene diamine (TEMED), Eastman Organic 
Chemicals, No. 8178. 
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~CTRIC FOCUSING 
In recent years, the development of the highly sensitive iso-
eiectric focusing technique has become a powerful tool for the ana-
lytical or preparative separation of ampholytes, especially proteins, 
and for the characterization of the ampholyte by determining its 
isoelectric point (pI). Isoelectric point determinations of re-
solved proteins can now be accomplished conveniently and with great 
reproducibility in a single experiment. The isoelectric focusing 
technique permits essentially complete analytical resolution of 
mixed protein components employing rather simply designed electro-
focusing equipment and experimental protocol. One can now conven-
iently resolve protein components in a mixture which have as small 
a difference as 0.02 pH units separating their isoelectric points. 
Isoelectric focusing of proteins is achieved when a direct 
current potential is applied to a system of electrolytes in which 
the pH steadily increases from the anode to the cathode. Each pro-
tein species will be resolved in a stabilized pH gradient at the 
zone in the gradient at which the pH of the gradient corresponds to 
the pI of the species. The focusing, or resolution of proteins, is 
therefore attributable to the electric field they are in; hence, the 
name, isoelectric focusing. A necessary prerequisite is that the 
electrolyte system is stabilized against uncontrolled convection and 
against remixing of resolved proteins. This is accomplished by 
applying a linear sucrose gradient within the electrofocusing cham-
ber of the column.· 
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In isoelectric focusing of proteins, a pH gradient having the 
iowest pH values at the anode and the highest pH values at the cath-
ode is utilized. When one adds a mixture of proteins with isoelec-
tric points occurring within the pH range of the pH-gradient, the 
component protein molecules of the mixture will exhibit their char-
acteristic charges. The charge of each protein component will be 
determined by the pl for that protein and the pH range of the gra-
dient corresponding to the position in the electrofocusing column 
where the protein is initially located. When a constant current is 
applied to such a system, each protein molecule of the mixture mi-
grates towards the pH value in the column where its net charge is 
zero. Each protein of the mixture is therefore resolved at the 
. 
point in the electrofocusing column where the pH is equal to the pl. 
This process is illustrated in Figure 11, which schematically 
depicts the resolution of three proteins marked (pI1 ), (pI2 }, and 
(pIJ) in an isoelectric focusing column. 
The pH Gradient 
In 1961, Svensson introduced the term "natural pH gradient." 
Such a pH gradient was termed a natural one, since it is formed by 
the electric current. Prior to turning on the current, the pH is 
constant throughout the solution. A pH gradient in equilibrium 
cannot be achieved until the current has transported each low-mo-
lecular weight ampholyte to its isoelectric point. Since this pH 
gradient is in equilibrium, it remains stable for long periods of 
time, and· unlike an artificial pH gradient (obtained by arranging 
pH/pl 
"" 
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Figure 11. Three proteins marked Cpl1), (pl2 ), and (pl3 ) are 
schematically electrofocused in a column. 
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buffer solutions of different pH in series so they can diffuse into 
each o.ther), it will not migrate. Therefore, the "natural pH gra-
dient" is an ideal medium for isoelectric fractionation of ampho-
iytes such as proteins. 
Svensson°s theoretical considerations (1961) and fundamental 
work (1962) defined the required properties of carrier ampholytes 
which would comprise the natural pH gradient for isoelectric focus-
ing of proteins. The prerequisites of any carrier ampholytes used 
for isoelectric fractionation are listed below: 
1) A carrier ampholyte should have good buffering capacity at 
its isoelectric point, so that it is capable of well-defining 
the pH at that point and of dominating the high-molecular am-
pholytes (proteins) which are to move in the zone where it 
reigns. 
2) A good buffering capacity is accompanied by good conductivity 
at the isoelectric point. 
3) The carrier ampholytes should have low molecular weights in 
order to be separable by dialysis or column chromatography 
from the high-molecular weight compounds which are to be 
electrofocused. 
4) The carrier ampholytes should also have a chemical composi-
tion that is different from the substance to be separated 
and analyzed, in order that conventional methods of identifi-
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cation and analysis of these substances may be applied with-
out disturbances from the carrier ampholytes. 
5) The carrier ampholytes should not react with or denature 
the· substance to be fractionated. 
Vesterberg and Svensson (1966) developed a method of synthe-
sizing ampholytes having the characteristics which had been de-
fined by Svensson (1961). These synthetic ampholytes were ali-
phatic polyamino-polycarboxylic acids exhibiting many values of 
pK for the same type of molecule and having great solubility in 
water. Vesterberg (1969) successfully accomplished the synthesis 
of carrier ampholytes which were a mixture of many isomers and 
homologues with different, closely spaced pK and pI values, cover-
ing the pH range from J to 10. This was accomplished by reacting 
a mixture of many different polyethylene-polyamines in aqueous 
solution with acrylic acid. The ampholytes with molecular weights 
ranging from JOO to 1000 are focused and fractionated in a multi-
compartment electrolyzer, into groups with closely spaced pI values. 
The carrier ampholytes, covering a multitude of pH ranges, 
are now commercially available from LKB Instruments, Inc., Rock-
ville, Maryland, under the trade name of Ampholine Carrier Ampho-
lytes. The carrier ampholytes may be characterized by the fol-
lowing general formulas 
---- CH 2 
wheres 
and, 
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- N - (CH )x I 2 
(CH2)x I 
NR2 
x = 2 or J 
R = H or 
- N - CH2 ----1 
R 
At the beginning of an isoelectric focusing experiment, the pH 
is constant throughout the electrofocusing column and is the average 
value of all the carrier ampholytes in the solution. Some of the 
carrier ampholytes are positively charged and others are negatively 
~charged. When a current is applied to the electrofocusing compart-
ment, these ampholines start migrating towards their respective 
electrodes. While they are migrating, a pH gradient is successively 
built up due to their buffering capacity. Each carrier ampholyte 
will establish a pH range corresponding to its isoelectric point. 
The carrier ampholytes ct'ter a 24 to 72 hour period will be dis-
tributed in a pH gradient which they, themselves, have created in 
order of their isoelectric points. 
The mixed protein sample that is to be separated into its com-
ponent fractions by the electrofocusing procedure is added to the 
electrofocusing compartment together with the carrier ampholytes. 
When the current is applied, the sample proteins will also start 
migrating toward their respective isoelectric points because of the 
PH gradient established by the carrier ampholytes. 
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The pH range of the Ampholine Carrier Ampholytes should be 
chosen as narrow as possible when electrofocusing to give the best 
resolution for each protein. The pH range should be just large 
enough to include the pI values of the proteins of interest. When 
electrofocusing a mixture of proteins for the first time, it is 
desirable to electrofocus a portion of the protein sample in the 
broadest pH range (J-10) before the optimum range can be selected 
for future electrofocusing experiments. 
The Density Gradient 
The carrier ampholytes and the protein sample in the electro-
focusing column must be stabilized against convection in some way. 
A suitable way to accomplish this is to use density gradient of 
decreasing concentration 1 from bottom to top, of sucrose or other 
non-ionic solutes (such as ethylene glycol) dissolved in the elec-
trofocusing solution. The linear sucrose gradient is arranged by 
filling the electrofocusing column with fractions of decreasing den-
sity (carrier ampholytes, sucrose, and sample) or by utilizing an 
LKB Gradient Mixer (LKB Instruments, Inc., Rockville, Maryland) 
designed specifically for filling the electrofocusing column. 
The gradient mixer gives a linear gradient of two solutions, 
termed "light" and'tiense" (containing sucrose) solutions. The 
protein mixture is added to one or a few fractions if the density 
gradient is made manually or in the "light" solution if the LKB 
Gradient Mixer is utilized. 
Electrode Soluti~ ::.---
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The carrier ampholytes located near either electrode must be 
protected from anodic oxidation and cathodic reduction. This is 
accomplished by surrounding the anode with a dilute acid solution 
such as phosphoric acid or sulfuric acid and the cathode with a di-
lute alkaline solution such as sodium hydroxide or ethanolamine. 
During the electrofocusing experiment, the dilute acid and base 
solutions are drawn to the respective electrodes. At the anode, the 
dilute acid solution gives a net positive charge to any nearby car-
rier ampholytes, which are thus repelled from the anode and hence, 
are protected from electrolytic decomposition. Similarly, the dilute 
base at the cathode results in the formation of negative ampholytes, 
thereby causing them to be repelled from the cathode. 
The Principle of a Practical Isoelectric Focusing Run 
The highly sensitive resolving power of the isoelectric focus-
ing technique can best be illustrated by an electrofocusing experi-
ment in which a mixture of commercially available hemoglobin A, s, 
and C preparations (Travenol Laboratories, Inc., Costa Mesa, Califor-
nia) was resolved and the pI values determined. A similar experi-
mental protocol was utilized to resolve microsomal and standard 
calcitonin preparations and to determine their pl values. 
Ampholine carrier ampholytes having a pH range of 7 to 9 were 
utilized to resolve a 14 mg mixture of hemoglobin A, s, and C into 
separated fractions whose characteristic pI values at 4° C was de-
termined 
• 
-108-
The entire electrofocusing column (LKB 8100 Arnpholine Column, 
LKB Instruments Inc., Rockville, Maryland) is thermostated at 4° C 
by utilizing a cryostat (Tamson Thermostatic Bath (TM-9) and circu-
iator (PBC-4, Neslab Instruments Inc., Portsmouth, New Hampshire), 
which circulated coolant around both the inner and outer electro-
focusing columns. The coolant consisted of equal volumes of dis-
tilled water and ethylene glycol. The central electrode valve was in 
the open position. The electrode solution for the central electrode, 
10 ml of .0.1 N phosphoric acid, was filled with an LKB 12000-1 vario-
perpex pump (LKB Instruments Inc., Rockville, Maryland) into the cen-
tral electrode compartment (containing a teflon rod around which a 
platinum wire was wrapped). This served as the anode during the iso-
electric focusing of the mixture of hemoglobins. 
The mixed hemoglobin sample, Ampholine carrier ampholytes of 
pH range 7 to 9, and sucrose were mixed together in the LKB Gradient 
Mixer so that the solution (110 ml total) gave a linear density gra-
dient when the electrofocusing compartment was filled with the peri-
staltic pump over a 1 h~ur period. The remaining space at the top 
of the electrofocusing column was filled with 10 ml of 0.1 N NaOH so 
that the upper platinum electrode was completely covered by electrode 
solution. This served as the cathode in the electrofocusing experi-
ment. A constant voltage (400 volts) provided by an electrophoresis 
power supply (Gelman Instrument Co., Ann Arbor, Michigan) was then 
applied to the electrofocusing column via the plugs at the central 
electrode terminal and upper electrode terminal and the isoelectric 
focusing of the hemoglobin mixture was started. In practice, the 
best results are obtained by placing the cathode at the top of the 
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electrofvcusing column for pH regions below pH 6, and the anode at 
the to_p of the column for pH regions above pH 6. If this practice 
is not followed, protein precipitation may occur at the top of the 
column and may disturb focused zones due to settling of the pre-
cipitate. 
When the current (at a constant voltage of 500 volts) decreased 
to a constant value of 2 ma all the carrier ampholytes in the elec-
trofocusing column have migrated to their isoelectric points. The 
hemoglobin A, S, and C also have focused at their isoelectric points; 
however, their contribution to the conductance was extremely low. 
The electrofocusing run in which hemoglobin A, s, and C were resolved, 
required a 48 hour electrofocusing time. In general, an electrofo-
~using run normally takes from 24 to 72 hours at a voltage of JOO to 
500 volts, depending on the ampholine pH range used. Generally 
longer electrofocusing times are required for resolution of proteins 
in narrower pH ranges of ampholines. 
At the completion of the electrofocusing procedure, the voltage 
was turned off and the central electrode valve was closed to prevent 
the anode electrode solution from mixing with the effluent. 
The outlet clamp for the electrofocusing column was then opened 
and the column was emptied by means of an LKB peristaltic pump. The 
effluent was monitored with an LKB Absorptiometer at 280 nm. Forty 
drop fractions (circa J.6 ml) were collected in test tubes and the 
PH of each fraction was measured at 4° C. 
Figure 12 shows an LKB 8100 Ampholine Electrofocusing Column in 
Which hemoglobin A, S, and C have been distinctly resolved. A large 
number of unidentified minor bands are also shown. This indicates 
-110-
Electrode 
• '- - Central Electrode 
_,.,_Hb-A 
,.._••lll•-Hb-8 
-Hb-C 
Figure 12. LKB 8100 Electrofocusing Column with com-
pleted separation of a mixture of hemoglobins A, S, 
and C in a pH gradient of 7 to 9. 
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the highly sensitive resolving power of the isoelectric focusing 
technique and clearly demonstrates that commercially "pure" prep-
arations of hemoglobin A, S, and C are, in reality, not at all in 
the pure form. 
Figure 13 depicts the absorption curve and superimposed pH 
curve obtained by eluting the electrofocused A, s, and C hemoglo-
pin bands from the column. The pH of the collected fraction at 
the elution peaks corresponds to the pI of the various resolved 
I 
hemoglobin components. 
pH B.O 
7.9 
7-B 
7.7 
Anode 
Electrode 
7.6 Solution 
7.5 
7.4 
7.3 
7.2 
7. 1 
7.0 
30 
-
27 
Hb-A 
pl 7.32 
Hb-S 
pl 7.18 
Hb-C 
pl 7.12 
23 
54 
22 20 
72 ml 
18 15 cm 
FIGURE 13. Separation of hemoglobin A, $, and .c mixture by the electrofocusing 
apparatus shown in Figure The curve with peaks shows the absorption in the 
eluate at 280 nm. The steadily increasing curve is a plot of the pH gradient 
superimposed. Isoelectric point values shown at the various peaks were read 
from the pH gradient curve. 
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CHAPTER III 
EXPERIMENTAL RESULTS 
The experimental portion of this dissertation consists of 
three parts. The first part deals with the subcellular localiza-
tion of calcitonin and the influence of calcium concentration on 
the biosynthesis of the hormone in subcellular fractions. Ovine 
thyroid gland slices were incubated in an in vitro biosynthetic 
medium consisting of Krebs-Ringer bicarbonate buffer (pH 7.4) con-
taining glucose, all the amino acids of ovine calcitonin, and in 
many instances, glycine-C-14 (UL), which served as a tracer amino 
acid. The calcium concentration of the incubation medium was the 
only parameter which was varied. Low calcium concentration incu-
bation medium contained 4.8 mg of calcium/100 ml, the physiologi-
cal, 11.5 mg of calcium/100 ml, and the high, 26.o mg of calcium/ 
100 ml. After incubation, the slices were homogenized and mito-
chondrial, nuclear, and microsomal subcellular fractions were ob-
tained by differential centrifugation. Aliquots of these three 
subcellular preparations obtained from incubation media containing 
the varying calcium concentrations were injected into rats and 
assayed for hypocalcemic activity. 
The second part of this report concerns establishing the 
identity of the hypocalcemic principle in the subcellular fraction 
by comparison with a standard calcitonin preparation and deter-
mining the homogeneity of the hypocalcemic entity at each stage 
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of hormone purification. This was accomplished by electrophoretic 
rractionation of the hypocalcemic preparations and of standard 
calcitonin preparations of known potency, in polyacrylamide gels. 
The hypocalcemic fraction was inspected for homogeneity in poly-
acrylamide· gels after passage through Sephadex G-100 and G-50 
chromato~aphic columns. 
The:last part of the experimental work to be described deals 
with the further characterization of the hypocalcemic subcellular 
and standard calcitonin preparations by determining a significant 
physical constant of this hypocalcemic principle, its isoelectric 
point (pI) by means of isoelectric focusing. Moreover, this tech-
nique permitted resolution of the hypocalcemic fraction into dis-
crete protein bands which could be recovered in milligram quanti-
ties and assayed for hypocalcemic activity. 
THE INFLUENCE OF INCREASING THE DOSE OF THE SUBCELLULAR FRACTION 
ON HYPOCALCEMIC ACTIVITY 
Protein synthesis occurs on the ribosomes and these subcellu-
lar organelles are prominent constituents of the heterogeneous 
microsomal fraction obtained by differential centrifugation which 
is composed of smooth and rough endoplasmic reticulum, dense gran-
ules, and free ribosomes. Therefore, it seemed quite proper to 
assay this subcellular fraction first for the hypocalcemic acti-
vity associated with this peptide hormone. In order to establish 
Whether or not this microsomal fraction would indeed exhibit 
hypocalcemic activity, two grams of sheep thyroid slices were 
-115-
placed in a series of 50 ml Erlenmeyer flasks which contained 10 
ml of a physiological calcium concentration incubation medium, 11.5 
Of calcium per 100 ml of Krebs-Ringer bicarbonate buffer. The mg 
ovine thyroid slices were incubated for four hours at J7° C in a 
constant temperature shaker water bath. The incubation was ter-
minated by placing the flasks in an ice-bath. The slices were im-
mediately homogenized and a microsomal subcellular fraction was 
obtained by differential centrifugation. The fresh microsomal 
preparation was immediately lyophilized. For hypocalcemic deter-
minations, various amounts of the microsomal material were dis-
solved in 250 pl of deionized water which served as the vehicle. 
Microsomal material in concentrations of 250 µg, 1,000 µg and 2,000 
pg per 250 pl of deionized water were assayed for hypocalcemic ac-
tivity in lJO to 160 g Holtzman rats which were fasted for 18 hr 
before their use for biological assay. This was done first of all, 
to establish whether or not this fraction was hypocalcemic, and 
secondly, to determine the injection dose which would result in a 
maximal hypocalcemic response. The various concentrations of mi-
crosomal material were injected intravenously into rats and the 
calcium concentration of the serum samples was determined before 
and 50 minutes after injection. 
The microsomal preparations were analyzed for protein con-
tent and the change in serum calcium was expressed as the change 
in calcium in mg%/10 µg protein. The influence on hypocalcemic 
activity of increasing microsomal injection doses is presented in 
Table VII. It is apparent that intravenous injection of as little 
as 250 µg of crude microsomal material evoked a hypocalcemic re-
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TABLE VII 
HYPOCALCE'MIC ACTIVITY OF INCREASING DOSES OF MICROSOMAL 
PREPARATIONS OBTAINED FROM INCUBATION MEDIA CONTAINING 
PHYSIOLOGICAL CALCIUM CONCENTRATIONS 
Dose Animal Ca m~ ~ Ca mg:'/o/ Net % 
µg No. to t50 10 µg Protein Change Change 
,250 £g l 10.40 8.50 -0.101 -1.90 -18.3 
2 10.10 9.68 -0.022 -0.42 - 4.2 
3 l0.90 10.40 -0.027 -0.50 - 4.6 
4 9.50 9.30 -0.011 -0.20 - 2.1 
5 ll.J5 10.10 -0.066 -1.25 -11.0 
6 10.20 9.80 -0.021 -0.40 
- 3.9 
Mean ! s. D. -0.041 :t 0.031 - 7.4 
.la 000 B,g 1 14.00 7.95 -0.173 -6.05 -43.2 
2 14.20 11.60 -0.074 -2.60 -18.3 
J 10.00 7.60 -0.069 -2.40 -24.o 
4 12.00 11.30 -0.020 -0.70 - 5.8 
5 8.10 7.70 -0.011 -0.40 - 4.9 
Mean ± s. D. -0.069 ± 0.057 -19.2 
r 2,000 j!g 1 13.60 8.35 -0.151 -5.25 -38.6 [ 
t 2 l0.75 6.90 -0.110 -3.85 -35.8 ~·· 
J 11.40 8.35 -0.088 -3.05 -26.8 ,. [ 
I: 4 l0.50 7.70 -0.080 -2.80 -26.7 I 5 11.JO 8.80 -0.072 -2.50 -22.1 6 11.00 9.40 -0.046 -1.60 -14.5 
7 13.JO 11.60 -0.048 -1.70 -12.ts 
Mean ± s. D. -0.085 t 0.036 -25.3 
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sponse, lowering the serum calcium by approximately 7% 1 while in-
jection of 2,000 µg of this fraction resulted in a 25% decrease in 
serum calcium of rats 50 minutes after injection. A concomitant 
increase in the specific activity term, mgs % calcium change/10 
pg protein, was also observed; the specific activity increased 
from -0,041 for the 250 µg dose to-0.085 for the 2,000 µg prepara-
tion. The 2,000 µg microsomal dose elicited a maximal hypocalcemic 
response. A number of attempts were made to assay a J,OOO µg dose 
for hypocalcemic activity; however, this amount of microsomal ma-
terial was quite insoluble in deionized water, often resulting in 
the death of test rats, probably due to obstruction of the circu-
latory system by the suspension. In the few surviving animals, 
at this dosage, serum calcium was decreased by approximately the 
same amount as with the 2 1 000 µg dose. It was therefore decided 
to utilize a 2,000 pg dose of mitochondrial, nuclear, and microso-
mal preparations for hypocalcemic determinations in all subsequent 
experiments. 
THE INFLUENCE OF PHYSIOLOGICAL AND HIGH CALCIUM CONCENTRATIONS IN 
THE INCUBATION MEDIUM ON THE HYPOCALCEMIC RESPONSE OF SUBCELLULA!i 
.fRACTIONS ISOLATED FROM INCUBATED THYROID SLICES 
Although the microsomal fraction exhibited hypocalcemic activ-
ity at all dose levels tested, a distinct possibility remained 
that the mitochondrial and nuclear preparations might also exhibit 
hypocalcemic activity. Brown and Ulvedal (1960) had localized TSH 
activity in the mitochondria and ACTH activity was found to be 
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dispersed over several subcellular fractions; however, no hormonal 
activity was found to be present in the nuclear fraction. Yet, one 
can not arbitrarily dismiss these fractions from any hypocalcemic 
determinations. Consequently, mitochondrial and nuclear fractions, 
were obtained from incubation media containing either physiological 
' I 
or high levels of calcium, 11.5 mg/100 ml and 26.0 mg/100 ml, re-
' 
spectively; and were assayed for hypocalcemic activity in rats at 
a dose of 2,000 µg. In these initial studies, no tracer amino 
acid (glycine-C-14) was utilized in the incubation media. 
A calcium concentration of 11.5 mg/100 ml of Krebs-Ringer 
bicarbonate buffer incubation medium was selected as a physiologi-
cal calcium concentration, since the normal serum calcium level 
in most mammals ranges from 9.0 to 12.5% depending on the test 
animal. In rats, the normal serum calcium level ranges from 9 to 
11.5%, therefore, the 11.5% calcium concentration was at the upper 
end of the normal range. The reason for selecting 26.0 mg/100 ml 
of Krebs-Ringer bicarbonate buffer as a high calcium concentration 
incubation medium was somewhat arbitrary. It is known that in 
mammals serum calcium levels seldom exceed 22 to 23 mg% even in 
severe cases of hyperparathyroidism or experimentally induced hy-
percalcemia; consequently, tqe high calcium concentration used 
here was slightly above the highest reported values for serum 
calcium. 
•1 
z 
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The influence of a physiological calcium concentration of the 
incubation medium on the hypocalcemic response in rats injected 
with aliquots of mitochondrial and nuclear fractions isolated from 
the incubated thyroid slices is shown in Table VIII. ·The hypocal-
cemic response of the microsomal preparation has already been noted 
in Table VII. Surprisingly, the nuclear preparation decreased the 
serum calcium of rats by approximately 27%. This was 2% more than 
the 25% decrease in serum calcium of rats injected with micros9mal 
material. The mitochondrial preparation, however, elicited only 
a slight hypocalcemic response. Although the hypocalcemic response 
of the nuclear and microsomal preparations were quite similar, in-
jection of the nuclear preparation resulted in only a -0.038 mg% 
change in serum calcium per 10 pg protein whereas the microsomal 
preparation changed serum calcium by -0.085 mg% per 10 pg protein. 
This indicated that the microsomal preparation exhibited over twice 
the hypocalcemic response per 10 pg of protein, as did the nuclear 
fraction. It appeared likely that the hypocalcemic response of 
the nuclear fraction could be attributed to significant microsomal 
contamination of this fraction. This possibility was borne out in 
further testing. 
The influence of a high calcium concentration on the hypocal-
cemic response of the microsomal, mitochondrial, and nuclear sub-
cellular fractions is shown in Table IX. In this experiment, only 
the microsomal preparation exhibited a hypocalcemic response, 
,. 
~ 
t 
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TABLE VIII 
HYPOCALCEMIC ACTIVITY OF MITOCHONDRIAL AND NUCLEAR PREPARATIONS 
AT A CONCENTRATION OF 2,000 µg OBTAINED FROM INCUBATION 
MEDIA CONTAINING PHYSIOLOGICAL CALCIUM CONCENTRATIONS 
Pre para ti on Animal Ca m~ £,,. Ca mg%/ Net % No. to t50 10 pg Protein Change Change 
Mitochondrial 1 8.10 8.30 +0.002 +0.20 + 2.5 
--
2 7.80 8.50 +0.006 +0.70 + 9.0 
3 8.10 7.00 -0.010 -1.10 -13.6 
4 7.40 7.60 +0.002 +0.20 + 2.7 
5 8.10 7.50 -0.005 -0.60 - 7.4 
-6 8.50 7.80 -0.006 -0.70 - 8.2 
7 8.50 7.60 -0.008 -0.90 -10.6 
Mean ± S. D. -0.00J ± o.ooo 
- J.7 
Nuclear 1 12.40 7.90 -0.066 -4.50 -J6.) 
2 9.50 6.50 -0.044 -3.00 -Jl.6 
) 10.40 6.oo -0.064 -4.40 -42.) 
/ 4 9.60 9.65 +o. 001 +0.05 o.o 
5 9.80 7.55 -0.018 -2.25 -23.0 
Mean :t s. D. -0.038 :t 0.028 -26.6 
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TABLE IX 
HYPOCALCEMIC ACTIVITY OF MICROSOMAL, MITOCHONDRIAL, AND NUCLEAR 
PREPARATIONS AT A CONCENTRATION OF 2,000 pg OBTAINED FROM 
INCUBATION MEDIA CONTAINING HIGH CALCIUM CONCENTRATIONS 
'·: .. ·1 .. ·.· I 
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10~ering serum calcium of rats by approximately 19%. The mitochon-
drial and nuclear preparations elicited a slight hypercalcemic re-
sponse in rats, raising the serum calcium levels by 8.4 and 4.9% 
respectively. No hypocalcemic response was noted in rats injected 
with the nuclear preparation obtained from incubation media con-
taining a high calcium concentration. This was in contrast to the 
hypocalcemic response of the nuclear fraction obtained from an in-
cubation medium containing a physiological calcium concentration 
as was noted in Table VIII, probably indicative of significant mi-
crosomal contamination in this fraction. Both the mitochondrial 
and nuclear preparations raised the serum calcium by approximately 
+ 0.015 mg% per 10 pg protein while the microsomal preparation de-
creased serum calcium by -0.047 mg% per 10 ~g protein, clearly in-
dicating that the microsomal preparation contained the subcellular 
locus for the hypocalcemic hormone. 
Tashjian and Warnock (1967) demonstrated that incubation of 
0 
crude porcine calcitonin in 0.03 N HCl at 110 C for 18 hours was 
accompanied by gradual loss of hypocalcemic activity, whereas heat-
ing this preparation at 110° C for 2 hours in 0.1 N HCl resulted 
in a more rapid inactivation of the molecule. However, heating 
the calcitonin preparation for 15 minutes at 110° C did little to 
alter the hypercalcemic response, thereby indicating the extreme 
thermostability of their crude CT preparation. Therefore, an at-
tempt was made to test the microsomal preparation which had decreased 
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the serum calcium level of rats by 25% (Table VII) for its ther-
mostability. Heat treatment of this preparation at 100° C for 2 
hours in 0.01 N HCl did not lead to inactivation. The data for 
the attempted heat-inactivation of this microsomal preparation 
obtained from an incubation medium having a physiological calcium 
concentration is presented in Table X. When this heat-treated 
preparation was assayed for hypocalcemic activity, a marked hypo-
calcemic response was noted. Serum calcium levels of rats receiv-
ing this preparation decreased approximately 29%, indicating no 
loss in hypocalcemic activity and the extreme thermostability of 
the microsomal preparation. 
Tashjian and Warnock (1967) had also shown that the time-
course of inactivation of -their crude porcine CT preparation by 
numerous proteolytic enzymes was extremely rapid. In order to 
demonstrate a similar effect with the hypocalcemic microsomal 
preparation, it was hydrolyzed for one hour at 37° C with pepsin 
at pH 2.7. The substrate:enzyme weight ratio was 10:1. As can be 
seen from Table XI, pepsin was extremely effective in destroying 
the hypocalcemic activity of the microsomal preparation. Now, 
instead of lowering serum calcium by approximately 25% (Table VII), 
injection of this pepsin-treated microsomal preparation resulted 
in approximately a 4% increase in serum calcium, or a change in 
calcium from -0.085 mg% per 10 pg protein to -0.001 mg% per 10 pg 
protein. This experiment indicated the protein nature of this 
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TABLE X 
HYPOCALCEMIC ACTIVITY OF HEAT-TREATED MICROSOMAL PREPARATION 
AT A CONCENTRATION OF 2,000 pg OBTAINED FROM INCUBATION MEDIA 
CONTAINING PHYSIOLOGICAL CALCIUM CONCENTRATIONS 
Pre para ti on Animal Ca m~ 6. Ca mg%/ Net % No. to t50 10 µg Protein Change Change 
Microsomal* 1 10.40 5.40 -0.148 -5.00 -48.l 
2 10.10 9.25 -0.025 -0.85 - 8.4 
3 7.90 6.oo -0.056 -1.90 -24.l 
4 11.20 6.55 -0.138 -4.65 -41.5 
5 11.50 10.45 -0.031 -1.05 - 9.1 
6 lJ.40 7.50 -0.175 -5.90 -44.o 
Mean :!: s. D. -0.096 :t 0.066 -29.2 
*Microsomal preparation heated for 2 hours at 100° C in 0.01 N HCl. 
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TABLE XI 
HYPOCALCEMIC ACTIVITY OF PEPSIN-TREATED MICROSOMAL PREPARATION AT 
A CONCENTRATION OF 2 1 000 pg OBTAINED FROM INCUBATION MEDIA 
CONTAINING PHYSIOLOGICAL CALCIUM CONCENTRATIONS 
Pre para ti on Animal Ca m~ 6 Ca mg%/ Net % No. to t50 10 µg Protein Change Change 
Microsomal* 1 9.30 10.00 +o. 0022 +0.70 +7.5 i: 
2 9.10 9.30 +0.0006 +0.20 +2.2 
J 8.60 9.05 +0.0014 +0.45 +5.2 
4 8.40 8.30 -0.0003 -0.10 -1.2 
5 a.oo 8.75 +0.0024 +0.75 +9.4 
6 8.10 8.30 -0.0006 +0.20 +2.5 
Mean ± S. D. -0.001 ! 0.0000 +4.3 
*Microsomal preparation hydrolyzed with pepsin for 1 hour at 37° c 
and pH 2. 7 at a substrateaenzyme weight ratio of 1011. 
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p.reparation and the sensitivity of the microsomal fraction to inac-
tivation by a proteolytic enzyme. 
A statistical analysis employing the unpaired Student's "t" 
Test was utilized to compare the hypocalcemic response of mito-
chondrial and nuclear preparations to that of the microsomal prep-
aration. The statistical comparison for the subcellular prepara-
tions obtained from incubation media containing physiological and 
high calcium concentrations is presented in Table XII. A compari-
son of the change in serum calcium mg% per 10 µg protein of heat-
treated microsomal preparation to that of untreated microsomal ma-
terial from an incubation medium containing a physiological calcium 
concentration indicated that there was no significant loss in hypo-
calcemic activity. However, hydrolyzing this same microsomal prep-
aration with pepsin for one hour resulted in a highly significant 
decline of hypocalcemic activity of this preparation when compared 
to untreated microsomes. Moreover, a significant difference in 
·hypocalcemic activity was noted when the mitochondrial and the nu-
clear preparation were compared to the microsomal preparation ob-
tained from an incubation medium containing a physiological cal-
cium ion concentration. Specific activity values (change in serum 
calcium in mg%/10 pg protein)_ of the three subcellular fractions 
Obtained from incubation media containing high calcium concentra-
tions were also subjected to statistical analysis (Table XII). Once 
again, a significant difference in hypocalcemic activity was noted 
* 
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'!'ABLE XII 
HYPOCALCEMIC ACTIVITY OF MICROSOMAL, MITOCHONDRIAL, AND NUCLEAR 
PREPARATIONS OBTAINED FROM INCUBATION MEDIA CONTAINING HIGH 
·AND PHYSIOLOGICAL CALCIUM CONCENTRATIONS 
Preparation t:i. Ca mg%/ 10 µg Protein 
Physiological 
Microsomal -0.085 + 0.036 
-
Microsomal** -0.096 + 0.059 
-
Microsomal*** +0.001 + o.ooo 
-
Mitochondrial -0.003 + o.ooo 
-
Nuclear -0.038 + 0.028 
-
High 
Microsomal -0.046 + 0.010 
-
Mitochondrial +0.015 + o. 026 
-
Nuclear +0.015 + 0.078 
-
% 
Change 
-25.3 
-29.2 
+ 4.3 
- J.7 
-26.6 
-19.4 
+ 8.4 
+ "-· 9 
P* 
NS 
0.001 
0.001 
0.05 
0.001 
0.05 
Probability of the significance of the difference of the means 
as determined by the use of an unpaired Student's "t" Test. 
** Heat-treated microsomal preparation (2 hr, 100° C and 0.01 N 
HCl). · 
*** Microsomal preparation hydrolyzed by pepsin for 1 hour at J7° C 
and pH 2.7. 
I 
J 
·~ 
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when the mitochondrial and the nuclear preparations were compared 
to the hypocalcemic response of the microsomal preparation obtained 
from a medium containing a high calcium concentration• 
THE INFLUENCE OF VARYING CALCIUM CONCENTRATIONS IN THE INCUBATION 
MEDIUM ON THE HYPOCALCEMIC RESPONSE OF SUBCELLULAR PREPARATIONS 
ISOLATED FROM INCUBATED THYROID SLICES AND ON THE EXTENT OF 
INCORPORATION OF GLYCINE-C-14 INTO THESE FRACTIONS 
The first series of experiments described above dealt with 
determining the subcellular locus of CT, defining the injection 
dose which would elicit a maximal hypocalcemic response, evaluat-
ing the thermostability of the molecule, and establishing its pro-
tein nature. These mitochondrial, microsomal and nuclear prepara-
tions were assayed for hypocalcemic activity without further puri-
fication. 
In this series of experiments, the incorporation of glycine-
C-14 (UL) into subcellular fractions obtained from incubation 
media containing physiological, low, and high calcium concentra-
tions was an additional parameter that was monitored. In addition, 
the subcellular preparations were subjected to a purification step. 
This consisted in passing the fractions through a column of Sepha-
dex G-100 which eliminated a large portion of the membranous 
macromolecular material associated with each subcellular fraction. 
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Sorgente (1969) had demonstrated that a very high calcium 
concentration (45 mg/100 ml) in the incubation media was accom-
panied by an increase in both synthesis and release of CT from 
ovine thyroid slices. It was therefore a possibility that a tra-
cer amino acid, such as glycine-C-14 (one of the prominent amino 
acids of ovine CT), could be incorporated preferentially into the 
subcellular fraction exhibiting hypocalcemic activity. It was 
also possible that the concentration of calcium in the biosynthe-
tic media could influence the extent of incorporation of label 
into the hypocalcemic fraction. Consequently, in vitro biosynthe-
tic media. were prepared as described previously; however, in this 
instance, uniformly labeled glycine containing 2.5 µCi of carbon-14 
was added to each biosynthetic medium. 
Microsomal, mitochondrial, and nuclear preparations obtained 
from incubation media containing physiological, low, and high cal-
cium concentrations were assayed for hypocalcemic activity, protein 
content and radioactivity. The hypocalcemic response of purified 
microsomal, mitochondrial, and nuclear preparations obtained from 
an incubation medium containing a physiological calcium concentra-
tion is shown in Table XIII. The microsomal preparation was the 
only fraction which exhibited hypocalcemic activity, lowering serum 
calcium levels of rats by 11.5%. The mitochondrial and nuclear 
preparations were slightly hypercalcemic, raising serum calcium 
levels by 1.0% and 5.3% respectively. The microsomal preparation 
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TABLE XIII 
- HYPOCALCEMIC ACTIVITY OF MICROSOMAL, MITOCHONDRIAL, AND NUCLEAR 
PREPARATIONS OBTAINED FROM INCUBATION MEDIA CONTAINING 
PHYSIOLOGICAL CALCIUM CONCENTRATIONS AND 
2.5 pCi OF GLYCINE-C-14 (UL) 
J>repara ti on Animal Ca mg% ~ Ca mg%/ Net % No. to t50 10 pg Protein Change Change 
Microsomal 1 11.10 10.00 -0.023 -1.10 - 9.9 
- 2 10.40 a.oo -0.050 -2.40 -23.1 
3 9.90 8.30 -0.034 -1.60 -16.2 
4 8.80 7.25 -0.033 -1.55 -17.6 
5 10.15 10.15 o.ooo o.oo o.o 
6 10.30 9.90 -0.008 -0.40 - 3.9 
7 10.05 9.05 -0.021 -1.00 -10.0 
Mean ! s. D. -0.024 ~ 0.017 -113 
Mitochondrial 1 10.49 10.00 -0.037 -0.40 - 3.8 
2 8.60 9.00 +0.037 +0.40 + 4.7 
3 8.60 9.00 +0.037 +0.40 + 4.7 
4 9.00 9.20 +0.018 +0.20 + 2.2 
5 9.60 9.10 -0.046 -0.50 - 5.2 
6 9.60 9.80 +o. 018 +0.20 + 2.1 
7 9.90 10.15 +0.023 +0.25 + 2.5 
Mean ± S. D. +0.007 ! 0.005 + 1.0 
Nuclear 1 9.95 9.60 -0.031 -0.35 - 3.5 
2 9.45 10.15 +0.063 +0.70 + 7~4 
/ 3 9.30 10.50 +0.107 +1.20 +12.9 
4 a.50 9.40 +0.080 +0.90 +10.6 
5 9.95 10.10 +0.013 +0.15 + 1.5 
6 9.80 10.20 +o. 036 +0.40 + 4.1 
7 9.90 10.60 +0.063 +0.70 + 7.1 
8 10.30 11.10 +0.071 +0.80 + 7.8 
9 10.45 10.50 +0.004 +0.05 + 0.5 
Mean ± S. D. +O. 045 t 0.042 + 5.J! 
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decreased serum calcium by -0.024 mg% per 10 µg of protein 
while both the mitochondrial and nuclear preparations slight-
ly increased serum calcium levels by +0.007 and +0.045 per 
10 pg protein, respectively. The microsomal preparation 
which had been purified by passage through a Sephadex G-100 
column actually exhibited less hypocalcemic activity per 10 
pg of protein (-0.024) than the unpurified microsomal prep-
aration (-0.085, Table VII). It is likely that a large per-
centage of the stored CT in this fraction is intimately as-
sociated with membranous material that was unable to pass 
through the chromatographic column. This could account for 
the smaller hypocalcemic response (11.5%), of purified micro-
somal preparation as indicated in Table XIII as compared 
to a 25.3% decrease in serum calcium of unpurified microsomes 
indicated in Table VII. 
The elution pattern, protein content, and radioactivity 
of a microsomal preparation obtained from an incubation medium 
containing a physiological calcium concentration and passed 
through a column of Sephadex G-100 is presented in Figure 14. 
The six to seven fractions representing the elution peak were 
pooled for the assay of hypocalcemic activity noted above. 
In this instance, the protein and radioactive peaks corres-
Ponded closely to the elution peak. The radioactive peak 
corresponded to approximately 2300 DPM / mg protein and the 
microsomal protein peak contained approximately 250 µg 
Protein / ml of eluent. Figure 15 shows the elution 
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pattern, protein content, and incorporation of glycine-C-14 into a 
~itochondrial preparation obtained from the same incubation medium 
as the previously cited microsomal preparation. The elution, pro-
tein, and radioactive peaks correspond rather closely. However, 
the protein peak of the mitochondrial preparation, 25 µg per ml 
eluent, was about 10 times less than the 250 pg protein/ml eluent 
of the microsomal preparation (Figure 14). This was not an unex-
pected result since it has been well established that protein syn-
thesis occurs on the ribosomes, which are constituents of the mi-
crosomal fraction. However, the radioactive peak of this mito-
chondrial preparation representing 3300 DPM/mg protein was actually 
somewhat higher than the radioactive peak of the microsomal prepa-
ration representing 2300 DPM/mg protein as indicated in Figure 14. 
This seemed to rule out the possibility that glycine-C-14 was pre-
ferentially incorporated into the hypocalcemic microsomal fraction. 
Similar data were observed with the nuclear preparation which was 
obtained from an incubation medium containing a physiological cal-
cium concentration as shown in Figure 16. The elution, protein, 
and radioactivity peaks overlapped quite closely. The protein 
peak, corresponding to approximately 20 µg of protein/ml eluent, 
was much less than the protein peak of the microsomal preparation. 
However, the peaks of radioactivity of the nuclear and microsomal 
preparations were of similar magnitude, being approximately 2700 
DPM per mg of protein for the nuclear preparation as compared to 
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z300 DPM per mg protein for the microsomal preparation (Figure 14). 
Sorgente (1969) demonstrated that a calcium concentration of 
45 mg/100 ml, a concentration four times greater than a physiologi-
cal calcium level, enhanced the biosynthesis and release of CT 
from thyroid slices in biosynthetic media. However, he did not 
determine the influence of a low calcium concentration on hormone 
biosynthesis and release. Therefore, microsomal, mitochondrial, 
and nuclear preparations were obtained from an incubation medium 
of Krebs-Ringer bicarbonate buffer containing a calcium concentra-
tion of 4.8 mg/100 ml. This low level of calcium in the incuba-
tion medium was selected due to its approximation to the physio-
logical minimum to which serum calcium could decline as occurs in 
parathyroidectomized animals or in animals on a severely restricted 
calcium diet. A change in the extent of tracer amino acid incor-
poration or an alteration in the hypocalcemic response of the 
three subcellular fractions at this low calcium concentration 
might give some indication of the degree of sensitivity of the 
hormone biosynthetic process to short-term deprivation of calcium. 
The influence of a low calcium concentration on hormone biosynthe-
sis and incorporation of glycine-C-14 is presented in Table XIV. 
The microsomal fraction decreased serum calcium by 12.4% and the 
change in calcium in mg% was -0.034 per 10 pg protein. These val-
ues are quite similar to those for the microsomal preparations 
obtained from a physiological calcium-containing medium (Table XIII) 
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in which the decrease in serum calcium was 11.5% and serum calcium 
was decreased by 0.024 mg%/10 pg protein. Unlike the microsomal 
preparation, injection of the_mitochondrial and nuclear prepara-
tions elicited less than a 2% hypocalcemic response in rats. 
Microsomal preparations obtained from incubation media containing 
either low or physiological calcium concentrations both lowered 
serum calcium by approximately 12%. Figure 17 shows the elution 
pattern, protein content, and radioactivity of a microsomal prepa-
ration obtained from an incubation medium containing 4.8 mg Ca/ 
100 ml of Krebs-Ringer bicarbonate buffer. The elution, protein, 
and radioactivity peaks corresponded quite closely. Once again, 
the peak protein content of the microsomal fraction was quite high, 
approximating 360 pg per ml of eluent. The radioactive peak of 
the purified microsomal preparation was approximately 5500 DPM/ 
mg protein. Since the hypocalcemic response of this microsomal 
preparation was almost identical to that of the microsomal prepa-
ration obtained from an incubation medium containing a physiologi-
cal calcium concentration, it was apparent that glycine-C-14 was 
being incorporated at an enhanced rate, into microsomal proteins 
other than CT. Actually, the high value can not be readily ex-
plained, since one would expect the same or lower levels of in-
corporation of tracer amino acid into a microsomal preparation 
obtained from an incubation medium containing a low calcium con-
centration. 
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The elution pattern, protein content, and radioactivity of a 
mitochondrial preparation obtained from an incubation medium con-
taining a low calcium concent~ation are exhibited in Figure 18. 
The elution, protein and radioactivity peaks correspond quite 
closely. An incongruent feature is a rather large protein peak 
of approximately 300 ~g/ml eluent compared to that observed for 
the mitochondrial preparation obtained from an incubation medium 
containing a physiological calcium concentration (Figure 15). 
However, the peak of radioactivity of approximately 3,000 DPM per 
mg protein is quite similar to that of mitochondrial and micro-
somal preparations obtained from incubation media containing low 
or physiological calcium concentrations. 
Figure 19 shows the elution pattern, protein content, and 
radioactivity of purified nuclear preparation obtained from an 
incubation medium containing a low calcium concentration. Once 
I again, there is a close correspondence between the elution, pro-tein, and radioactivity peaks. The radioactivity peak corresponds 
j to approximately 5500 DPM per mg protein. The high radioactivity 
I peaks of approximately 5500 DPM/mg protein of the nuclear (Figure 19) and microsomal preparations (Figure 17) do not indicate a 
consistent trend of increased incorporation of radioactivity into 
protein of subcellular fractions obtained from media containing 
Since the mitochondrial preparation had a radioactivity peak of 
only 3,000 DPM per mg protein (Figure 18). 
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Figure 19 • Protein content (• e), radioactivity (•---•), and elution pattern 
( ) of lyophilized nuclear preparation from a low calcium concentration incuba-
tion medium passed through a column of Sephadex G-100. Flow rate - 35 ml/hr; 4 ml 
fractions collected. Fractions assayed for hypocalcemic activity ( ). Two 
times the expansion of the %T scale. 
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The hypocalcemic response of subcellular fractions incubated 
in media containing a high calcium concentration is presented in 
Table XV. The mitochondrial ~nd nuclear preparations were slightly 
hypercalcemic, increasing serum calcium by 6.4 and 6.3%, respec-
tively. But the microsomal fraction was extremely hypocalcemic, 
decreasing serum calcium by 22.5% and changing serum calcium by 
-0.083 mg% per 10 µg protein. This clearly indicated that a high 
calcium concentration in the incubation medium had stimulated cal-
citonin biosynthesis in the microsomal fraction. The 22.5% de-
crease in serum calcium was almost twice that observed with micro-
somal preparations obtained from incubation media containing phys-
iological calcium concentration (11-.5%, Table XIII) and low ( 12 .4%, 
Table XIV) calcium concentrations. Moreover, the change in serum 
calcium of -0.085 mg per 10 pg protein was over twice that observed 
from microsomes obtained from an incubation medium containing a 
physiological calcium concentration (which changed serum calcium 
by -0.024 mg% per 10 pg protein) and those obtained from a medium 
containing a low calcium concentration (which changed serum cal-
cium by -0.034 mg% per 10 µg protein). The elution pattern, pro-
tein content, and radioactivity of the microsomal preparation 
obtained from an incubation medium containing a high calcium con-
centration is shown in Figure 20. The protein peak corresponded 
to 400 pg protein per ml eluent. The peak of radioactivity was 
900 DPM/mg protein and occurred several fractions beyond the 
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TABLE XV 
HYPOCALCEMIC ACTIVITY OF MICROSOMAL, MITOCHONDRIAL, AND NUCLEAR 
PREPARATIONS OBTAINED FROM INCUBATION MEDIA CONTAINING HIGH 
CALCIUM CONCENTRATIONS AND 2.5 µCi OF GLYCINE-C-14 (UL) 
pre para ti on Animal Ca m~ l:l. Ca mg%/ Net % No. to t50 10 µg Protein Change Change 
!1.!crosomal 1 11.16 9.03 -0.049 -2.13 -19.1 
2 11.48 9.08 -0.055 -2.40 -20.9 
3 11.10 8.67 -0.056 -2.43 -21.9 
4 10.92 9.03 -0.044 -1.89 -17.3 
5 11.99 9.08 -0.067 -2.91 -24.3 
6 11.23 8.37 -0.066 -2.86 -25.5 
7 11.16 9.13 -0.047 -2.03 -18.2 
8 11.40 8.41 -0.140 -2.99 -26.2 
9 11.74 8.56 -0.149 -3.18 -27.1 
10 l0.93 8.17 -0.129 -2.70 -25.3 
11 10.51- 8.21 -0.107 -2.30 -21.9 
Mean ± S. D. -0.083 ± 0.040 -22.5 
Mitochondrial 1 8.74 9.14 +0.011 +0.40 + 4.6 
2 8.79 10.22 +o. 039 +1.43 +16.3 
3 8.99 9.20 +0.006 +0.21 + 2.3 
4 8.55 9.10 +0.015 +0.55 + 6.4 
5 8.74 9.40 +o. 018 +0.66 + 7.6 
6 9.46 9.56 +0.003 +0.10 + 1.1 
Mean '± S. D. +0.015 ± 0.010 + 6.4 
Nuclear l 9.35 10.00 +o. 023 +0.65 + 7.0 
2 . 10. 06 8.99 -0.038 -1.07 -10.6 
3 9.10 10.57 +o. 052 +l.47 +16.2 
4 8.74 9.25 +0.018 +0.51 + 5.8 
5 9.25 10.86 +0.057 +1.61 +17.4 
6 9.71 9.89 +0.006 +0.18 + 1.9 
Mean ± s. D. +o. 020 ± 0.033 + 6.3 
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Figure 20. Protein content (e-e), radioactivity (.6.--·.6.), and elution pattern 
( ) of lyophilized microsomal preparation from a high calcium concentration 
incubation medium passed through a column of Sephadex G-100. Flow rate - 35 ml/hr; 
4 ml fractions collected. Fractions assayed for hyp6calcemic activity ( ). 
Two times the expansion of the %T scale. 
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elution and protein peaks. The relatively small amount of incor-
poration of glycine-C-14 into this fraction is not readily explain-
ed since one would expect increased i~corporation of the label into 
a preparation undergoing increased protein biosynthesis. This low 
amount of radioactivity was not a consistent finding since Figure 
21 shows that the mitochondrial preparation had 2500 DPM per mg 
protein, The elution and protein peaks corresponded quite closely. 
The elution pattern, protein content. and radioactivity of a 
nuclear preparation which was obtained from an incubation medium 
containing a high calcium concentration is shown in Figure 22. 
Jn this particular experiment. the protein peak occurred far be-
yond the elution and radioactive peaks. The protein peak was 
rather small. representing 50 µg of protein per ml eluent, and the 
radioactivity peak was approximately 6.ooo DPM/mg protein. The 
foregoing study which monitored the incorporation of glycine-C-14 
into subcellulRr fractions did not demonstrate a preferential in-
corporation of the tracer amino acid in~o the hypocalcemic, micro-
somal fraction. Moreover, the extent of incorporation 0£ the 
label into subcellular preparations was not influenced by the cal-
cium concentration of the biosynthetic media, since no consistent 
,patterns in glycine-C-14 incorporation were evident. However. it 
was apparent that glycine-C-14 was being incorporated into all of 
the proteins of the microsomal. mitochondrial. and nuclear prepa-
rations without any preferential incorporation into CT of the mi-
crosomal preparation. 
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Figure 21 • Protein content (e e) • radioactivity (.A---•), and elution pattern 
( ) of lyophilized mitochondrial preparation from a high calcium concentration 
incubation medium passed through a column of Sephadex G-100. Flow rate - 35 ml/hr; 
4 ml fractions collected. Fractions assayed for hypocalcemic activity { -- ). Two 
times the expansion of the %T scale. 
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A statistical analysis was utilized to compare the hypocal-
cemic response of Sephadex G-100-purified and labeled mitochondrial, 
and nuclear preparations to that of the consistently hypocalcemic 
microsomal preparations. The analysis, employing an unpaired 
student's "T" Test, is presented in Table XVI. A significant dif-
ference in hypocalcemic activity was evidenced when the mitochon-
drial and nuclear preparations obtained from incubation media con-
taining a physiological calcium concentration were compared to the 
hypocalcemic response of the microsomal preparation which was ob-
tained from the same type of biosynthetic media. While the micro-
somal preparation decreased serum calcium by 0.024 mg% per 10 µg 
protein, the mitochondrial preparation and nuclear preparation 
actually increased serum calcium by 0.007 and 0.045 mg%/10 pg 
protein, respectively. Similarly, the mitochondrial and nuclear 
preparations, obtained from incubation medium containing a low 
calcium concentration, were significantly different in their hypo-
calcernic responses from that of the microsomal preparation obtained 
from this biosynthetic medium. The microsomal fraction decreased 
serum calcium by 0.034 mg%/10 pg protein while the mitochondrial 
fraction decreased serum calcium by only 0.005 mg%/10 µg protein 
and the nuclear preparation by 0.007 mg%/10 ug proteino Moreover, 
a highly significant difference in hypocalcemic activity was noted 
when the hypocalcemic response of the microsomal preparation ob-
tained from a medium containing high calcium concentration was 
compared to th~~t of mitochondrial and m.lclear preparations ob-
tained from the same incubation medium. 
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TABLE XVI 
HYPOCALGEMIC ACTIVITY OF PURIFIED MICROSOMAL, !UTOCHONDRIAL, AND 
NUCLEA.-q PREPAHATIONS OBTAINED FROM INCUBA'I'ION MEDIA CONTAINING 
LOW, PHYSIOLOGICAL, AND HIGH CALCIUM CONCENTRATIONS 
Preparation 
fLl_Y.S i 019.EJ.~1 
Microsomal 
Mitochondrial 
Nuclear 
~ 
Microoomal 
Mitochondrial 
Nuc.;lear 
High 
Microsomu.l 
Mitochondrial 
Nuclear 
==- -:::=r~.:;-···-----..... ~---
*Probability of the 
A Ca mg%/ 
10 µg Protein 
-0.024 + 0.017 
+0.007 + 0.005 
-
+o. 045 + 0.042 
-
-0.0)4 + 0.024 
-
-0.005 + 0.014 
-
-0.007 + 0.026 
-
-0.08J + 0.040 
+o. 015 + 0.010 
-
+o. 020 + 0.033 
-
-
significance of the 
% 
Change 
-11.5 
+ l.. 0 
+ 5.3 
. -12.4 
-
1.8 
- 1.5 
-22 .. 5 
+ 6.4 
+ 6.J 
~----
difference of the 
determined by the use of an unpaired Student's "t" Test. 
0.001 
0 .. 001 
0.01 
0.05 
0.001 
0.001 
means as 
·I 
' I 
' I 
I 
I 
I 
1 
t 
' J 
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The influence of varying calcium concentrations on the hypo-
calcemic response of microsomal preparations is shovm in· Table 
XVII. In this instance, the hypocalcemic response of Sephadex 
G-100 purified microsomal preparations obtained from incubation 
media of low and high calcium concentrations was compared to that 
of a microsomal preparation obtained from an incubation medium 
containing a physiological calcium concentration. It is quite ap-
parent that lowering the calcium concentration of the biosynthetic 
media (4.8 mg/100 ml) does not significantly alter the hypocal-
cemic response of the microsomal preparation when compared to that 
of a microsomal preparation obtained from a medium containing a 
physiological calcium concentration. However, increasing the cal-
cium concentration of the biosynthetic medium to 26 mg per 100 ml 
buffer results in a very significant increase in the hypocalcemic 
response of the microsomal preparation. This clearly demonstrates 
that a high calcium concentration in the incubation medium en-
hances CT biosynthesis at the subcellular level, even though in-
corporation of glycine-C-14 into the microsomal preparation is not 
enhanced by this calcium concentration. 
QJ:LARAQTERIZATION OF MICROSOMAL AND STAND~RD CAJ.,CITON1.1LPREPA!{.ATIONS 
BY POLYACRYLAMIDE GEL ELECTROPHORESIS 
.. The second part of this investigation dealt with establishing 
the identity o~ the hypocalcemic micros0mal fraction by comparison 
with a standard calcitonin preparation of known potency. To ac-
complish this, microsomal and standard calcitonin preparations of 
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TABLE XVII 
THE INFLUENCE OF VARYING CALCIUM CONCENTRATIONS ON THE 
HYPOCALCEMIC RESPONSE OF MICROSOMAL PREF.A,-qATIONS 
---
___ ,,,,.. ___ 
-~-·-·-"' 
Preparation Ll,. Ca mg%/ % P* 10 pg Protein Change 
·--- ---..-----
Physiological -0.024 ± 0.017 -11~5 
Low -O.OJ4 + 0.024 -12.4 NS 
High -0.0BJ ± o. 040 -22.5 0.005 
====----
*Probability of the significance of the difference of the means as 
determined by the use of an unpaired Student's "t" Test. 
' 
l 
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)Cnown potency were electrophoretically fractionated in polya.cryl-
amide gels. Microsomal fractions were then assayed for homog::?n~-­
i tY in polyacrylamide gels after purifjcation through Sephadex 
G-100 and G-50. 
Initial experiments consisted in the electrophoretic resolu-
tion in polyacrylamide gels of a standard calcitonin preparation 
having a potency of 88 MRC units/mg. A cationic polyacrylamide 
gel system was used. It was determined that 200 µg of this stan-
dard CT preparation per 200 µl of sample gsl solution W\Scre suffi-
cient for resolving this calcitonin preparation into its component 
peptide fractions after an electrophoretic running time of one 
hour and twenty minutes with a current of 2i ma per gel column. 
The densitometer trace of this cationic standard gel is presented 
in Figure 23. Readily apparent from the densitometer trace are 
two well-defined protein oands in these gels. The resolved band 
nearest the end of the separation gel was the largest and most 
intensely stained. Virtually all of the standard CT sample had 
electrophoretically migrated from the sample gel into the separa-
tion gel. 
A number of attempts were then made to resolve the Sephadex 
G-100 purified microsomal preparation in this cationic polyacryl-
amide gel system as was achieved with the standard preparation. 
IrJ.i tial attempts to resolve this preparation were performed at 
200 µg of microsomal sample per gel. Electrophoresis was carried 
out for the same length of time and milliamperage per gel as had 
proved successful in resolving the standard calcitonin preparation. 
However, none of the sample material electrophoretically migrated 
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Figure 23. Densitometer trace of a stained poly-
acrylamide gel. Two hundred micrograms of an 
88 ~RC unit calcitonin standard were resolved in 
a cationic gel system. 
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into the separation gel. In repetitive attempts to resolve this 
microsomal preparation, the sample concentration was incr·eased to 
i,500 pg per gel. These rather high sample concentrations were 
utilized since it was apparent that a large portion of the micro-
somal preparation was not dissolved in the sample gel solution. 
This insoluble material was probably the remnants of the membra·· 
nous macromolecular material of the microsomal fraction which was 
impossible to solubilize in the sample gel. Once again, all at-
tempts to resolve the microsomal preparation in a cationic gel 
proved to be unsuccessful. Since the microsomal preparation could 
not be resolved in cationic gels as was the standard CT prepara-
tion, this cationic gel system could not be utilized to establish 
the identity of the hypocalcemic microsomal material by comparison 
with a standard CT preparation. Therefore, attempts were made to 
electrophoretically resolve the standard calcitonin and microsomal 
preparations into their component protein fractions in an anionic 
gel system. A standard CT preparation at a concentration of JJJ 
µg per gel column was electrophoretically fractionated in an an-
ionic gel at a current of 2~ ma per column for one hour and forty 
minutes. Bromphenol blue served as the tracking dye in this an-
ionic gel system. The trial run proved to be successful. The 
standard calcitonin preparation could be resolved into its com-
ponent protein bands in both cationic and anionic polyacrylamide 
gel systems. This indicated the amphoteric nature of the standard 
CT preparation. However, not all of the standard CT preparation 
was resolved iu the anionic gel system as evidenced by the sub-
stantial amount of sample remaining unresolved in the sample. 
-156-
A densitometer trace of a resolved JJJ )lg calcitonin standard 
pre para ti on is shown in Figure 24. An unusual finding was that in 
the anionic gel system, three major resolved protein bands (bands 
i, 2 and J) were evident as compared to the two bands observed in 
the cationic gels (Figure 2J). There was also a minor, rather in-
distinct band at the beginning of the separation gel and a diffuse 
band a. short distance beyond this minor band. It was possible 
that the major band (band 1) and the band adjoining it (band J), 
•, · which were observed at the end of the separation gel, represented 
I 
I 
I 
I 
I 
a better resolution of the single broad band which was observed at 
the end of the cationic standard CT gel {Figure 2J). 
Initial electrophoretic separations of Sep.had.ex G-J.00 micro-
somal preparations at sample concentrations varying from 200 to 
i,500 )lg at a constant current of 2t ma per gel column and one 
hour and forty minutes electrophoretic separation time indicated 
that the microsomal preparation could, indeed, be resolved in -'i:;his 
anionic gel system. Good resolution of protein bands was achieved 
at a sample concentration of 1,500 )lg• Thus, this concentr·ation 
was routinely used for electrophoretic resolution. A densitometer 
trace of the Se:phadex G-100 microsomal preparation is shown in 
Figure 24. The three protein bands at the end of the separation 
gel consisting of two prominent bands (band 1 and 2) and one band 
{band 3) next to the dense bottom band were in identical positions 
to those cf the JJJ ug CT standard. An additional small band was 
evident a shcrt distance from the end of the stacking gel which 
corre~'3p1:mded to the minor band in the densitometer trace of the CT 
standard. A densely stained band occurred at the interface of the 
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Figure 2~ Densitometer traces of electrophoretically resolved hormone 
preparations in anionic polyacrylamide gels. A, an 88 N~C unit calci-
tonin standard at a concentration of JJJ µgJ B, Sephadex G-100 microsom-
al preparation at a concentration of 1,500 µg1 C, Sephadex G-50 micro-
somal preparation at a concentration of 1,500 µg. 
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separation and stacking gels c-.1 though it is not shown in the den·· 
sitometer trace. This band may be attributable to macromolecular 
111aterial such as the remnants of the membranous portion of the 
1111crosomal fraction. Such densely stained bands at the stacking 
gel/separation gel interface are routinely observed when serum 
proteins are fractionated in polyacrylamide gels. 
A Sephadex G-50 purified microsomal preparation was run at 
the same sample concentration and milliamperage per gel as that 
for the Sephadex G·-100 purified preparation. A densitometer trace 
of this preparation is presented in Figure 24. '1.1he two dense 
bands (band 1 and 2) at the end of the separation gel still re-
mained and were identical in position to the standard calcitonin 
preparation. However, the protein band (band J) seen next to the 
dense band in the densitometer trace of the Sephadex G-100 gel and 
the anioni.c standard CT preparation was no longer evident. There 
was a very minor protein band a short distance from the end of the 
stacking gel. Once again, a dense band remained at the separation 
gel/stacking gel interface but is not shovm on the densitometer 
trace. 
An electrophoretic separation was performed with the CT stan-
dard, the Sep~adex G-100, and the Sephadex G-50 microsomal prepara-
tions in the same electrophoretic unit, thereby subjecting these 
three preparations to identical conditions of milliamperage per 
gel, electrophoretic separation time, and gel concentration. This 
was done to verify that the two major protein bands observed with 
these preparations were indeed attributable to the same peptide 
fraction in the CT standard, the Sephadex G-100, and the Sephadex 
' I i 
' I 
l 
' 
I 
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G-50 preparations. In all instances, the two major resolved pro-
tein bands of the standard CT and microsomal preparations corres-
ponded well as seen in Figure 25. It is also apparent that the 
5ephadex G-50 purification step of the microsomal preparation had 
removed a peptide band (band J) which was evident in the sta~dard 
CT preparation and the Sephadex G-100 preparation (Figure 24 and 
25). 
CHARACTF~IZATION OF MICROSOMAL AND STANDARD CALCITONIN fR~:AT.191:!~ 
BY ISOELECTRIC POCUSING 
Further characterization of the standard calci tonin prepara·· 
tion and microsomal calcitonin preparations was accomplished by 
isoelectric focusing. This highly sensitive, resolving technique 
was utilized to determine ·a physical constant, the isoelectric 
point, of both standard and microsomal calcitonin preparations. 
Seven milligrams of a standard CT preparation having a poten-
cy of 88 ~1RC units were electrofocused in an LKB 8100 Electrofocus-
ing Column in a pH gradien·t extending from pH J to 6. Electro-
phoretic resolution of the standard CT preparation was completed 
after 48 hours. The electrofocusi.ng column was then slowly emp-
tied starting from the anode electrode solution and the elution 
pattern at 280 nm was monitored. Fractions o:f :forty drops each 
were collected and the pH of these fractions was determined at 
4° C~ This permitted the drawing of a pH curve for the entire 
electrofocusing column. The elution pattern and the pH curve for 
the standard CT preparation are shown in Figure 26. The standard 
'----------------~ 
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Fig;Jre 25. Polyacryla<nide gels re~ resenti,;1g electro-
phoretically resolved standard and microsomal calci-
tonin preparations. The calcitcnin standard at a con-
centrati on of JJJ µg and the Sephadex G-100 and G-50 
purified microsomal preparations were fractionated in 
anionic gels under identical conditions. The standard 
calcitonin preparation at a concentration of 200 ?g 
was resolved in an anionic gel system and is shown 
for comparison. 
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Figure 26. Separation of 7 mg, of a standard calcl tonin preps.ration 
having a potency of 88 MRC uni ts by the I.1.KB 8100 Elcctrofocusi.ng col-
umn in a pH gradient extending from pH 3 to :60 The curve with two 
peaks shows the absorption of eluate at 280 nmo The steadily incre?..t~­
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C'..f' prepe.ra.tion was resolved into two :protein bands. The pl val-
ues of these two resolved protein bands were determined from the 
plot of the steadily increasing pH curve. Th~ resolved protein 
band, repri-::sented by the elution peak nearest the anode electrode 
solution had a. pI of ). 70 w.hile the pI of the second resolved pro-
t~in band was J.94. 
A similar type o:f determination was carried out with a Sepha-
dex G-50 pu.rifi.ea microsomal preparation which was obtB.ined from 
an' incubation medium containing a physiological calcium concentra-
tion. However, ln this instance, the microsomal material was re-
solved in a pH g"!'adient extending from pH J ... 0 to 5. o.. 'I'he narrower 
pH gradient was utilized since a preliminary electrophoretic reso-
lution of microsomal material in a broad pH gradient extending fron 
pH 3.0 to 10.0 indicated that the pI of the protein(s) of the mi·· 
crcsomal ma:terial was approximately 4 .. o. Figure 27 shoitiS -che 
electrophoretic resolution of 14 mg of microsomal material in the 
LKB 8100 EJ.ectrofocusing Column. Electrofocus.i...ng was carried out 
for t-}8 tours. The elution pattern was monitored at 280 r .... "n and 40 
drop fractions were collected. A pH curve for the entire electro· 
focusing column was determined at 4° c. The microsomc>.l prepara-
ti.or• l'•:lS rZ;3olved into two distinct protein band~:; having pI values 
of J .. 4·9 and J.,8i+; these were determined from the plot of the ste::>.d~ 
curve. These pI values for the microsomal CT 
preparation we:.-e quite similar to the pI values of J. 70 and J. 94· 
obtained fc:..~ th~' twci resolved protein bands of the standard CT 
P ·t~ /n•. "/) repar.::. ,.LOH , r 1.gure .::.c. ,. It is possible that the pl values of 
the two preparations woulc have been more nearly the same had the 
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Figure 27. Separation of 14mg of Sephadex G-50 purified microsomal 
preparation by the LKB 8100 Electrofocusing Column in a pH gradient 
extending from pH J to 5. The curve with the two peaks shows the ab-
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plot of the pH gradient superimposed, 
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standard CT preparation been resolved in the same narrower pH 
gradient {pH J.O to 5.0) in which the microsomal CT preparations 
had been electrophoretically resolved. The isoelectric focusing 
procedure did establish the pl values of the protein components of 
both the standard and microsomal CT preparations, and the identity 
of the microsomal CT preparation with that of the standard CT prep-
aration •. It is also possible that the slight differences in pl 
values between the two resolved protein bands of the standard and 
microsomal CT preparations could be attributed to species differ-
ences in amino acid composition of the CT molecule. The standard 
porcine CT molecule is known to differ from ovine CT molecule at 
four positions, at amino acid residue number 14, 15, 19, and 22 
(Figure 2), thereby resulting in slightly different pI values be-
tween the two molecules. Most of the amino acid differences be-
tween porcine and ovine CT are conservative. The phenylalanine 
residues at position 19 and 2 of the porcine molecule are replaced 
by tyrosine in the ovine CT molecule and the basic arginine resi-
due at position 14 of the porcine molecule is replaced by lysine, 
another basic amino acid, in the ovine CT molecule. The only sig-
nificant change in replacement of an amino acid residue is noted 
'--at position 15 where the amino acid, amide asparagine, in the por-
cine molecule, is replaced by an aspartic acid residue in the ovine 
CT molecule. This change in amino acid at position 15 could ac-
count for the slight differences in the observed pI values. 
Three forty-drop fractions corresponding to each of the two 
elution peaks in the resolved microsomal material were then passed 
through a column of Sephadex G-50 to remove most of the contamina-
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ting ampholytes from the resolved microsomal proteins. Approxi-
~ately 2 mg of purified microsomal material was obtained from each 
of the elution peaks. The radioactivity of 200 pg of microsomal 
material from the elution peaks having pl values of 3.49 and 3.84 
(Figure 27) was determined. It was not possible to determine the 
specific activity in terms of DPM/mg protein. There was still.a 
slight amount of ampholyte contamination with each of the resolved 
microsomal preparation and it interfered with the determination of 
protein by the Lowry method. Therefore, radioactivity was expressed 
f as counts per minute ( CPl\'1) per 200 pg of sample. Neither resolved 
I fraction exhibited enhanced incorporation of labeled glycine. The 
fraction having a pI of 3.49 had 238 CPM per 200 pg of sample, 
w~ile that of the fraction having a pI of 3.84 had a value of 215 
CPM per 200 µg sample. Once again, this demonstrated that no pre-
t ferential incorporation of glycine-C-14 into microsomal proteins 
was occurring. 
The two electrophoretically resolved microsomal fractions were 
then assayed for hypocalcemic activity. In order to have sufficient 
quantities of resolved microsomal material for biological assay de-
terminations, three isoelectric focusing runs were required. 
These were carried out as previously described. In the three in-
stances, the microsomal material was electrophoretically resolved 
into two protein bands and the pI values of each band did not dif-
fer by more than !O.l pH unit. Bioassays were performed as pre-
viously described: however, in this instance. the injection dose 
was 1,000 µg of electrophoreticallyresolved and Sephadex G-50 
Purified microsomal CT preparation. The hypocalcemic activity of 
I 
'I 
I 
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these preparations are shown in Table XVIII. The microsomal CT 
•aterial having a pI value of approximately 3.5 decreased serum 
calcium by 9.6% while the change in serum calcium was O.OJl mg% 
I per 10 pg protein. Injection of microsomal CT material having a 
t pl value of approximately J.8 resulted in a similar hypocalcemic 
response~ since the serum calcium was decreased by 8.8% and the 
1 change in serum calcium was 0.027 mg% per 10 pg of protein. 
f The hypocalcemic responses of the two electrophoretically re-
t 
' 
t 
' t 
solved microsomal CT fractions having pI values of 3.49 and J.84 
were compared to that of the unresolved microsomal CT preparation 
obtained from an incubation medium containing a physiological cal-
cium concentration. The statistical evaluation of the hypocalcemic 
responses is shown in Table XIX. The resolved microsomal protein 
bands with isoelectric points of J.49 and J.84 were not statisti-
cally different in their hypocalcemic response from that of unre-
solved microsomal material. 
' I 
t 
' t. 
' 
' 
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TABLE XVIII 
HYPOCALCEMIC ACTIVITY OF ELECTROPHORETICALLY RESOLVED MICROSOMAL* 
PREPARATIONS OBTAINED FROM AN INCUBATION MEDIUM CONTAINING 
A PHYSIOLOGICAL CALCIUM CONCENTRATION 
AND 2.5 pCi OF GLYCINE-C-14 (UL) 
Animal Ca m£:% ~ Ca mg%/ Net % 
J>reparation No. to t50 10 µg Protein Change Change 
Microsomal 
-
1 11.50 10.45 -0.031 -1.05 - 9.1 
pl ::: 3.49 2 11.35 10.10 -0.037 -1.25 -11.0 
3 io.51 9.94 -0.017 -0.57 - 5.4 
4 11.41 10.17 -0.037 -1.24 -10.9 
5 l0.52 9.34 -0.035 -1.18 -11.2 
Mean t s. D. -0.031 t 0.010 
- 9.5 
Microsomal 1 10.10 9.25 -o. 025 -0.85 - 8.4 
pl = 3. 84 2 l0.93 10.40 -0.016 -0.53 - 4.8 
3 9.60 9.10 -0.015 -0.50 - 5.2 
4 10.06 8.99 -0.0)2- -1.07 -10.6 
5 11.00 9.40 -0.047 -1.60 -14.5 
Meant S. D. -0.027 ± u.010 
- 8.7 
*Fourteen milligrams of Sephadex G-50 purified microsomal material 
was electrophoretically fractionated into two protein peaks in an 
LKB 8100 Electrofocusing Column in a pH gradient extending from 
PH 3 to 5. The first resolved protein band had a pl of 3.49 and 
the second had a pl of J.84. 
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TABLE XIX 
THE HYPOCALCEMIC RESPONSE OF ELECTROPHORETICALLY 
RESOLVED MICROSOMAL PREPARATIONS* 
A Ca mg%/ % 
Preparation 10 pg Protein Change 
' Microsomal -0.024 + 0.017 -11.5 
Microsomal -0.031 + 0.010 
- 9.5 
-pI=J.49 
Microsomal -0.027 + 0.010 - 8.7 
-pI=J.84 
P** 
NS 
NS 
, * The microsomal preparations having pI values of 3.49 and J.84 
were resolved in an LKB 8100 Electrofocusing Column in a pH 
gradient extending from pH J to 5. 
, ** Probability of the significance of the difference of the means 
as determined by the use of an unpaired Student's ttt" Test. 
' f 
• 
' t 
, I 
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' l 
I 
I 
. J 
CHAPTER IV 
DISCUSSION 
Since the postulated existence of calcitonin by Copp et al • 
I 
' (1962) and its discovery and isolation from the thyroid gland by 
Hirsch et al. (1963), a large body of information has accumulated 
concerning the cell of origin, chemistry, and sites of action of 
this hypocalcemic hormone. However, full clarification of the 
factors involved in the mechanism of action, metabolism, duration 
of action, control of secretion, and physiological role of this 
hormone in the maintenance of mammalian mineral homeostasis have 
not been elucidated. 
This study was concerned with further clarification of one of 
these areas of investigation, the control of calcitonin secretion; 
hence, its localization in thyroid glands and factors involved in 
its biosynthesis. More specifically, this study dealt with the 
subcellular localization of this hypocalcemic hormone in ovine 
thyroid glands, determining the influence of varying calcium ion 
concentration on hormone biosynthesis at the subcellular level, and 
establishing the identity of the hypocalcemic species with a ref-
erence standard calcitonin preparation by polyacrylamide gel elec-
trophoresis and by isoelectric focusing. In addition, this inves-
tigation has provided for the first time, in so far as is known, 
information on the isoelectric point(s) of standard porcine and 
microsomal ovine calcitonin preparations. 
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Calcitonin is secreted by the thyroid gland into the general 
circulation when a naturally occurring stimulus of hypercalcemia 
occurs. Its action is to markedly retard bone resorption as evi-
denced by the rapid decrease in blood calcium levels. When calci-
tonin is administered to rats, it produces a hypocalcemia which is 
manifest~d shortly after hormone administration and reaches a peak 
approximately one hour after the hormone injection (Hirsch et al., 
1964; Kumar et al., 1965) and it is effective even in parathyroid-
ectomized rats (Gudmundsson e~ al., 1966). Considerable evidence 
has been presented which indicates that CT inhibits the PTH-in-
duced resorptive process both in vivo and in vitro. In vivo ex-
periments of Milhaud and Moukhtar (1966), Johnston and Diess (1966), 
Klein _g1 ~· (1967) have consistently demonstrated that CT is ef-
fective in blocking PTH-induced bone resorption and may play a 
role in preventing bone matrix degradation as evidenced by the 
dramatically decreased excretion of hydroxyproline in intact rats 
(Martin et al., 1966, and Rasmussen et al., 1967), These experi-
ments provided evidence for the concept that CT administration re-
tarded all phases of bone resorption and that its action was not 
by direct inhibition of PTH. 
The characteristic hypocalcemic response and the retardation 
of PTH-induced mineral resorption by CT has been demonstrated in 
in vitro experiments utilizing bone cultures (Friedman and Raisz, 
1965; Friedman et al., 1968; Aliapoulios et al., 1966; Raisz and 
-- -- ---~ - -
Nieman, 1967; Reynolds and Dingle, 1968; and Brand and Raisz, 1972), 
and isolated and perfused limbs (Macintyre et.§;!., 1967). These 
experiments have clearly demonstrated that the hormone is bio-
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10gically active in in vitro systems and that its action in these 
systems may provide valuable information about its normal physio-
logical role in mammals. 
The problems associated with the control of CT secretion 
have been studied extensively. The mechanism(s) that controls the 
level of circulating hormone is akin to that controlling PTH. It 
is well-established that PTH secretion is controlled directly by 
blood calcium concentration, hypocalcemia enhancing secretion and 
I 
hypercalcemia abolishing secretion. Calcitonin secretion has also 
been shown to be dependent upon blood calcium concentration. The 
level of this hormone in the peripheral circulation is in direct 
proportion to increases in calcium concentration above normal 
levels. The observations of Copp et al. (1962), Kumar et al. (1963), 
Care (1965), and Care~ al. (1968) provided ample evidence that 
the extent of CT secretion from the thyroid is directly dependent 
upon the calcium concentration of the blood flowing through the 
thyroid gland, rising as the calcium level increases and falling 
as it decreases. The 'C' cells of the thyroid release CT only in 
response to the actual calcium concentration of the blood flowing 
through the thyroid and the secretion rate is not dependent on the 
rate, degree, or direction of calcium flux in the blood. These 
observations correlated well with the evidence presented by Foster 
~ al. (1964) and Matsuzawa and Kurosumi (1967) who demonstrated 
that hypercalcemic stimulation resulted in a gradual decrease of 
densely staining secretory granules of the 'C' cells. The highly 
sensitive radioimmunoassay technique of Deftos et al. (1968), Lee 
~ ~· (1969) and Cooper et al. (1971) confirmed that CT is being 
l 
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continuously secreted, even at physiological concentrations of 
blood calcium and that a rapid increase in CT secretion resulted 
when hypercalcemia was induced followed by a rapid decline in 
l 
hormone when normocalcemia'was restored. 
----~ ... "'-----~ 
The feasibility of utilizing in vitro biosynthetic media for 
studying the biosynthesis and release of hormones has been well-
established. In vitro biosynthetic media containing either slices 
or homogenates of such endocrine tissues as the hypothalamus 
(Takabatake and Sachs, 1964), anterior pituitary (Adiga et al., 
1965), parathyroid glands (Hamilton and Cohn, 1969 and Hamilton 
!! al., 1971), and thyroid glands (Sorgente, 1969 and Radde et al., 
1970) have been utilized to monitor the biosynthesis and release 
of hormones. These endocrine tissues exhibited the physiological 
regulatory mechanism in in vitro biosynthetic media which is typ-
ical of the gland in vivo, thereby providing a valuable insight 
into the factors involved in the physiological regulation of hor-
mone synthesis and release. 
Pertinent to this investigation, Sorgente (1969) utilized 
an in vitro biosynthetic medium containing thyroid gland slices 
in an effort to establish the role of calcium and magnesium ion 
at the tissue level on the synthesis and release of CT. Sorgente's 
biosynthetic media contained ovine thyroid slices which were in-
cubated (4 hr, 37° C) with glycine-C-14 in Krebs-Ringer bicarb-
onate buffer containing glucose (320 mg/100 ml) and all the amino 
acids of calcitonin (20 mg/l). The calcitonin, which was isolated 
by salt precipitation from incubated thyroid slices, was assayed 
for hypocalcemic activity in rats. Sorgente's experiments indi-
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cated that a high calcium concentration (45.6 mg%) in the bio-
synthetic medium stimulated both synthesis and release of CT 
since there was a 50% increase in the hypocalcemic response above 
physiological levels. However, varying the magnesium ion concen-
tration was without effect in the CT regulatory mechanism. Later, 
Radde et al. (1970) presented evidence that a high calcium concen-
tration in the biosynthetic medium was directly responsible for 
enhanced CT release into biosynthetic media. 
In this investigation, Sorgente's in vitro biosynthetic me-
dium was utilized for the incubation of ovine thyroid slices. 
Further, his experimental findings were confirmed in this study 
and provided a working model to allow for extrapolation to xhe 
subcellular level. Thns, in this study, three distinct subcellu-
lar fractions, the microsomes, the mitochondria, and the nuclei 
were obtained from incubated thyroid slices by differential cen-
trifugation and were assayed for hypocalcemic activity in rats to 
determine the subcellular locus of CT. The influence of a vary-
ing calcium ion concentration on biosynthesis at the subcellular 
level was investigated by utilizing incubation media containing 
low (4.8 mg%), physiological (11.5 mg%), and high (26.0 mg%) cal-
cium concentrations. The incorporation of glycine-C-14 into these 
subcellular fractions was monitored in an attempt to determine 
whether the hypocalcemic fraction could be shown to reflect an 
enhanced incorporation of labeled amino acid, a further evidence 
of calcitonin biosynthesis. In addition, this approach would 
determine whether the alterations in the calcium ion concentration 
could effect the extent of incorporation of labeled amino acid into 
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the hypocalcemic fraction. 
Assaying subcellular fractions for hormonal activity is not 
an unprecedented investigative procedure since Brown and Ulvedal 
(1960) localized hormonal activity in a number of anterior pitui-
tary fractions. Similarly, Hamilton and Cohn (1969) demonstrated 
that the 105,000 x g particulate fraction of parathyroid glands 
exhibited hypercalcemic activity which is characteristic of PTH. 
Moreover, Bauer and Tietelbaum (1966) and Cooper and Tashjian 
(1966) provided evidence that the 100,000 x g particulate frac-
tion of pigs and rats exhibited hypocalcemic activity. 
In the work reported here, the microsomal subcellular prep-
aration was the only fraction which consistently exhibited hypo-
calcemic activity and a maximal hypocalcemic response occurred at 
a dose of 2,000 pg. Microsomal preparations obtained from bio-
synthetic media containing physiological and high calcium concen-
trations were demonstrated to have significant differences in 
hypocalcemic activity when compared to mitochondria and nuclei 
from these biosynthetic media. These experiments with unpurified 
subcellular preparations clearly demonstrated that the microsomes 
were the subcellular locus of this hypocalcemic principle. 
The microsomal CT preparation was not inactivated by heat, 
thereby indicating its thermostability. The ability of this 
preparation to withstand high temperature might be attributed 
to the protective influence of non-specific protein macromolecu-
lar material associated with these crude subcellular preparations. 
However, the microsomal preparation was readily inactivated by 
the proteolytic enzyme, pepsin. These characteristics of the 
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unpurified hypocalcemic principle in the microsomal fraction are 
in accordance with the findings of Tashjian and Warnock (1967) in 
their studies with crude extracts of porcine CT. 
The experiments of Hamilton and Cohn (1969) and Hamilton 
et al. (1971) demonstrated that a labeled amino acid which was a 
--
constituent of bovine PTH could be preferentially incorporated 
into a 100,000 x g particulate fraction which elicited a hyper-
calcemic response when injected into rats. Moreover, the extent 
of incorporation of the labeled amino acid into the hypercalcemic 
fraction was dependent upon the calcium concentration of the bio-
synthetic medium. Incorporation of the labeled amino acid into 
the hypercalcemic fraction was inversely proportional to the 
calcium concentration of the biosynthetic medium, being decreased 
at high calcium concentrations and increased at low calcium con-
centrations. These in vitro observations correlated well with 
the normal physiological response of PTH to hypocalcemia. 
A distinct possibility therefore existed that a tracer amino 
acid, such as glycine-C-14 (a prominent constituent of ovine CT), 
could be incorporated preferentially into the hypocalcemic micro-
somal fraction and that varying the calcium concentration of the 
biosynthetic media might influence the extent of incorporation of 
the labeled amino acid. However, this investigation revealed 
that no such preferential incorporation occurred. Similarly, the 
extent of incorporation of the labeled amino acid into the various 
subcellular fractions was not influenced by the calcium concen-
tration of the biosynthetic medium, since no consistent trend in 
glycine-C-14 incorporation occurred among subcellular fractions 
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obtained from incubation media containing low, physiological, and 
high calcium concentrations. However, it was apparent that gly-
cine-C-14 was being incorporated non-specifically into all of the 
proteins associated with the microsomal, mitochondrial, and nuclear 
preparations and not specifically into the hypocalcemic micro-
somal fraction. 
Although no consistent patterns of incorporation of label 
into subcellular preparations could be discerned, it was readily 
observed from the closely corresponding radioactivity, protein and 
elution peaks, that each of these subcellular fractions was rather 
homogeneous in its protein composition. For, unlike Sorgente's 
observation of multiple radioactivity and protein peaks at the 
tissue level, only a single elution, protein, and radioactivity 
peak was observed for each of these subcellular preparations. 
This clearly indicated that a single subcellular fractionation 
step resulted in more purified protein preparations, especially 
the hypocalcemic microsomal preparation, than had the harsher 
multi-step isolation scheme utilized by Sorgente. This study 
confirmed the feasibility of isolating CT by a completely differ-
ent procedure than the commonly employed extraction method from 
whole thyroid glands. 
Although no consistent patterns in radioactive label incor-
poration were observed, the influence of calcium concentration at 
the subcellular level was very prominent. A high calcium con-
centration (26.o mg%) in the biosynthetic media resulted in a 
highly significant increase in the hypocalcemic response of 
Sephadex G-100 purified microsomal preparations resulting in 
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almost a 2-fold increase in hypocalcemic activity as compared to 
the hypocalcemic response of microsomes obtained from incubation 
media containing physiological and low calcium concentrations 
which decreased serum calcium by approximately 12%. This sub-
stantiated the concept that the effect of calcium ion was a direct 
one at the subcellular level as well as at the whole tissue level. 
No alteration in the hypocalcemic response was detected in 
microsomes obtained from an incubation medium containing a low 
·calcium concentration when the response was compared to that of 
microsomes derived from incubation media containing physiological 
levels of calcium. This indicated, possibly, that a four hour 
period of incubation of thyroid slices at a low calcium concentra-
tion (4.8 mg%) was not adequate time to alter the biosynthetic 
process of the 'C' cells or that a sufficient amount of CT was 
present in the 'C' cells which could not be depleted in four 
hours. A third possibility was that CT biosynthetic mechanism(s) 
was only sensitive to increasing calcium ion concentration in the 
'C' cells and not to calcium levels below physiological levels. 
It was also likely that the 'C' cells of the thyroid continued 
normal CT synthesis from residual unlabeled amino acids in the 
cells during short term (4 hr) calcium deprivation. Since CT bio-
synthesis is significantly enhanced in the microsomal preparations 
obtained from incubation media containing a high calcium concen-
tration, it is possible that calcium ion may exert its effect on 
hormone biosynthesis in a number of ways. High calcium ion con-
centration could possibly enhance the activity of one or more of 
the enzymes involved in the synthesis of the calcitonin molecule. 
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The CT standard could be resolved in both cationic and 
~ anionic polyacrylamide gels. It is possible that two differently 
charged species of the standard porcine CT molecule were present, 
perhaps due to the method of extracting this hormone preparation 
from whole porcine thyroid glands. A more satisfactory explana-
tion is not presently available since the porcine CT extraction 
procedure, utilized by Dr. Robert Schleuter of Armour Pharmaceu-
l ticals, Kankakee, Illinois, is now being patented and is therefore 
not available for inspection. 
The microsomal material could be electrophoretically frac-
tionated only in anionic polyacrylamide gels. It is likely that 
the native ovine molecule was therefore predominantly negatively 
charged since migration of the microsomal material proceeded 
towards tha anode. A slight difference between the porcine and 
ovine CT molecule is that the ovine has an aspartate residue at 
position 15 whereas the porcine molecule has an asparagine resi-
due and this may account for the ability of the ovine molecule to 
be resolved only in anionic gels. 
The homogeneity of microsomal preparations was monitored 
after passage of the microsomal material through Sephadex G-100 
and G-50 chromatographic columns. The Sephadex G-50 purification 
step had removed one of the protein bands seen in the Sephadex 
G-100 preparations. It was also apparent that a large portion 
of the hypocalcemic microsomal fraction was probably macromolec-
ular material which was either uncharged or too large to be re-
solved in the small pore separation gel. Hence, the large quan-
tities of sample required (1,500 pg) to electrophoretically 
t 
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resolve the Sephadex G-100 and G-50 microsomal preparations as 
compared to the standard CT preparation (JJJ ~g). This does not 
present a serious disadvantage since it is likely that the iso-
lation procedure for the standard porcine CT preparation required 
much lar~er quantities of porcine thyroid glands than did the sub-
, 
cellular fractionation procedure utilized in this study to ob-
tain microsomal fractions. 
The microsomal and standard CT preparations were further 
·characterized by isoelectric focusing. This procedure allowed 
the first determination yet reported of the isoelectric points of 
these two molecules. The microsomal preparation was electrophor-
etically resolved into two protein bands having isoelectric points 
of J.49 and J.84 in a pH gradient extending from J to 5. The 
standard porcine CT preparation was also resolved into two protein 
bands having quite similar isoelectric points of 3.70 and J.94 in 
a pH gradient of 3 to 6. The closeness of the isoelectric points 
of the electrophoretically resolved bands of the ovine and porcine 
CT preparations further established the identity of the hypocal-
cemic principle of the microsomal preparation with a standard CT 
preparation. The slight discrepancy in the pI values of the 
resolved band between the two CT preparations may be attributed to 
either the use of a broader pH gradient (pH 3 to 6) utilized for 
resolving the standard CT pr~paration or more likely, to the spe-
cies differences already alluded to in amino acid composition of 
the CT molecule. This may result in a slightly different elec-
trophoretic resolution of the porcine molecule in the electro-
focusing column as compared to the ovine microsomal preparation. 
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Each of the two electrophoretically resolved microsomal pro-
tein bands were found to contain hypocalcemic activity. It was 
--
therefore likely that the highly sensitive resolving power of the 
isoelectric focusing technique had separated two slightly differ-
ent charged species of the same ovine CT molecule. The biological 
assay of electrophoretically resolved microsomal preparations was 
hampered by ampholyte contamination of the protein bands and there-
fore allowed for poor recovery of this purified material. This is 
attributable to the closeness of the molecular weights of the 
largest ampholyte species (M. W. to 1800) as compared to the CT 
molecule having a molecular weight of J600. 
The fact that CT was localized in the microsomal fraction, 
that its biosynthesis is enhanced by high calcium concentrations in 
in vitro biosynthetic media, and that the microsomal hormone prep-
aration was characterized by polyacrylamide gel electrophoresis 
and isoelectric focusing, lays the groundwork for further studies. 
The subcellular fractionation technique may be utilized as an 
alternative large scale hormone isolation procedure for CT and 
possibly for other hormones such as insulin and glucagon of the 
pancreas, should they be associated with a particular subcellular 
fraction. It is an isolation and purification procedure which 
does not involve harsh extraction methods which tend to denature 
or alter the composition of biologically active species. The 
technique would be especially amenable to isolation of highly 
purified CT preparations from ultimobranchial tissues of fish or 
sharks which Copp and his associates have shown to have extremely 
~---------------
r 
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potent CT preparations. This is possible since there is no con-
tamination of the 'C' cells in this tissue with large amounts of 
thyroglobulin, thyroid hormones, and parathyroid tissue as occurs 
with the thyroid 'C' cells in most mammalian species. Moreover, 
the monitoring of labeled amino acid incorporation into a hypo-
calcemic subcellular preparation in an in vitro biosynthetic 
medium such as the one utilized in this study might be more ad-
vantageously studied in a system utilizing homogenates of ultimo-
branchial tissue. There would be two advantages to such a system 
since in a gland homogenate of ultimobranchial tissue, there would 
be fewer membranes present to hinder transport of a labeled amino 
acid and incorporation- of label should proceed more rapidly. 
Secondly, one would not be hindered with the possibility of in-
corporation of tracer amino acid into as many non-specific proteins. 
r 
" 
CHAPTER V 
SUMMARY AND CONCLUSIONS 
From the information provided by the studies of Hamilton 
and Cohn (1969), Hamilton et al. (1971), and Sorgente (1969) on 
--
the il'! yj.._!;ro biosynthesis of parathyroid hormone and calcitonin 
and the experiments of Brown and Ulvedal (1960) which localized 
hormonal activity of anterior pituitary within several subcellu-
lar fractions, it appeared likely that the subcellular locus of 
ovine CT could be determined as well as the influence of calcium 
ion on hormone biosynthesis at the subcellular level. Conse-
quently, ovine thyroid gland slices were incubated in in y..i:tr.£ 
biosynthet.ic medieo_ containing low (4.8 mg%), 'physiological (11.5 
mg%), and high (26.o mg%) calcium concentrations and 2.5 pCi of 
glycine-C-14, which served as a tracer amino acid. After incuba-
tion, the slices were homogenized and mitochondrial, nuclear, and 
microsomal subcellular fractions were obtained by differential cen-
trifugation. 
Microsomal, mitochondrial, and nuclear preparations were 
assayed for hypocalcemic activity at a dose of 2,000 pg. It was 
determined that the microsomes were the subcellular locus of cal-
citonin. A hypocalcemic microsomal preparation which had de-
creased serum calcium level of rats by 25% could not be inactivated 
by heating at 100° C for 2 hours in 0.01 N HCl. However, this 
same preparation was readily inactivated by incubation for 1 hour 
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at J7° C with the proteolytic enzyme, pepsin, at a substratea 
enzyme weight ratio of 10 to 1. These findings are known charac-
teristics of unpurified calcit-0nin preparations. 
Microsom~l, mitochondrial, and n~clear preparations purified 
by passage through a column of Sephadex G-100 were assayed for 
hypocalcemic activity, protein content, and radioactivity. Once 
again, hypocalcemic activity was consistently demonstrated in the 
microsomal preparation. Microsomal preparations obtained from 
the low and physiological calcium concentration incubation media 
reduced serum calcium levels of rats by approximately 12%. How-
ever, a microsomal preparation obtained from a high calcium con-
centration incubation medium decreased serum calcium levels of 
rats by 22.5%, a highly significant increase in hypocalcemic ac-
tivity. These findings indicated that a high calcium concentra-
tion in the in vitro biosynthetic media had stimulated calcitonin 
biosynthesis in the microsomes. The elution, protein, and radio-
activity peaks of the mitochondrial, microsomal, and nuclear prep-
arations corresponded closely. This indicated that the subcellu-
lar fractionation procedure could be effectively utilized as an 
alternative isolation procedure to the whole gland extraction 
methods for calcitonin. However, no preferential incorporation 
of glycine-C-14 into the hypocalcemic microsomal preparation was 
observed. The labeled amino acid was being incorporated non-
specifically into all three of these subcellular preparations. 
Standard porcine and ovine microsomal calcitonin preparations 
were fractionated into their component protein bands by polyacryl-
amide gel electrophoresis. The microsomal fraction was inspected 
r 
I 
for homogeneity in polyacrylamide gels after passage through 
Sephadex G-100 and G-50 chromatographic columns. A comparison of 
the electrophoretic resolutio~ of these preparations in anionic 
gels under identical conditions of milllamperage per gel, elec-
trophoretic resolution time, and acrylamide gel concentration, es-
tablished the identity of the hypocalcemic principle in the micro-
somal preparation with a standard porcine calcitonin preparation 
of known potency. 
The isoelectric points of a microsomal and a standard calci-
tonin preparation of known potency (88 MRC Units per mg) were de-
termined by isoelectric focusing. Fourteen milligrams of Sephadex 
G-50 purified microsomal preparation were electrophoretically re-
solved in a pH gradient extending from pH J to 5 into two protein 
bands having isoelectric points of 3.49 and J.84. Seven milli-
grams of the standard porcine calcitonin preparation were also re-
solved into two protein bands having quite similar isoelectric 
points of 3.70 and 3.94 in a pH gradient extending from pH J to 6. 
The highly sensitive resolving power of this technique was em-
ployed to obtain milligram quantities of each of the two electro-
phoretically resolved protein bands of the microsomal preparation. 
These two protein fractions were both found to possess hypocalce-
mic activity when injected into rats. 
This investigation indicated that the microsomal fraction is 
the locus of ovine calcitonin and that high calcium concentration 
enhances hormone biosynthesis of this fraction. In addition, the 
first deterrninationsof the isoelectric points of standard porcine 
and microsomal ovine calcitonin preparations were established. 
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ABSTRACT 
Abstract of the dissertation entitled "CALCITONIN ACTIVITY 
OF PARTICULATE FRACTIONS OF THE OVINE THYROID GLAND" submitted by 
Peter Rudolf Oeltgen in partial fulfillment of the requirements 
for the degree of Doctor of Philosophy, February, 1973. 
Oyine thyroid gland slices were incubated (4 hr, J7° C) in 
an in vitro biosynthetic medium consisting of a Krebs-Ringer bi-
carbonate buffer (pH 7.4), glucose (320 mg/100 ml), all the amino 
acids of ovine calcitonin (20 mg/l) and glycine-C-14. The incu-
bations were carried out in media containing low (4.8 mg%), phys-
iological (11.5 mg%}, and high {26.o mg%) calcium concentrations. 
After incubation, the slices were homogenized and mitochondrial, 
nuclear, and microsomal subcellular fractions were obtained by 
differential centrifugation. After purifica~ion by passage through 
a column of Sephadex G-100, these fractions were assayed for hypo-
calcemic activity, protein content, and radioactivity. 
Hypocalcemic activity was consistently demonstrated in the 
microsomal preparation. The microsomal fraction was found not to 
be inactivated by heat, but was readily inactivated by incubation 
with the proteolytic enzyme, pepsin, thereby exhibiting known 
characteristics of the molecule. Purified microsomal preparations 
derived from the low and physiological calcium concentration incu-
bation media reduced serum calcium levels of rats by approximately 
12%. However, a microsomal preparation obtained from a high cal-
cium concentration incubation medium decreased serum calcium levels 
of rats by 22.5%, a highly significant increase. The elution, 
r 
protein, and radioactivity peaks corresponded closely. 
Standard and microsomal calcitonin preparations were frac-
tionated into their protein components by polyacrylamide gel 
electrophoresis. The microsomal fraction was inspected fer homo-
geneity in polyacrylamide gels after passage through Sephadex 
G-100 and G-50 chromatographic columns. A comparison of the elec-
trophoretic resolution established the identity of the hypocal-
cemic principle in the microsomal preparation with a standard 
calcitonin preparation of known potency. 
Isoelectric points of the microsomal and standard calci~onin 
preparations were determined by isoelectric focusing. The micro-
somal preparation was electrophoretically resolved in a pH gra-
dient extending from 3 to 5 into two protein bands having isoelec-
tric points of 3.5 and 3;8. The standard ca~citonin preparation 
was also resolved into two protein bands having quite similar iso-
electric points of 3.7 and 3.9 in a pH gradient of 3 to 6. 
The results of this investigation indicated that the micro-
somal preparation was the only particulate fraction of ovine 
thyroid tissue that exhibited calcitonin activity and that high 
calcium concentration enhanced hormone biosynthesis in this frac-
tion. Determination of the isoelectric points of ovine and por-
cine calcitonin was achieved by isoelectric focusing. 
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